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ABSTRACT OF DISSERTATION

Flavin Modification and Redox Tuning in the Bifurcating Electron Transfer Flavoprotein
from Rhodopseudomonas palustris: Two Arginines with Different Roles

Electron bifurcation is considered as a third fundamental mode of energy
conservation mechanism in addition to two well-known mechanisms, substrate level
phosphorylation and oxidative phosphorylation. In electron bifurcation endergonic and
exergonic redox reactions are coupled. The newly discovered flavin based electron
bifurcation in electron transfer flavoproteins (ETFs) helps to reduce low potential
ferredoxin, which provides electrons to drive biologically demanding reactions such as
atmospheric dinitrogen fixation in diazotroph and methane production in methanogens.
Current research demonstrates the capacity for electron bifurcation in the
Rhodopseudomonas palustris ETF (RpalETF) system. RpalETF contains two chemically
identical but functionally different FADs: ET-FAD is bound in highly mobile domain II,
which sits in a stable base created by domains I and III. Bf-FAD is buried in between
domains I and III. The two flavins execute contrasting, complementary electron transfer
reactions. Whereas one mediates single electron transfer (ET-FAD), the other accepts
electrons pairwise (Bf-FAD), yet both flavins’ sites include a conserved Arg sidechain.
R273 favors the anionic semiquinone (ASQ) of ET-FAD, whereas R165 near the Bf-FAD
appears not to, possibly due to neutralization of its positive charge by nearby C174. R273
forms a 𝜋-𝜋 stacking interaction with ET-FAD whereas R165 appears to form hydrogen
bond interactions with Bf-FAD.
To learn whether the active site arginine residues have different effects on their
respective neighboring flavins, we replaced each of the Args in turn with chemically
conservative, and divergent substitutions. We utilized site directed mutagenesis to
specifically replace the residues with Gln (nearly isosteric to Arg and polar), Lys
(positively charged like Arg but lacking a bidentate H-bonding capability), His (having a
pKa closer to 7 so that its charge is tunable by solution pH), and Ala (a nonpolar small side
chain that serves as a control). Our data show, R273 plays a vital role in Bf-ETF by
stabilizing the ASQ of the ET-FAD, whereas R165 favors binding of the Bf-FAD that is
essential for electron bifurcation in RpalETF.

Along with the electron bifurcation studies, we report an irreversible, pH
dependent, site selective, enzyme mediated, anaerobic chemical modification of ET-FAD
to a pink amino FAD, which opens a new perspective with which to understand the 726
nm band formed in bifurcating ETF.

KEYWORDS: Bifurcating electron transfer flavoproteins, Electron bifurcation, Active
site arginine residues, Reduction midpoint potential, Flavin chemical
modification, Amino flavin
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CHAPTER 1. INTRODUCTION

1.1.

Flavins and flavoproteins

Flavins are yellow-colored organic cofactors found in flavoproteins. Since the time of their
initial characterization in the 1930s, flavin adenine dinucleotide (FAD), flavin
mononucleotide (FMN) became established as the most common versions of this cofactor
found in flavoproteins1. Although many bacteria, plants and yeasts can synthesize the
riboflavin precursor (vitamin B2), human and animals must consume it in their diet2.
Among the hundreds of identified flavoproteins, most contain non-covalently bound FAD
or FMN, but in 10% of flavoproteins FMN or FAD is covalently attached to either His,
Cys, or Tyr residue(s). FAD is found in a majority of cases and only 25% of flavoproteins
contain FMN3.

ADP

Riboflavin

Figure 1. 1: Chemical formula of FAD and its constituents.

1

The tricyclic isoalloxazine ring in FMN and FAD is the catalytically active moiety and
consists of a hydrophobic xylene ring (ring 1, see Figure 1.2), a hydrophilic
dihydropyrazine (ring 2) and an electronegative pyrimidine ring (ring 3)4. Based on more
than 40 flavoprotein crystal structures, the majority of the flavin-protein interactions are
via the N10-ribityl side chain and the pyrophosphate, which binds to the most conserved
residues in the flavoprotein family1, 5. However, the isoalloxazine ring forms strong
hydrogen bonding interactions via N1, C(2)O, N3, C(4)O and N5, thus increasing the
flavin’s tendency to reduction6. Because of the flavin’s chemical versatility, flavoproteins
can be involved in oxidation, reduction, energy production, light emission, detoxification,
protein folding, biodegradation, biosynthesis, apoptosis, and DNA repair processes7.
However due to their redox-active cofactor, the majority of flavoenzymes are
oxidoreductases3.

1

2

3

Figure 1. 2: Molecular labelling of isoalloxazine ring. R is the side chain containing ribose
sugar and Adenosine diphosphate (ADP) in FAD.

1.2.

Redox properties of flavins

Flavins are capable of one- and two-electron transfer reactions. The isoalloxazine ring is
the site of flavin catalyzed enzymatic reactions, and the oxidized flavin is particularly
susceptible to nucleophilic attack at N5 and C4a (Figure 1.2)5. Its extended conjugation is

2

not only responsible for the yellow color but also enables it to accept and donate one or
two electrons during redox catalysis1. This implies that oxidized (OX) flavin forms a
semiquinone (SQ) upon accepting an electron, or a hydroquinone (HQ) upon accepting two
electrons. Free in solution at pH 7 (when not enzyme bound) flavin only accumulate to ≈
1% in the SQ state because the reduction potential (E°) of the OX/SQ couple (E°’OX/SQ = 313 mV) is smaller than that of the SQ/HQ couple (E°’SQ/HQ = -101 mV)8, 9. Moreover, the
2e reduction potential (E°’OX/HQ = -207 mV)8 of free flavin is higher than that of the
pyridine nucleotides, NADH and NADPH (E°’ = -320 mV)4 therefore, free flavin accepts
electrons pairwise to produce the HQ state from OX (Figure 1.3 shows reduction of
oxidized authentic FMN to HQ when free in solution). During the reduction of OX flavin,
absorbance at 450 nm (band 1) and 374 nm (band 2) decreases as the less strongly
absorbing HQ accumulates.

band 1
band 2

Figure 1. 3: Reduction of authentic FMN in solution with sodium dithionite. Around 76
µM of FMN in 400 µl of buffer containing 20 mM bis-Tris Propane, 200 mM KCl, and
10% (w/v) glycerol at pH 8.

3

However, the E°’s of protein-bound flavin can greatly vary from +153 mV10 to -430 mV11
due to the interactions of amino acid side chains with the isoalloxazine ring. These play a
crucial role in tuning the reactivity of the flavin. In general, a positive charge is believed
to increase the flavin E°s and a negative charge, or a hydrophobic environment are expected
to lower them12. The SQ can exist as a neutral SQ (NSQ) or an anionic SQ (ASQ) with an
estimated pKa value of 8.55 for flavin free in solution8. Upon binding to a specific protein,
depending on the pH and the interactions with the isoalloxazine ring in the protein’s
binding pocket, either ASQ or NSQ may be stabilized and accumulate midway through
reductive titrations. Some enzymes suppress the SQ while others stabilize it to populate
100% of sites. In latter case, protein may stabilize NSQ over a broad range of pHs where
protein is stable. In such cases the flavin pKa would be shifted from 8.55 to higher than
12.51, 13. On the other hand, if the protein stabilizes ASQ, the flavin pKa is significantly
lower1.

4

A

OX

NSQ

ASQ

B

HQ

C

Figure 1. 4: Oxidation and protonation states of isoalloxazine ring: Typically, isoalloxazine
can exist in four different oxidation/protonation states, A) Oxidized Glucose Oxidase
(GOx) from Aspergillus niger reduction at pH 9 in 20 mM bis-Tris-Propane buffer, 200
mM KCl, 10% (w/v) glycerol, accumulating ASQ. B) ASQ state of GOx reduces to HQ
state. C) Reduction of oxidized flavodoxin from D. vulgaris at pH 7.4 in 20 mM bis-TrisPropane buffer, 200 mM KCl, 10% (w/v) glycerol, accumulating NSQ. In all cases the
initial OX spectrum is blue-violet and the final one is brick-red.

5

During a sequential reduction of flavin, the yellow oxidized flavin can accumulate either
as red ASQ radical or blue NSQ radical upon accepting an electron. The reduction
significantly changes the absorption spectrum of oxidized flavin, and the different SQ
states can be easily distinguished by their characteristic absorption peaks (increased
absorbance at 374 nm or near 600 nm). During the reduction band 1 intensity decreases at
454 nm and band 2 amplitude increases at 374 nm for ASQ (Figure 1.4A). NSQ forms a
distinct diagnostic absorption peak at longer wavelength from 500 - 700 nm (Figure 1.4C).
Further reduction by second electron produces the colorless HQ state, both band 1 and 2
intensities decrease (Figure 1.4B).
Flavins not only facilitate protein purification, but also ensue biochemical characterization.
Characteristic spectral features and large spectral differences between the various flavin
oxidation states make it easy to monitor the events occurring in the course of flavoprotein
catalysis. In this thesis, the redox tunability, optical activity, and chemical versatility of
flavins were utilized to study the electron bifurcation mechanism in electron transfer
flavoproteins (ETFs) and chemical modification of the isoalloxazine ring.
1.3.

Electron transfer flavoproteins

Electron transfer flavoproteins (ETFs) are a large group of heterodimeric, FAD-containing
proteins14. Biochemical characterization shows that the majority of the well-characterized
ETFs conduct single-electron transfer reactions15. Members of the ETF family include the
mitochondrial EtfAB proteins (the subunits are known as A and B or α and β in earlier
literature), they are involved in lipid and amino acid metabolism16. This family of ETFs
has been shown to accept electrons from up to 10 different acyl-CoA dehydrogenases and
transfer them to ETF-quinone oxidoreductase (ETF-QO), which then conveys the electrons
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to the respiratory electron transport chain. In addition to the ETFs work with ETF-QO,
some bacterial ETFs are involved in more specialized metabolism, such as trimethylamine
oxidation by methylotrophic bacterium14. Other ETF homologs were found in nitrogen
fixing and diazotrophic bacteria, where their genes are called fixA and fixB with reference
to nitrogen fixation. Sequence homology studies by Weidenhaupt et al. demonstrate that
FixA and FixB are equivalent to EtfB and EtfA, respectively17. In an effort to simplify the
nomenclature, our published work introduced a new nomenclature based on the size of the
subunits (Chapter 2), wherein the larger subunit is called EtfL (=ETFA/FixB) and the small
subunit is called EtfS (=ETFB/FixA)18. In addition to FixA and FixB, FixC and FixX are
associated with nitrogen fixation. FixC corresponds to a truncated ETF-quinone
oxidoreductase while FixX is a Ferredoxin (Fd) like protein. Thus, FixC and FixX are
together homologous to ETF-QO. ETFs are also known in archaea19. In summary, ETFs
interact with variety of electron donors and acceptors, throughout the kingdoms of life15.
Members of the ETF family have been divided into groups based on sequence homology
and functional identity (detailed discussion is in Chapter 3). Group I ETFs are well studied
ETFs, including mammalian mitochondrial ETFs and some bacterial ETFs16, 17. They
accept electrons from dehydrogenases and transfer electrons to ETF-QO. Among the
Group 1 ETFs, the three-dimensional structures of human ETF and Paracoccus
denitrificans ETF are nearly identical20, 21. Group 2 ETFs include FixAB from nitrogen
fixing organisms. A well-studied Group 3 ETF is from Methylophilus methylotrophus
(Mmet) strain W3A116.
Based on their three-dimensional structures, heterodimeric ETF contains three domains.
Domain I is composed of N-terminal region of ⍺ (L) subunit and is not involved in cofactor
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binding20, 21. Whereas Domain III is entirely made up of β (S) subunit and contains an AMP
molecule deeply buried. Domains I and III together form a shallow bowl where Domain II
sits21. Domain II is composed mostly of the C-terminal half of the ⍺ (L) subunit and the
C-terminus of the β (S) subunit. Domain II incorporates a single FAD molecule bound by
residues from the ⍺ (L) subunit. This region is highly conserved in entire ETF family15, 16
(Figure 1.5). The FAD molecule in these ETFs is involved in the electron transfer reactions,
whereas the AMP plays a structural role16. Group 1 ETFs containing one FAD and an AMP
are known as canonical ETFs15.

Domain II

ET-FAD
Domain I

Domain III

AMP

Figure 1. 5: Ribbon diagram of the crystal structure of Paracoccus denitrificans ETF (1efp.
pdb)21.

In addition to canonical ETFs, ETFs containing two FADs from Acedaminococus
fermentans, Megasphaera elsdenii, Acetobacterium woodii, Azotobacter vinelandii,
Rhodopseudomonas palustris, Pyrobaculum aerophylum, Thermotoga maritima, and
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Clostridium kluyveri have been identified, and they are Group 2 ETFs15. These are known
as bifurcating ETFs (Bf-ETFs). The AMP portion of the second FAD binds in place of the
AMP of canonical ETFs in Domain III, and the FMN portion of binds in the interface
between Domains I and III. Thus, unlike the case in canonical ETFs, Domain I of Bf-ETFs
participates in cofactor binding4 (Figure 1.6). Bf-ETFs engage in flavin based electron
bifurcation (FBEB)22. We study FBEB in the Rhodopseudomonas palustris (Rpal) ETFAB
system.

Domain II
ET-FAD

Domain III

Domain I

Bf-FAD

Figure 1. 6: Ribbon diagram of bifurcating ETF (RpalETF) based on the structures of
Acidaminococcus fermentans ETF (AfeETF, 4KPU.pdb)4.
1.4.

Electron bifurcation

In higher organisms, solar energy is conserved in the form of chemical energy by two
fundamental energy conservation mechanisms, substrate level phosphorylation and
transmembrane potentials generated by electron transport. Most anaerobic microbes lack
the option of an respiratory electron transport chain, and so produce less energy in the form
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of ATP23. However, anaerobic organisms can survive with less ATP and use low potential
reduced ferredoxin (Fd) to provide driving force in energy metabolism in addition to being
an electron transfer reagent22-24. For example, many anaerobic organisms produce butyrate
during their energy metabolism23-25. In this process reduction of high potential crotonylCoA to butyryl-CoA by NADH is coupled to production of reduced low-potential Fd. This
reaction is catalyzed by Bf-ETF complexes. As the name implies, ETF participates in
transferring electrons from NADH, however it is also coupling two different reactions,
unlike canonical ETFs4, 22-25.
Electron bifurcation is considered as a third mode of energy conservation, in which a
thermodynamically unfavorable endergonic reaction is coupled to an exergonic reaction.
Energy released by the favorable reaction is used to drive the endergonic reaction, so that
the net reaction is favorable22. This natural process was first described by Peter Mitchell
(1976) in the ubiquinone cycle catalyzed by complex Ⅲ in aerobic respiration, where it
doubles the efficiency of electron transfer’s ability to produce a proton motive force4, 22. In
contrast to quinone based electron bifurcation, FBEB was first identified by Wolfgang
Buckel and Rolf Thauer in 20084, 22-25. Flavin based electron bifurcation plays a crucial
role in several energy limited anaerobic organisms, and some authors suspect that electron
bifurcation was operative even at the origin of life4, 22, 23.
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Figure 1. 7: Scheme showing flavin based electron bifurcation mechanism in Bifurcating
ETFs containing ET-FAD (yellow) and Bf-FAD (Green): Aend is endergonic electron
acceptor such as flavodoxin (Fld) and Fd, Aex is the exergonic electron accepter such as
crotonyl-CoA to butyryl-CoA BCD-complex.
1.5.

Flavin based electron bifurcation (FBEB)

The best studied flavin based electron bifurcating system is the electron transfer
flavoprotein-butyryl-CoA dehydrogenase (ETF-BCD) complex, which catalyzes butyrate
formation reaction in many anaerobes such as Clostridium kluyveri4,

23-25

. ETF-BCD

complex bifurcates the two electrons it receives from NADH (NADH/NAD⁺, E⁰’ = -320
mV) to two different pathways, with one electron participating in the exergonic reduction
of crotonyl-CoA to butyryl-CoA (E⁰’ = -10 mV) and the other passing to Fd or Fld in a
reduction that would be endergonic (E⁰’= -402 mV) if conducted alone

4, 24, 25

. Based on

current knowledge, Bf-ETFs have two flavins: a bifurcating flavin (Bf-FAD, as shown in
Figure 1.6) and an electron transfer flavin (ET-FAD)4, 26, 27 as shown by our published work
described in Chapter 218. Buckel and Thauer’s mechanism posits that the pair of electrons
from NADH is accepted by Bf-FAD and one of these is transferred via ET-FAD to the
BCD dehydrogenase (operating in reverse to the named reaction). The second electron is
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proposed to go directly from Bf-FAD to ferredoxin (Fd) or flavodoxin (Fld). Repetition of
this process would produce two reduced Fd (Fe4S4) clusters or reduced Fld, plus butyrylCoA4, 23-25.
Many other FBEB systems have been identified since 2008, in anaerobic bacteria and
archaea. These include electron bifurcating transhydrogenase in Clostridium kluyveri,
caffeyl- CoA reductase and lactate dehydrogenase in Acetobacterium woodii, [FeFe]hydrogenases in Thermatoga

maritima, Morella thermoacetica and Clostridium

autoethanogenum, formate dehydrogenase in Clostridium acidurici, and heterodisulfide
reductase in methanogenic archaea24.
1.6.

Biological role of FBEB

The energy rich reduced ferredoxin contributes to reduction of NAD+ or production of
molecular hydrogen from protons, which increases the ATP yield via substrate level
phosphorylation by generating more acetate than the butyrate or lactate22, 24. Moreover,
reduced ferredoxin is important in many diverse reactions of anaerobic metabolism. For
example, nitrogen fixing organisms use ferredoxin as an electron source for the nitrogenase
reaction that converts atmospheric N2 to ammonia needed for production of biological
building blocks such as DNA, RNA, and proteins22, 23, 28. In methanogenic archaea, H2/CO2
is converted to methane with the help of reducing equivalents from ferredoxin. Therefore,
FBEB plays a very important role in anaerobes. Because flavins remain abundant in modern
aerobes, and because the anaerobes perform diverse chemistry with great importance to
energy conservation and climate, it is important to understand this pervasive and potent
mechanism that has only recently been exposed. The ETFs are a convenient system in
which to do so because this ubiquitous unit participates in a broad range of complexes so
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understanding one of them can be expected to provide insight into all of them.
The crystal structure of EtfAB from Acidaminococcus fermentans (Afe) revealed that
distance between the two flavin isoalloxazine rings is 18 Å, which is too distant for direct
electron transfer4. In addition, although the ETF-NAD+ complex structure showed Hbonding between the AMP-ribose portion of NAD+ and the protein, the interaction
between NADH and the Bf-FAD site could not be resolved. Nevertheless, these data
confirm binding of NADH near the Bf-FAD and therefore direct reduction of Bf-FAD by
NADH. The authors propose that dynamics of domain II resolve the distance problem by
bringing ET-FAD 14 Å closer to Bf-FAD, and thereby facilitating transfer of one electron
from the Bf-FAD HQ to the ET-FAD. The resulting ASQ of the Bf-FAD would then
donate its remaining electron to Fd4. The above m echani sm follows naturally from
the E°s of free flavin, E°’OX/ASQ = -313 mV, E°’ASQ/HQ = -101 mV, E°’OX/HQ = -207 mV8,
because the OX/ASQ redox couple is much more negative than the OX/HQ couple,
indicating that, conditions that favor semiquinone formation, actually favor its further
reduction even more, so that it is not stable (and therefore reactive). This is a requirement
for FBEB to be able to donate an electron to the much lower potential ferredoxin (≤420
mV)25.
The thermodynamic landscape underlying ETF-mediated electron bifurcation can be studied by
determining the E° values. Midpoint reduction potentials for the bound flavins of the ETFBCD complex from Megasphaera elsdenii have been measured, E°’OX/ASQ = +81 mV,
E°’ASQ/HQ = -136 mV, E°’OX/HQ = -280 mV26. These values are consistent with electron flow
from NADH to crotonyl-CoA based on the proposed mechanism. Extending beyond
MelsETF, Duan et al., Schut et al. tested the thermodynamic foundation for bifurcation in
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other ETFs by determining the E°s in Rhodopseudomonas palustris (Rpal) and
Paerobaculum aerophylum (Pae) ETFAB, respectively19, 29. In addition to these groups,
Sucharitakul et al. determined the E° values of AferETF as well as its complexes with BCD
and Fd, showing that the quarternary structure of the complex affects the E°s30.
E° values determined in PaeETF support the same proposed mechanism19. The E° observed
for Ox/HQ in Bf-FAD is -285 mV, more positive than that of NADH/NAD+ (E° = -320
mV), confirming that NADH can donate electrons to Bf-FAD. The E°s of the Ox/ASQ and
ASQ/HQ redox couples of ET-FAD are -94 mV and +33mV, respectively, meaning that
Bf-FAD can donate an electron to ET-FAD, regardless of which state it is in, with plenty
of driving force to spare. Moreover, the E° values (+33, -94, -285 mV) in PaeETF are
comparable to those of Megasphaera elsdenii ETF, and ensure that the envisioned electron
transfers are thermodynamically favorable, yet still energy conserving. Based on the
determined E° values in PaeETF, the ET-FAD accumulates in the ASQ state and then
acquires a second electron to form HQ. However, the Bf-FAD undergoes two-electron
reduction from its OX state to the HQ without accumulation of any stable SQ state.
In Duan et al. 2018, E° values were determined at pH 9 in bis-Tris Propane (BTP) buffer29,
wherein we now suspect based on spectral features that a novel flavin derivative may have
been present (Discussed in Chapter 4). Therefore, the E° of both ET-FAD and Bf-FAD
were determined at pH 8 (Discussed in Chapter 3). The new values are slightly different
from the old values but they both support the hypothesis of FBEB. Crucially, the high E°
we obtained for the ET-FAD’s OX/ASQ couple indicates that this flavin rests in the ASQ
state in vivo. This means that the ET-FAD is only capable of accepting one more electron
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and guarantees that the second one will be constrained to transfer to the low-E° acceptor,
Fld or Fd. Thus, our measured E°s inform on the efficiency of FBEB.
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Figure 1. 8: Ribbon diagram of bifurcating ETF (RpalETF) based on the structures of
Acidaminococcus fermentans ETF (AfeETF, 4KPU.pdb)4: Based on the calculated E°
values in Duan et al.29, the electron flow during the FBEB is shown here.

This highly attractive RpalETF model was tested in a different approach by removing the
Bf-FAD from the RpalETF (Chapter 2). Here our goal was to demonstrate the function of
individual flavin in the absence of other flavin’s contribution. Our findings show that ETFAD still acts as a higher potential acceptor in the absence of Bf-FAD and NADH was
unable to bind to the Bf-FAD binding site. Crucially, this study tested the locations of each
of the two flavin functionalities in the structural models. By targeting a known site by sitedirected mutagenesis, it was possible to unambiguously assign the other one to retained
functions.
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Both Bf-FAD and ET-FAD are chemically identical but functionally different. ET-FAD
accumulates an ASQ intermediate, whereas SQ formation is thermodynamically
suppressed in Bf-FAD. These contrasting redox behaviors of the two flavins in this system
in turn point a spotlight on the roles of active site residues in tuning the reactivity of the
bound flavins. Paradoxically, both active sites contain a conserved arginine residue, even
though the two sites produce different reactivity. This raises a question as to whether these
two conserved positively charged active site arginine residues have different effects in the
two binding sites. To test this hypothesis, variants with different chemical identities were
generated and the E°s were determined (Discussed in Chapter 3).
1.7.

Chemical modifications of flavins in RpalETF

The large majority of flavoenzymes contain non-covalently bound FAD or FMN as the
coenzyme31. Another set of flavoproteins contain covalently bound flavin, and this covalent
linkage is mainly via the xylene ring. In covalently attached flavins, either the C8 or the
C6 position tends to be modified and attached to an amino acid side chain to form 8histidylflavin, 8-cysteinylflavin, or 6-cysteinylflavin32. Apart from covalently bound
flavins, other naturally occurring riboflavin derivatives have been described, such as the
coenzyme 5-deazoflavin, F420. This plays a central role in archaeal methanogenesis and
used by Streptomyces species in antibiotics biosynthesis33. Streptomyces davawensis and
Streptomyces Cinnabarinus also synthesize an 8-dimethylated-aminoriboflavin derivative
called roseoflavin which is the only known flavin with an antibiotic activity34, 35. During
isolation of the ETF from Megasphaera elsdenii (formaly known as Peptostreptococcus
elsdenii), non-covalently bound riboflavin derivatives, 8-OH-FAD and 6-OH-FAD were
identified in addition to normal FAD in the purified protein36, 37. 6-OH-FAD was also found
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during purification of the pig liver glycolate oxidase36. In addition to these flavin
derivatives, spontaneously formed 8-formyl-FAD (8f-FAD) has been found in wild-type
(WT) human ETF and pig ETF, and formate oxidase38-44.
In this work we report the solvent accessibility and susceptibility of ET-FAD of RpalETF
to chemical modifications (in Chapter 4). Similar to homologous human ETF and pig ETF,
RpalETF forms 8f-FAD. In addition, RpalETF can produce a novel amino flavin derivative
under anaerobic conditions. The precursor for this conversion is our amine buffer
(confirming the previously reported solvent accessibility of the ETF flavin in Domain II45).
Furthermore, we prove here that the amino flavin derivative is responsible for the
remarkable Charge Transfer (CT) band demonstrated in Duan et al. 202046.

17

Roseoflavin

8-OH-FAD

6-OH-FAD

8f-FAD
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Tris

Figure 1. 9: Flavin derivatives and amine buffers.
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acid (ADA)

Table 1. 1: Abbreviations
Full name

Abbreviations

Flavin adenine dinucleotide

FAD

Flavin mononucleotide

FMN

Adenosine monophosphate

AMP

Adenosine diphosphate

ADP

Oxidized

OX

Semiquinone

SQ

Neutral semiquinone

NSQ

Anionic semiquinone

ASQ

Rhodopseudomonas palustris

Rpal

Electron transfer flavoproteins

ETF

bis-Tris-Propane

BTP

N-(2-acetamido) iminodiacetic acid

ADA

Flavin based electron bifurcation

FBEB

Sodium dithionite

NaDT

Xanthine Oxidase

XO
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CHAPTER 2. SPECTROSCOPIC AND THERMODYNAMIC EVIDENCE OF THE
LOCATIONS OF THE FADS IN THE NITROGEN FIXATION-ASSOCIATED
ELECTRON TRANSFER FLAVOPROTEIN
Reproduced from Ref18 with permission from the Royal Society of Chemistry.
2.1

Abstract

Flavin-based electron bifurcation allows enzymes to redistribute energy among electrons
by coupling endergonic and exergonic electron transfer reactions. Diverse bifurcating
enzymes employ a two-flavin electron transfer flavoprotein (ETF) that accepts hydride
from NADH at a flavin (the so-called bifurcating FAD, Bf-FAD). The Bf-FAD passes one
electron exergonically to a second flavin thereby assuming a reactive semiquinone state
able to reduce ferredoxin or flavodoxin semiquinone. The flavin that accepts one electron
and passes it on via exergonic electron transfer is known as the electron transfer FAD (ETFAD) and is believed to correspond to the single FAD present in canonical ETFs, in domain
II. The Bf-FAD is believed to be the one that is unique to bifurcating ETFs, bound between
domains I and III. This very reasonable model has yet to be challenged experimentally.
Herein we used site-directed mutagenesis to disrupt FAD binding to the presumed Bf site
between domains I and III, in the Bf-ETF from Rhodopseudomonas palustris (Rpal). The
resulting protein contained only 0.80 ± 0.05 FAD, plus 1.21 ± 0.04 bound AMP as in
canonical ETFs. The flavin was not subject to reduction by NADH, confirming absence of
Bf-FAD. The retained FAD displayed visible circular dichroism (CD) similar to that of the
ET-FAD of RpalETF. Likewise, the mutant underwent two sequential one-electron
reductions forming and then consuming anionic semiquinone, reproducing the reactivity
of the ET-FAD. These data confirm that the retained FAD in domain II corresponds the
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ET-FAD. We conclude that the site in domain II harbors the ET-FAD whereas the mutated
site between domains I and III is the Bf-FAD site.

2.2

Introduction

The term ETF denotes a family of electron transfer flavoproteins that convey electrons
between redox enzymes and compounds in energy metabolism15,
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. Their shared

heterodimeric structure is described by three domains, as shown in Figure 2.120, 21. The
most familiar ‘canonical’ ETFs function in mitochondria receiving electrons from diverse
acyl-CoA dehydrogenases and passing them one at a time to the quinone pool via an ETFquinone oxidoreductase16.These are the group 1 ETFs15. Recently, some ETFs have been
discovered to possess electron transfer bifurcating activity: ability to accept a pair of
electrons from NADH and use one to generate a strong reductant such as flavodoxin
hydroquinone (HQ) or reduced ferredoxin. This endergonic electron transfer is paid for by
exergonic transfer of the other electron to a strong electron acceptor via a corresponding
partner enzyme, such as a quinone reductase in the case of ETFs associated with nitrogen
fixation4, 15, 19, 28, 47, 48. The bifurcating ETFs identified so far are all members of group 215.
Their capacity to redistribute energy among electrons allows proprietor organisms to
employ abundant mid-range reductants to drive demanding reactions that require greater
reducing power28. Thus, life-limiting processes such as nitrogen fixation (E°’ = - 400 mV)
are made possible based on NADH (E°’ = -320 mV)49.
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Figure 2. 1: Ribbon diagrams of bifurcating ETF (Bf-ETF, left) and a canonical ETF (right)
based on the structures of Acidaminococcus fermentans ETF (AfeETF, 4KPU.pdb)4 and
Paracoccus denitrificans ETF (PdeETF, 1EFP.pdb)21. The FAD common to all known
ETFs is in yellow stick Cs with CPK coloring of other atoms, whereas the second FAD
found only in Bf-ETFs is in green and the AMP that replaces it in canonical ETFs is in
magenta. The central inset highlights in red the two Thr residues of RpalEtfS that were
replaced by Ala in our T94A.S/T97A.S variant (‘T94/97A ETF’). These Thrs are conserved
among Bf-ETFs and shared by AfeETF. Arcs indicate the three domains of the ETF fold.
Domain I is formed by the large subunit (EtfL, dark blue) while domain III is formed by
the small subunit (EtfS, light blue). Domain II is composed primarily of EtfL but EtfS also
contributes its C-terminal helix. Domain II is understood to adopt different orientations
relative to the base formed by domains I and III47. This and other molecular graphics were
produced using chimera50.

A subgroup of Bf-ETFs is found associated with nitrogen fixation and members are
therefore named ‘Fix’ (subgroup 2d ETFs15). Although our system of study is the FixAB
of Rhodopseudomonas palustris, we retain the ETF notation because our work applies to
Bf-ETFs in general. All known ETFs contain FAD bound in domain II (the domII site,
Figure 2.1), but the Bf-ETFs possess a second FAD whose AMP portion binds in place of
the AMP of canonical ETFs.1 The FMN portion is bound between domains I and III (the
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domI/III site, Figure 2.1)4, 47. The protein imbues the two flavins with distinct properties,
enabling them to play complementary roles. In Bf-ETFs, the flavin that accepts a pair of
electrons from NADH and sends one to each of two pathways is called the bifurcating
flavin (Figure 2.1). Besides the activity of pairwise (2-e) electron transfer reactivity, this
flavin has been shown to have a lower reduction midpoint potential (E°)29. The other flavin
is believed to mediate single-electron (1-e) transfers from the Bf-flavin to the electronaccepting quinone reductase of the Fix system28, or other electron accepting enzyme more
generally. Thus, this flavin is known as the electron transfer FAD: ET-FAD29. Both of the
sequential 1-e transfers have E°s above that of the Bf-flavin26, 29. Because this reactivity
resembles that of canonical ETFs, the ET-flavin is believed to occupy the domII site, by
analogy with the sole FAD of canonical ETFs4, 51. By process of elimination, the flavin in
the domI/III site is believed to be the Bf-flavin. Indeed, NAD+ is seen binding near this
FAD in a crystal structure of the Bf-ETF from Acidaminococcus fermentans (AfeETF)4.
Moreover, this FAD is absent from canonical ETFs, which cannot accept electrons from
NADH. Thus, it has become accepted that the Bf-flavin resides in the domI/III site and the
ET-flavin residues in domII. However, this highly attractive model4, 26 remains to be tested
in a hypothesis-driven way. To do so, we employed site-directed mutagenesis to
unambiguously target the domI/III binding site, providing protein localized perturbations
to disrupt binding of one FAD. A combination of spectroscopic and thermodynamic
measurements was then used to test the functional identity of the remaining FAD (Bf-FAD
vs ET-FAD). This strategy additionally exploits the finding that the two FADs of RpalETF
possess distinct UV-vis absorption and visible CD signatures, besides their differing
reactivities29. Our results assign the ET-FAD to the domII site.
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2.3

Results
2.3.1

Mutation of the flavin-binding site between domains I and III

With the objective of disrupting FAD binding to one site with minimal effects on the other,
we targeted the site between domains I and III because canonical ETFs are stably folded
despite lack of a flavin in that site, providing precedent for our goal of a one-flavin ETF.
Mutations were chosen that convert amino acids conserved among Bf-ETFs to identities
found among canonical ETFs, to further increase the likelihood of a well-behaved variant
protein. Nine different mutant fixA and fixB genes were generated and the constructs were
transformed as A–B pairs into E. coli. ETFs with mutations in both monomers were not
sufficiently well expressed or stable enough to characterize, however the double mutant
encoding T94A/T97A EtfS combined with the WT construct encoding EtfL yielded
significant quantities of ETF in the soluble fraction (‘T94/97A ETF’, see Figure 2.1). In
this variant, molecular modelling indicates that our mutations will remove two hydrogen
bonds to the ribose and one to the flavin portion of the domI/III FAD. Thus, the resulting
protein should retain the domII FAD, but bind AMP in domain III in lieu of the domI/III
FAD. T94/97A ETF was purified with the aid of His tags on each subunit, with a typical
yield of 1.25 mg L-1 of culture. AMP was provided in the buffer used during cell lysis to
favor retention or binding of AMP52. Indeed, Sato et al. demonstrated that prior binding of
AMP favors FAD binding to pig ETF53.
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2.3.2 Cofactor content of T94/97A ETF
The T94A and T97A amino acid substitutions were designed to abrogate binding of one of
the two FADs, so total FAD content was quantified by two methods. Based on
fluorescence54, T94/97A ETF contains 0.79 ± 0.05 FAD (n = 2) per dimer. Optical
absorbance suggested similar FAD content of 0.86 ± 0.07 (n = 3) per dimer. Because our
mutations recreate features of the AMP site of canonical ETFs, we also quantified bound
AMP based on the absorbance at 260 nm of cofactors released from the protein, after
accounting for the concentration of FAD (Figure 2.2). We find that there are 1.21 ± 0.04
(n = 3) AMP per dimer. According to Sato et al., AMP can also bind to the FAD binding
site of canonical ETFs52, 53, thus, suprastoichiometric AMP could have occupied a small
fraction of the domII FAD binding sites, however these will not contribute to the visible
range of our optical spectra.
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Figure 2. 2: UV-Vis spectra of cofactors released from 28 μM T94/97A ETF (black),
authentic FAD (blue) and authentic AMP (red). The vertical scale of the authentic FAD
spectrum was adjusted to mimic a concentration 23 μM as for the released FAD spectrum,
and the spectrum of authentic AMP was adjusted to concentration to reproduce a
concentration of 33 μM as for that of released AMP. These concentrations result from the
finding of 0.8 FAD per ETF dimer and 1.2 AMP per ETF dimer.

2.3.3

Visible spectrum of T94/97A ETF resembles that of the ET-FAD of RpalETF

The absorption spectrum of T94/97A ETF was weaker in the visible range than that of WT
RpalETF, consistent with lower FAD content (above) but the signal also had a different
shape, with a much smaller dip between the two bands (Figure 2.3). Although the longwavelength band peaked at 450 nm, as for free FAD, the shorter-wavelength band peaked
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at 394 nm, red shifted by 18 nm from the λmax of free FAD but similar to the λmax near 400
nm observed for ET-FAD in other Bf-ETFs4, 51.

Figure 2. 3: Visible spectra of T94/97A ETF and cofactors released from it, showing that
the released flavin has a spectrum similar to authentic FAD whereas its signal when bound
in purified 37.6 µM T94/97A ETF protein is perturbed, reflecting interactions with the
protein environment.

However, the FAD released from T94/97A ETF upon protein denaturation was
indistinguishable from authentic FAD (Figure 2.3) indicating that the unusual spectral
signature is not a consequence of covalent modifcation40, 55. Indeed, barely separated bands
have been observed in the Bf-ETFs from Afer and Megasphaera elsdenii4, 26.Thus the
unusual signature of T94/97A ETF-bound flavin must be attributed to the protein
environment, and moreover an environment that may be characteristic of Bf-ETFs26. The
barely resolved flavin signal of MelsETF corresponds to the presumed ET-FAD26 as does
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the similar signal from AfeETF because it is reduced at higher E°4. This suggests that
T94/97A’s FAD is the ET-FAD. Because we disrupted the domI/III site, this in turn
suggests that the ET-FAD resides in the domII site.

2.3.4

Circular dichroism spectrum of T94/97A ETF resembles that of ET-FAD of WT
RpalETF

Although the amount of FAD present in T94/97A ETF is compatible with 80% occupancy
of one of the two sites, it is also possible that the FAD is distributed among both sites at
40% occupancy. To learn whether the FAD was predominantly in one of the two sites,
rather than distributed in both, we exploited circular dichroism (CD) signals from the
bound flavins56. Free FAD exhibits very weak CD despite its strong visible absorption56, 57
but can display significant CD in the range 300–500 nm when bound in protein sites57, and
the CD signals vary widely depending on the identity of the protein. Indeed, the two FADs
in WT RpalETF display readily distinguishable CD signals56. Equal distribution of FAD
between the two sites in T94/97A ETF should produce a CD spectrum similar to that of
WT RpalETF but weaker, whereas occupation of just one of the two sites should reproduce
one or the other of the signals from single sites. Indeed, the visible CD spectrum of
T94/97A ETF closely matches that of the ET-FAD (Figure 2.4), at two different pHs
(Figure. 2.5). Thus, T94/97A ETF retains predominantly the ET-FAD, and we confirm that
ET-FAD is located in the domII site because the other site was mutated to favor binding of
AMP over FAD. Consistent with possession of only ET-FAD, T94/97A ETF was not
reduced upon addition of NADH (Figure 2.6)26. Similarly, NADH does not reduce
canonical ETFs26, although WT RpalETF is rapidly reduced by NADH demonstrating an
aspect of bifurcation activity that is attributed to the Bf-FAD26, 29. Thus, failure to react
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with NADH indicates absence of the Bf-FAD from T94/97A ETF, consistent with the CD
signal and FAD quantitation, and confirms that the domI/III site would normally contain
the Bf-FAD.

Figure 2. 4: Visible CD spectrum of T94/97A ETF (in purple) in the oxidized (OX) state,
compared with control spectra. These are (in red) the spectrum of WT RpalETF in which
only the Bf-FAD is OX (the ET-FAD is HQ and therefore makes very little contribution),
and (in black) the CD signal of the ET-FAD from WT RpalETF. The latter was obtained
by collecting the CD spectrum of fully OX RpalETF and then subtracting away the
contribution of Bf-FAD (red) to reveal the contribution of the ET-FAD.3 The CD spectrum
of the FAD in T94/97A ETF shows better agreement with the ET-FAD CD signal vs. the
Bf-FAD CD signal. Note that vertical offsets of 250 were applied to the two WT RpalETF
signals in order to avoid overlap with the spectrum of T94/97A ETF.
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Figure 2. 5: CD spectra of T94/97A ETF at pHs 8 and 9. Most of the data in this thesis
were collected at pH 8, in order to suppress formation of 8-formyl flavin. However
corresponding data on WT RpalETF were collected at pH 9. Comparison of the visible CD
spectra demonstrate that the flavin electronic structure of T94/97A ETF is not significantly
different at pH 8 than at pH 9, so comparisons can be made between pH 8 T94/97A
RpalETF and pH 9 WT RpalETF.
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Figure 2. 6: Visible spectra documenting the result of stepwise addition of NADH to 35
μM T94A/T97A ETF. The signature of oxidized flavin persisted despite accumulating
NADH, but the protein began to aggregate at high [NADH] (note rising baseline, especially
at short wavelengths).

2.3.5

Redox activity of T94/97A ETF

While the CD signal indicates that the flavin experiences a similar protein environment in
T94/97A ETF as the ET-FAD of WT RpalETF, we also tested its functionality. We
expected that the FAD of T94/97A ETF should have reactivity resembling that of the ETFAD of WT RpalETF, but perturbed reactivity would be evidence of long-range coupling
between the two flavin sites. Specifcally, the ET-FAD is expected to accept electrons one
at a time, forming an ASQ before adopting a HQ state. Figure 2.7 shows that the domII
FAD of T94/97A ETF retains the characteristic 1-e activity of the ET-FAD, undergoing
reduction by dithionite or reducing equivalents from xanthine oxidase (via a mediator) to
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form ASQ, as indicated by growth in intensity near 374 nm and at wavelengths longer than
500 nm. Further reduction caused diminution of intensity at 374 nm. Thus, dithionite
titration of T94/97A ETF showed a biphasic titration profile (Figure 2.7). The protein's
instability upon full reduction to HQ resembles behavior reported for the ET-FAD in
MelETF51 Thus, the domII FAD of T94/97A ETF retains the type of reactivity expected
for ET-FAD upon mutation of the domI/III site.

Figure 2. 7: Visible spectra observed in the course of stepwise reduction of T94/97A ETF
with dithionite, and plot of the absorbance (A374) illustrating the change in the nature of the
reaction after dithionite exceeded 1 eq. In the first phase of reduction A374 increases,
whereas in the second it decreases. The concentration of ETF-bound FAD was 34 µM.
2.3.6

Reduction midpoint potentials of T94/97A ETF

We quantified ET-FAD reactivity in T94/97A ETF by measuring the E° associated with
reduction of the oxidized (OX) state to the anionic semiquinone (ASQ), E°OX/ASQ. In
titrations of WT RpalETF, the optical signals of the two FADs are overlapped so the spectra
did not reveal which flavin was undergoing reduction. However, this ambiguity is absent
from the T94/97A ETF because only the domII FAD is present. E°OX/ASQ was determined
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using anaerobic spectro-electrochemical titrations and xanthine/xanthine oxidase to deliver
reducing equivalents in the presence of mediator and the reference dye methylene blue
(MB)58. Figure 2.8 shows that the log of the ratio of the OX to reduced (RED) fractions of
[OX]

dye adherers to a linear correlation vs. the analogous log ratio for the FAD 𝑙𝑜𝑔 ([ASQ]) as
expected from the Nernst equation. The slope of 0.49 agrees well with the theoretical value
of 0.5 expected for 1-e reduction of FAD consistent with the appearance of ASQ features
in the optical spectra. The intercept of the line yielded an E°OX/ASQ of - 7 ± 4 mV at pH 8.0
(average over three separate experiments), based on an E° of - 19 mV for MB at this pH59.
This is higher than the corresponding E°OX/ASQ of WT RpalETF of - 47 mV29, revealing a
long–range effect of the amino acid substitutions and/or absence of a flavin in the domI/III
site.
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A

Figure 2. 8: A) Difference spectra observed in the course of reductive titration of T94/97A
ETF (374 and 450 nm) and methylene blue (664 nm). Each difference spectrum shown is
an observed spectrum minus the spectrum at the end of the first phase of reduction (Figure
2.7). The difference spectra thus emphasize changes associated with the reduction of OX
to ASQ. B) plot of log ([oxidized FAD]/[reduced FAD]) for the flavin of T94/97A ETF vs
analogous quantity for the dye illustrating linear behavior consistent with the Nernst
equation. The slope near 0.5 is consistent with a 1-e event. The best fit is y = 0.491x0.126.
R2 = 0.996.

2.4

Discussion

RpalETF is a group 2 ETF, along with all the ETFs known to bifurcate and to contain two
FADs19, 51. This and the close association of the fixA and fixB genes with a gene apparently
encoding an ETF-quinone oxidoreductase as well as genes for nitrogen fixation15 indicate
that the RpalETF is a Bf-ETF15. Our work builds on elegant experiments by Shiga's team
wherein replacement of the more tightly-bound flavin with a covalently modified analog
was used to demonstrate that electron transfer from NADH flows to that FAD and thence
to the other one (‘FAD-2’)26. This implied that FAD-2 was the ET-FAD. In complementary
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work Chowdhury et al. observed the adenine portion of NAD+ bound near the domI/III
FAD suggesting that it is the one that accepts hydride, consistent with the fact that it is the
flavin whose presence distinguishes Bf-ETFs from canonical ETFs.
Herein, we have confirmed experimentally that the FAD bound in domII, corresponding to
the single FAD of canonical ETFs21 is indeed the one with the higher E°s characterizing
sequential 1-e events29, the ET-FAD4, 25, 29. Because our T94/97A ETF retains the very
weak CD signal and barely resolved absorbance spectrum of ET-FAD, these too are
confirmed to reflect the domII site. The domI/III FAD whose binding site we perturbed
must therefore be the Bf-FAD with a single lower E° describing a 2-e reaction19, 26, 29.
Thus, our experiments confirm the accepted model for Bf-ETFs4,

26, 28, 29, 48

. Our

mutagenesis strategy sought to produce a system resembling the canonical ETFs, allowing
us to test the analogies that had been used to infer ET function for the domII site of BfETFs. We targeted conserved amino acid residues in the domain I/III flavin binding site:
T97, T94, V232, G127, and D93 in the EtfS protein, residues whose identities are
differently conserved in canonical vs. Bf-ETFs, along with R165 in EtfL. Unfortunately,
many of the double mutants containing substitutions in both proteins were not stable
enough for us to be con dent that no FAD would be released in the course of redox
titrations or were poorly expressed. However, ETFs bearing substitutions in only EtfS
proved more stable and of those, T94/97A ETF was the successful candidate with respect
to protein expression and stability. We speculate that many of our other substitutions had
adverse effects on the interface between the two monomers. We exploited the very different
CD signals of the two FADs in RpalETF and demonstrated that the signal retained by
T94/97A ETF is the one previously assigned to the ET-FAD29. Because the CD signal of
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T94/97A ETF is very similar to that of the ET-FAD of WT RpalETF, which also resembles
the CD signal of Methylophilus methylotrophus ETF, our CD results further confirm the
analogy between the ET-FADs in the different groups of ETFs. Based on the similarity of
the CD signal of T94/97A ETF to that of the ET-FAD in WT RpalETF, it appears that the
domII site does not experience altered electrostatic anisotropy due to the amino acid
substitutions and lack of flavin in the domI/III site, consistent with the distance between
the two sites and their locations in different domains. T94/97A ETF has a weaker
absorbance spectrum than does the WT, as expected based on its lower FAD content. Its
spectrum resembles that of the ET-FAD of AfeETF and MelETF with respect to shape
(Figure 2.3), displaying peaks at 394 and 450 nm and lacking a prominent dip between two
bands4,

51

. Although 8-formyl flavin is formed in many canonical ETFs40,
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, such a

modification appears not to be responsible for T94/97A ETF’s unusual spectrum, as the
flavin released from T94/97A ETF does not display the optical signature of 8-formyl flavin.
NADH proved unable to reduce our T94/97A ETF, instead producing aggregation,
although the corresponding WT RpalETF underwent full reduction by NADH29. This
confirms the absence of Bf-FAD in the T94/97A ETF. T94/97A ETF nevertheless
underwent stepwise reduction with the 1-e donor dithionite to form ASQ (evident at 374
nm and 550 nm) and then HQ, retaining the reaction pattern of wild type ET-FAD26, 29. In
WT RpalETF changes at 550 nm were complicated by loss of a CT band attributed to BfFAD that absorbs in that region29. The relative instability of the HQ of T94/97A ETF is
consistent with earlier findings in bifurcating MelETF, where reduced ET-FAD
dissociates51. Indeed, T94/97A ETF is much more stable in the ASQ state than in the HQ
state, as for canonical ETFs60, 61. Thus, our mutations have produced an ETF with many
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biophysical properties in common with canonical ETFs, by replacing only two residues
and preventing acquisition of the Bf-FAD.
Our E°OX/ASQ value of (- 7 ± 4 mV) is in the range of those observed for ET-flavins of BfETFs ( -47 to +81 mV)19, 26, but at the negative end of the range of values reported so far
for canonical ETFs of +196 to -1429, 61. It was suggested that charge transfer between
reduced ET-FAD and oxidized Bf-FAD produced a long-wavelength signal in RpalETF29.
This, and proposed conformational interactions4, 47 could influence the E°s of the ET-FAD
depending on the status of the Bf-flavin60. As predicted by the charge-transfer hypothesis,
the long wavelength signal is absent in the T94/97A ETF. Thus, the higher E°OX/ASQ of
T94/97A ETF compared to WT RpalETF could reflect effects of absence of a flavin in the
domI/III site. In particular, the ASQ state of ET-FAD might be more favorable in T94/97A
ETF due to there being one less phosphate nearby (~13 Å) because the Bf-FAD is replaced
by AMP. Overall, we speculate that the location of the Bf-flavin between domains I and
III, contributed by the two subunits of ETF, makes the Bf-flavin’s activity amenable to
modulation by movement of one domain relative to the other.
2.5

Conclusions

Spectroscopic properties and chemical reactivity were used to determine which of
RpalETF’s flavin-based activities were retained after mutagenic disruption of FAD binding
in the site between domains I and III. Thus, we established that the ET-FAD shared with
canonical ETFs is retained in domain II. It follows that the Bf- flavin is the one bound at
the interface between domains I and III, in agreement with the accepted model.
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2.6

Methods
2.6.1

Molecular biology

Mutations were introduced into the genes for RpalETF: fixA containing a C-terminal His
tag and fixB containing a N-terminal His tag in the plasmids pMCSG28 (carbenicillin
resistant) and pMCSG21 (spectinomycin resistant), respectively29. At the level of the
protein, we adopt the letters S and L to identify the small and large subunit of the
heterodimer, respectively, because these are homologous to the S and L subunits of other
ETFs. However due to different gene orders in the fix operon the large FixAB subunit is
FixB whereas the large ETF subunit is EtfA. Our proposal to adopt an ‘S’ and ‘L’ notation
instead seeks to circumvent the confusion engendered by EtfAB’s correspondence to
FixBA. We retain the traditional notation for genes in order to retain correspondence with
extensive annotation in databases. Back-to-back orientation primers encoding the desired
amino acid substitutions were designed using NEB base changer (Table 2.1) and employed
according to the vendor’s recommendations to introduce the mutations via polymerase
chain reactions using Q5 High Fidelity DNA polymerase (New England Biolabs, Ipswich
MA). A pair of constructs encoding EtfS and EtfL were then used to transform competent
Nico21(DE3) Escherichia coli (New England Biolabs, Ipswich MA), to permit protein
expression.
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Table 2. 1: The mutants were made by creating mutations in both genes, fixA encoding
EtfS, and fixB encoding EtfL. A fixA gene-bearing plasmid and a fixB gene bearing plasmid
were co-transformed into E. coli to permit expression of variant ETFs. Doubly substituted
proteins could be produced by combining two mutated genes, while singly substituted ETF
could be produced by combining one mutant fix gene with a WT one.

Chain

Substitution

Forward Primer

Reverse Primer

S

T94A/97A

5’-GCGGCGAG

5’-CAGCGCGTCGG

CTACGCGCTCGCCGCC-3’

AGCCGGCGAAGAACC3’

S

S

T94P/T97V

G127E

5’-GCGCCGAGCTACG

5’-CAGCGGGTCGGA

CGCTCGCCGCC-3’

GCCGGCGAAGAACC-3’

5'-ACCTGGGCGGTGT

5'-GCAGACCATCGA

CTTCGTCGATGGTCTGC-3'

CGAAGACACCGCCCAG
GT-3'

S

S

S

V232K

V232Y

D93T

5’-GCCGACGGTGAA

5’-GAACCGCGGAGG

AAAGCGCGTGTTCG-3’

CCGCAC-3’

5’-GCCGACGGTGTA

5’-GAACCGCGGAGG

CAAGCGCGTGTTCGCAC-3’

CCGCAC-3’

5’-CGCCGGCTCCACCA

5’-AAGAACCGATCG

CGCTGGCG-3’

GTCAGCAG-3’
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Table 2.1 (continued)
L

L

R165Q

R165K

5’-CGCCGCGACGCAG

5’AGCGAATTGTCG

CCGACCTTCG-3’

GAGTCGAC-3’

5’-CGCCGCGACGAAA

5’AGCGAATTGTCG

CCGACCTTCG-3’

GAGTCGAC-3’

Note: Primers for G127E were designed using Agilent QuickChange Primer design.
2.6.2 Protein expression and purification
The T97A/94A ETF variant of RpalETF carrying a C-terminal His tag on fixA(S) and Nterminal His tag on fixB(L) was grown in Terrific Broth medium supplemented with 20
mg/mL riboflavin, 20 mg/L adenosine 5-monophosphate (AMP), 2 mM MgSO4, 100
µg/mL of carbenicillin and 100 µg/mL of spectinomycin. Cultures were grown at 37 °C
with shaking at 250 rpm until they reached an optical density (OD) at 600 nm of ~1 and
then cooled to 18–20 °C. Gene expression was induced with 0.1 mM IPTG and the cultures
were grown for 20 hours at 18–20 °C. Cells were harvested by centrifugation at 11900 g
at 4 °C for 10 min. Harvested cells (10 g /L culture) were washed with PBS (phosphate
buffered saline at pH 7.4 containing 137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, and 2
mM KH2PO4) and then lysed by resuspending in 80 mL of BugBuster (primary amine free,
Millipore) supplemented with 1 mM AMP, 2 µL/80 mL of benzonase nuclease HC (250
U/µL), 2 µL/80 mL of lysozyme (30 kU/µL), 1 mM TCEP (tris(2-carboxyethyl)
phosphine) and 1 mM AEBSF (4-(2-aminoethyl)benzenesulfonyl fluoride) hydrochloride
protease inhibitor and incubated at 4 °C with stirring for 2 hours. The insoluble fraction
was removed by centrifugation at 15 000 g for 45 min at 4 °C.
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Clarified cell lysate was mixed with 1.5 mL of co-nitrilotriacetate (NTA) resin (Thermo
Fisher) that had been pre-equilibrated with 3 mL of equilibration buffer containing 20 mM
Tris pH 7.4, 500 mM KCl, 10% (w/v) glycerol and 1 mM TCEP. After a binding interval
of 30 min with gentle stirring at 4 °C, protein-bound resin was loaded into a column
(2.5×30 cm) and washed with 20 bed volumes of wash buffer containing 20 mM Tris pH
7.4, 500 mM KCl, 10% (w/v) glycerol, 1 mM TCEP, and 20 mM imidazole. Protein was
eluted with 2 bed volumes of elution buffer containing 20 mM Tris pH 7.4, 500 mM KCl,
10% (w/v) glycerol, 1 mM TCEP, and 100 mM imidazole. Eluate was subjected to buffer
exchange by gel filtration on 10-DG desalting column (Bio Rad) in order to remove the
imidazole and transfer the protein to the working buffer containing 20 mM bis-Tris Propane
(pH 8.0), 200 mM KCl and 10% (w/v) glycerol.
2.6.3

Cofactor quantification: AMP quantification.

The protein concentration (µg/mL) was determined using the Pierce 660 nm protein assay
with bovine serum albumin as the standard (Thermo Fisher scientific, Waltham, MA) but
corrected for the amino acid composition of RpalETF62. ETF concentration was calculated
based on the molecular mass of 74, 545 Da29. In individual 1.5 mL microcentrifuge tubes,
400 µL of 28 µM ETF in working buffer was added and wrapped in aluminum foil to
exclude light and prevent photochemical transformation of cofactors. Cofactors were
released by denaturing the ETF by heating at 100 °C for 10 min after which denatured
protein was removed by centrifugation at 14, 000 g for 10 min after cooling the samples.
Supernatant was transferred to a quartz cuvette and the optical spectrum was recorded on
a HP 8453 spectrophotometer. Absorbance at 450 nm was used to determine the released
flavin concentration (ℇ450 = 11.3 mM-1 cm-1)26. From this and FAD’s (ℇ260 = 35.93 mM-1
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cm-1) we calculated the absorbance due to FAD at 260 nm. The excess A260 was used to
determine the concentration of AMP (ℇ260 = 15.0 mM-1 cm-1)63 .
2.6.4

Circular dichroism

CD spectra were recorded using a JASCO J-800 series spectropolarimeter from 600 to 300
nm at 4 °C in a 1.0 cm path length quartz cuvette with the following parameters: scan speed
= 100 nm min-1, bandwidth = 2.00 nm, scanning speed = 100 nm min-1, and three
accumulations. The molar ellipticity was calculated using the equation, [θ] = θ/ (c × l), in
which θ is the ellipticity in millidegrees, c is the concentration in mM, and l is the cell path
length in cm.
2.6.5

Fluorometric quantification of FAD.

ETF (0.4 mL of 6 µM) was denatured by incubating at 100 °C for 10 min in the dark, as
above. Denatured protein was removed by centrifugation at 14, 000 g for 10 min after
cooling. The supernatant was transferred to a microcentrifuge tube and diluted 10-fold with
working buffer. The emission spectrum of the solution was recorded at 20 °C using a
Thermo Fisher Lumina fluorimeter with the following parameters: excitation at λex = 450
nm, emission measured over λem = 480–600 nm, scan speed = 100 nm min-1, excitation slit
5 nm, emission slit 5 nm, gain: ‘high’, data interval: 0.5 nm, instrument zeroing conditions,
emission shutter: closed. After collection of an initial spectrum, 2 µL of 6 mU
phosphodiesterase solution was added (Abnova, cat no. P5263) to convert FAD into FMN
and AMP, thereby releasing the flavin from adenine-mediated fluorescence quenching54.
Emission spectra were recorded each minute after mixing, until no further changes are
observed using the same settings as given above54. The maximum emission value was
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converted to an FMN concentration based on a calibration curve of emission amplitude at
524 nm vs [FMN], generated using authentic FMN (14H0610, 70% purity, Sigma).
2.6.6

Reductive titration of T94/97A RpalETF by NADH and sodium dithionite

Reductive titrations were performed in inert atmosphere, monitored using a HP 8452A
spectrophotometer (Agilent technologies) equipped with an OLIS controller, inside a glove
box (Belle Technology, Waymouth, UK), using a 1 cm path length self-masking quartz
cuvette at room temperature. ETF was reduced by small aliquots amounting to 2 µM
NADH each after dilution into the reaction (ℇ340 = 6.22 mM-1 cm-1)26 or 5.6 µM sodium
dithionite ( ℇ315 = 8.04 mM-1 cm-1)64. This low concentration provides sufficient driving
force to fully reduce the FAD at the pHs of 8 and 9 that we used65.
2.6.7

Reduction midpoint potential determination

Potentiometric titrations were also monitored optically using

a HP 8452A

spectrophotometer (Agilent technologies) equipped with an OLIS controller in an inert
atmosphere afforded by a glove box (Belle Technology, Waymouth, UK) using a 1 cm path
length self-masking quartz cuvette at room temperature. Xanthine oxidase in combination
with xanthine was used to provide a slow continuous delivery of reducing equivalents66.
The reaction mixture contained 400 µM xanthine, 5 µM methyl viologen, 16.2 µM
T94/97A ETF, and 3 µM methylene blue (MB, as a reference dye, E° = -19.0 mV, pH 8.0)
in working buffer. The reaction was initiated by addition of 10 nM xanthine oxidase, and
spectra were recorded every 1 min. The reduction midpoint potential E°OX/ASQ of the
reduction of OX FAD to ASQ was calculated by relating the extent of reduction of FAD
with the extent of concurrent reduction of the reference dye. Conversion of OX to ASQ
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was quantified based on absorbance changes at 388 nm, the dye isosbestic, while the
reduction of the MB dye was quantified based on loss of absorbance at 664 nm.
The point in the titration corresponding to the maximum ASQ concentration was identified
and treated as the endpoint of the first 1-e reduction and assigned to full conversion to
ASQ based on the agreement between the shape of the spectrum and that of authentic
samples of 100% ASQ. Each spectrum up to that point in the titration was converted to a
difference spectrum by subtracting the endpoint spectrum, to reveal the remaining OX
population (Figure 2.8). The first point in the titration was not 100% OX, as the RpalETF
undergoes slow spontaneous reduction in the glove box. However, the amount of ASQ in
the spectrum could be estimated by subtracting a weighted spectrum of purely ASQ
RpalETF in such a way as to produce a flat zero baseline at wavelengths > 500 nm where
ASQ is positive, but OX generally does not absorb. The weighting required to accomplish
this revealed what fraction, f, of the total starting absorbance corresponded to ASQ, and
thus the magnitude of the residual population, 1- f, that underwent reduction in the course
of the measurement. We obtained 0.05 < f <0 .10 in three titrations. The difference spectra
were thus interpreted to reflect the reaction of the (1- f) portion of the sample and for the
example of the midpoint in the change, f + (1-f)/2 = 0.5 + f/2 of the sample is ASQ while
0.5-f/2 is OX. Absorbance at 388 nm (dye isosbestic) was used to find the absorbance
change due to reduction of FAD and thereby to calculate to calculate the fraction of OX
converted to ASQ. [FADOX]/[FADASQ] at each point in the titration were calculated from
the fractional populations. A664 was used to calculate the extent to which oxidized dye,
DYEOX, was converted to reduced dye, DYERED. The ratio of oxidized to reduced dye along
with that of the FAD were employed in the Nernst equation,

44

𝑜
𝑜 )
[DYE𝑂𝑋 ]
𝑛𝐹𝐴𝐷
𝐹(𝐸𝐷𝑌𝐸
− 𝐸𝐹𝐴𝐷
𝑙𝑜𝑔 (
)=
𝑙𝑜𝑔 (
) + 𝑛𝐹𝐴𝐷
𝑛𝐷𝑌𝐸
2.303𝑅𝑇
[DYE𝑅𝐸𝐷 ]
[FAD𝐴𝑆𝑄 ]

[FAD𝑂𝑋 ]

where nFAD, nDYE denote the number of electrons acquired by the flavin and the dye
respectively during the reaction under study, and F, R and T are Faraday’s constant, the
[FAD

]

ideal gas constant, and the temperature, respectively. A plot of 𝑙𝑜𝑔 ([FAD 𝑂𝑋 ]) versus
𝐴𝑆𝑄

[DYE

]

𝑙𝑜𝑔 ([DYE 𝑂𝑋 ]) , was used to determine nFAD from the known value of nDYE = 2. The
𝑅𝐸𝐷

intercept of the plot then permits calculation of E°FAD for the ET-FADOX/ASQ.
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CHAPTER 3. EFFECT OF ACTIVE SITE CONSERVED ARGININE RESIDUES IN
RHODOPSEUDOMONAS PALUSTRIS (RPALETF) IN REDOX TUNING,
STABILITY, AND BF-FAD BINDING.

3.1

Abstract

Electron bifurcation couples endergonic and exergonic electron transfer reactions to
generate a lower potential reducing equivalent. Therefore, this is considered as a third mode
of energy conservation mechanism in biological systems. The bifurcating EtfAB system
from Rhodopseudomonas palustris (Rpal) employs two FADs, one in each monomer of
the AB dimer. The two flavins execute contrasting, complementary electron transfer
reactions. Whereas one mediates single electron transfer (ET-FAD), the other accepts
electrons pairwise (Bf-FAD), yet both the flavin’s sites include a conserved Arg sidechain.
R273 favors the ASQ of ET-FAD, whereas R165 near the Bf-FAD appears not to, possibly
due to neutralization of its positive charge nearby C174. R273 forms a 𝜋-𝜋 stacking
interaction with ET-FAD whereas R165 appears to form hydrogen bond interactions with
Bf-FAD. To learn whether the active site arginine residues each have different effects on
their respective neighboring flavins, we replaced each of the Args in turn with chemically
conservative, and divergent substitutions. Based on reductive titrations, all the variants
retained the WT pattern of single electron reactivity at the ET site and pairwise reactivity
of the Bf-FAD. However, R273H-RpalETF and R273A-RpalETF variants accumulated
significantly less anionic semiquinone (ASQ) than either WT or R273K-RpalETF. This
confirms the significance of electrostatic stabilization of the ASQ. Redox titrations
performed at pH 7, 8, and 9 suggest that the substituting H273 residue remains neutral at
these pHs. In the bifurcating site, R165K did not affect the formation of the ASQ of ETFAD, but removal of residue 165’s positive charge in R165H resulted in diminished
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stability, prevented FAD binding in the Bf site at pH 8. Therefore, R273 plays a vital role
in Bf-ETF by stabilizing the ASQ of the ET-FAD, whereas R165 favors binding of the BfFAD that is essential for electron bifurcation in RpalETF.
3.2

Introduction

Flavin based electron bifurcation (FBEB) couples endergonic and exergonic electron
transfer reactions. FBEB has been observed in complexes containing at least one FAD and
has been studied in several systems so far, such as the electron transfer flavoprotein
butyryl-CoA dehydrogenase complex (ETF-Bcd)24. ETF-Bcd couples exergonic reduction
of crotonyl-CoA to butyryl-CoA (E°´= -10 mV) to endergonic reduction of ferredoxin (Fd,
E°´= -420 mV) by NADH (E°´= -320 mV)4.

By combining these reaction steps,

unfavorable, energy-demanding electron transfer to Fd from NADH is rendered favorable.
We studied the electron bifurcating electron transfer flavoprotein (Bf-ETF) from
Rhodopseudomonas palustris (Rpal). Rpal is a diazotrophic bacterium that employs a fourprotein complex called FixABCX to enable photosynthetic electron transfer to drive
nitrogen fixation (hence the ‘fix’ in FixABCX)67. Given the homology between FixAB and
known Bf-ETFs, it was hypothesized that the FixAB portion of FixABCX is an ETF, and
uses electron bifurcation to generate low-potential reducing equivalents for nitrogenase.23
Thus FixAB can be denoted as EtfSL15, 17, 20, 28 where S and L indicate the small and large
protein subunits that make up the ETF.
The first ETFs to be characterized function as intermediate electron carriers between
primary dehydrogenases and terminal respiratory systems. These are known as canonical
(group 1) ETFs and the heterodimeric structure consists of three domains (see Figure 1.5).
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Domains I and III together form a base domain containing an AMP buried predominantly
in domain III of the S subunit, whereas a FAD molecule is bound in domain II51, 53, 63 (the
‘head domain’) of the L subunit. The head domain undergoes a large rigid-body rotation
that has been proposed to control the sequence of electron transfer reactions10, 14, 16. The
Bf-ETFs comprise a second group within the ETFs15 and are distinguished by having a
second FAD residue in place of AMP. The AMP portion of this second FAD takes the
place of the AMP of canonical ETFs, but the FMN portion extends through domain III of
the S subunit towards domain I of the L subunit, such that the flavin is bound in the
interface between domains I and III4.
The two FADs are chemically identical but functionally distinct, as a result of their
different environments. The FAD in domain II is known as the electron transfer FAD (ETFAD) since it is present in canonical ETFs as well. The FAD unique to Bf-ETFs is known
as the bifurcating FAD (Bf-FAD), because NADH is believed to bind adjacent to it and it
displays redox reactivity compatible with electron bifurcation18, 29 4, 26, 27. Based on studies
of Acidaminococcus fermentans Bf-ETF (AferETF)4, Megasphera elsdenii ETF
(MelsETF)25 and Azotobacter vinlendii FixABCX68, Bf-FAD accepts 2 electrons as a pair
from NADH and transfers them individually in two simultaneous one-electron reactions to
-1- a higher potential acceptor (crotonyl CoA in Afer) via ET-FAD, and -2- a low potential
acceptor flavodoxin (Fld) or Fd4, 27. Repetition of this process produces butyryl-CoA and
2 equivalents of reduced Fd or Fld (Figure 1.7 as shown in Chapter 1). To date, all the BfETFs employ Fld or Fd as a lower potential acceptor.
The different reactivities of the two FADs must stem from the different protein sites in
which they reside. Therefore, the identities of amino acids that form each of these sites
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provide the bases for the ET-FAD’s ability to transfer electrons one at a time, vs. the BfFAD’s ability to accept electron pairs from NADH. These functionally relevant amino
acids are expected to be conserved. Indeed, multiple studies have demonstrated the
sequence similarity of members of the ETF family17, 20, 21, 69. In 1996, Weidenhaupt et al.
categorized ETFs into two groups. Group 1 included ETFs from human, rat, Paracoccus
denitrificans (Pden). These are the canonical ETFs, and they share 50% sequence identity
even though they span distantly related organisms from prokaryotes to eukaryotes. Group
2 comprises ETFs from the methylotrophic organism W3A1 and nitrogen fixing organisms.
Whereas Group 1 ETFs are constitutively expressed, the ETFs associated with specialized
metabolic activities including nitrogen fixation are synthesized only under specific
conditions, when the bacteria are cultured with trimethylamine or under nitrogen-fixing,
anoxic conditions, respectively. Group 2 ETFs shared only 30% of sequence identity with
Group 1 ETFs and may organisms possess one of each17. More recently, Kim’s team has
found sequence similarities among these Group 1 and 2 ETFs, the least amino acid
sequence similarly lies within the large subunit EtfL, which forms domains I and II.
Domain I interacts with the flavin group of the Bf-FAD but does not interact with the AMP
portion20, 21. However the AMP of canonical ETFs or that portion of the Bf-FAD is bound
exclusively in the small subunit EtfS (domain III) and facilitates protein folding20 providing
for this domain’s higher amino acid conservation. Costas et al. refined the classification of
Group 2 into subcategories and enlarged the range of the sequences compared to include
more recently identified members of the ETF family. Based on structural, functional, and
phylogenetic differences, five groups were proposed15. In this more comprehensive
scheme, Group 1 still represents housekeeping canonical ETFs including those from
human, P. denitrificans and WA3115. Some organisms possess Group 2 ETFs with two
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flavins, which are associated with electron bifurcation, for example Afer, Mels, Rpal, and
Azatobacter vinelandii ETFs. These show significant sequence similarities with canonical
ETFs with respect to the ET-FAD binding domain. Indeed, amino acids in closest to the
ET-FAD are highly conserved in throughout the entire ETF family. Elsewhere in the ETF
structure, differences between the sequence motifs that characterize Group 1 (nonbifurcating ETFs) vs the motifs characterizing Group 2 (bifurcating ETFs) were examined
to understand the functional differences and to identify amino acids that could be
responsible for bifurcating activity4, 15.
Previous studies also reported reduction midpoint potentials (E°s) for the OX/ASQ couple
of FAD from the human (+22 mV), Pig (+4 mV) and Pde (-6 mV). These E°OX/ASQ from
Group 1 ETFs were very similar, whereas the corresponding E°OX/ASQ of MmetETF
belonging to Group 3 was found to be +153 mV (all E°s are reported vs. (NHE) normal
hydrogen electrode). Even though there are strictly conserved residues in the immediate
vicinity of the FAD (ET-FAD) shared over the entire ETF family, MmetETF’s exceptional
stabilization of the anionic semiquinone (ASQ) demonstrates that additional factors are
also at work. In MmetETF, the FAD domain is rotated by around 40° relative to that in the
ETFs from human and Pde. This decreases the solvent accessibility of the isoalloxazine
ring of FAD. In addition, there is a salt bridge between R237.L in domain II and Glu163.S
in domain III70. Several studies have revealed that Arg237 is responsible for stabilizing the
ASQ state of the ET-FAD of canonical ETFs, and confers a kinetic block on full reduction
to the dihydroquinone state (HQ)10. However analogous studies have not yet been done on
any Bf-ETF. Moreover, another conserved Arg is observed in the site that accommodates
the Bf-flavin, but it has not been investigated.

50

The Arg273.L is one of several residues conserved near the ET-FAD, and present in both
canonical and bifurcating ETFs20, 21, 70. Crystal structures show the corresponding residues
to be R227 in P. denitrificans21, R249 in human20, and R253 in AferETF4. In all cases, the
guanidinium group is located next to the si face of the flavin. Because the 1e-reduced state
of this FAD is the anionic semiquinone (ASQ), it is intuitively appealing to find that there
is a positively charged residue nearby. However the negative charge of ASQ is generally
delocalized through the N(1)-C(2)O region of the flavin isoalloxazine ring, so it is
interesting to also see that His283 of human ETF hydrogen bonds to the flavin O(2) of the
C(2) carbonyl, and may aid the positive charge of Arg249 in stabilizing the ASQ71. Both
residues and interactions are conserved in the crystal structure of AferETF, which has 40%
sequence identity with RpalETF4. In AferETF the reduction midpoint potential at pH 7
(E°’) of the ET-FAD OX/ASQ couple is E°’OX/ASQ = +134 and E°’ASQ/HQ = -36 mV. In
PaeETF +33 mV, -94 mV and in MeslETF +81 mV, -136 mV respectively. Thus, all three
Bf-ETFs for which the E°s are known have a value for formation of ASQ that is at least
120 mV higher than the value of reduction of ASQ, predicting over 90% population of that
state, at maximum. A stable SQ state, in turn, will effectively ensure that the ET-FAD
mediates single electron transfer rather than pairwise transfer, and the high E°OX/ASQ
additionally predicts that the enzyme will rest in the ASQ state of the ET-FAD.27 Thus it
will be unable to accept more than one electron and act as a gate, preventing both electrons
from NADH from escaping down the exergonic path. If the intermediate ASQ is
destabilized in ET-FAD, there is no longer possibility for electron bifurcation and lower
potential acceptors would not get reduced. Thus, the E° values of the ET-FAD are very
important determinants of bifurcating activity, providing motivation for understanding the
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role of a positive charged Arg residue near the ET-FAD. ET-FAD is known to be in the
ASQ state in the reducing physiological conditions
Based on all these observations related to amino acid conservation among canonical ETFs
and RpalETF, and the effect of Arg residues in tuning the redox potential of ET-FAD seen
in human and MmetETF, we believe the stabilization of ASQ in ET-FAD during electron
bifurcation is due to the presence of positively charged R273. On the other hand, it is
believed thus Bf-FAD is incapable of forming an intermediate ASQ. Nevertheless, another
Arg, R165, is conserved in the Bf site and forms a bidentate hydrogen bonding interaction
with N5 as its observed in AferETF R1464. This raises the question of why R165 doesn’t
stabilize the ASQ of Bf-FAD as R273 does in ET-FAD.
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Domain II
R273

ET-FAD

Domain I

C174
Bf-FAD
R165
Domain III

Figure 3. 1:Ribbon diagrams of bifurcating ETF (Bf-ETF) based on the structures of
Acidaminococcus fermentans ETF (AfeETF, 4KPU.pdb)4. The FAD common to all known
ETFs is in yellow stick Cs with CPK coloring of other atoms, whereas the second FAD
found only in Bf-ETFs is in green. The insets highlight in purple the two R273, R165
residues of RpalEtfL and their interactions with ET and Bf-FAD respectively. These Args
are conserved among Bf-ETFs and shared by AfeETF. Domain I is formed by the large
subunit (EtfL, red) while domain III is formed by the small subunit (EtfS, light blue).
Domain II is composed primarily of EtfL but EtfS also contributes its C-terminal helix.
Domain II is understood to adopt different orientations relative to the base formed by
Domains I and III47. This and other molecular graphics were produced using chimera50.

To test the roles of these Arg residues individually we utilized site directed mutagenesis to
specifically replace the residues with Gln (nearly isosteric to Arg and polar), Lys
(positively charged like Arg but lacking a bidentate H-bonding capability), His (having a
pKa closer to 7 so that its charge is tunable by solution pH), and Ala (a nonpolar small side
chain that serves as a control). To assess the impact of the mutations on the thermodynamic
properties of the FADs, we measured the E° values. Here we present these and other
quantitative data to show that R273 is vital for RpalETF to stabilize ASQ at ET-FAD,
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whereas His substitutions at Bf site is not tolerated by the protein and Lys substitution
neither alter the function of FADs nor stability of the protein. Specifically, R165 is
important for binding of the Bf-FAD, which plays a structural role in addition to being the
site of electron bifurcation.
3.3

Results
3.3.1

Expression, flavin content, and stability of variants

Considering the ET-FAD’s stable ASQ intermediate between the OX and HQ states, we
and others speculated that a crucial feature of the ET site would be the conserved Arg273
residue that should be positively charged under physiological conditions. However,
RpalETF demonstrates that conservation of a nearby Arg is not a determinant of a stable
ASQ state, as the bifurcating site also contains a conserved Arg. Thus, the effect appears
more nuanced that the identity of the residue, and we expect that the interaction between
Arg and flavin is different nature in the Bf site than in the ET site. Indeed, R273 is seen in
crystal structures to form a 𝜋-𝜋 stacking interaction with ET-FAD whereas R165 appears
to form a bidentate hydrogen bonding interaction at N5 position of Bf-FAD (see Figure
3.1). To test the natures of the interactions, we generated mutants using site directed
mutagenesis to remove the positive charge (replacement with Ala or Gln) or to remove
bidentate H-bonding (replacement with Ala or Lys). To make the charge tunable via
modulation of pH we also replaced Arg with His. Amino acid substitutions were made in
each of the two flavin-binding sites separately.
For variants affecting Arg273 in the ET site, and R165K, recombinant proteins were
expressed in soluble form and purified. The yields of 20-25 mg per liter of culture were
comparable to that of the WT indicating similarly stable and soluble proteins. Consistent
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with this, the soluble variants all contained 2 FAD per heterodimer after purification
including exposure to a buffer suppplemented with FAD to repopulate any FAD binding
sites having good affinity (Table 3.1). The R165H variant could be purified with two FADs
bound at pH 9 but retained only one bound FAD at pH 8 (Figure 3.2C).
Table 3. 1: Flavin quantifications: Cofactor quantification was carried out based on Aliverti
et al.54
Protein

Trial 1

Trial 2

Average

WT

2.01

2.00

2.00 ± 0.00

R273A

2.08

2.00

2.04 ± 0.06

R273H

2.05

2.00

2.03 ± 0.04

R273K

2.06

2.12

2.09 ± 0.07

R165K

2.00

2.00

2.00 ± 0.00

R165H

0.97

0.8

0.88 ± 0.12

Note: Standard deviation of 0.00 indicates both trials gave closer values.
ETF genes encoding R273Q and R165Q and R165A substitutions expressed well but
partitioned into the insoluble fraction and/or produced colorless, sparingly stable protein
in minute yield. This suggests that replacement of Arg with an uncharged polar Gln
disfavors flavin binding at both the sites which in turn diminishes protein solubility and
thereby produces a lower yield, despite robust gene expression. Indeed, presence of Ala in
the 165 position has the same effect as Gln. The fact that Ala is well tolerated in the ET
site may reflect that site’s surface exposure that could allow adjustments on the part of the
flavin or even access to positively charged buffer molecules able to compensate for the
absent Arg side chain.
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The Tm values marking the midpoint of thermal denaturation in bis-Tris Propane (BTP)
buffer display the same trends. Protein secondary structure was monitored by CD spectra
polarimetry as the temperature was raised. All variants studied displayed similar secondary
structure content at 25 °C. The variants that were soluble and readily purified all had Tm
values only slightly lower than that of WT. The exception was the R165H-RpalETF variant
for which the Tm was somewhat lower. This further supports the conclusion that a positive
charge is needed to stabilize Bf-FAD binding.
Table 3. 2: Tm data: All the mutants (around 17-30 µM of protein) were in 20 mM BTP
buffer, 200 mM KCl and 10% (w/v) glycerol at pH 8. Data were collected using 0.2 cm
pathlength quartz cuvettes, (n = number of trials).

Protein

Tm (°C)
(n=2)

WT

46 ± 2

R273A

44 ± 0

R273H

44 ± 0

R273K

44 ± 0

R165H

40 ± 2

R165K

44 ± 0

Based on the molecular model AfeETF, 4KPU.pdb4. R165H engages in bidentate hydrogen
bonding with Bf-FAD (see Figure 3.1). It may be that the His imidazole is not well
positioned to form the same hydrogen bonding interactions as the guanidinium of Arg,
because His has a shorter stalk and is bulkier compared to the longer more flexible Arg.
Indeed, replacing Arg with Lys better preserved the stability of RpalETF. This could also
be because Lys has a long enough stalk to interact with the flavin N5 and retains the
positive charge of Arg. Lys may also stabilize the negative charges of the phosphate groups
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of Bf-FAD. This is consistent with the lower FAD incorporation by R165H-RpalETF at
pH 8. R165K-RpalETF and WT contain 2FADs per dimer whereas R165H-RpalETF
contains less than 1FAD per dimer (ref. Table 3.1). We speculate that the positively
charged R or K side chains stabilize doubly anionic pyrophosphate in FAD at pH 8,
whereas the neutral H side chain would not depress the pyrophosphate pKa, allowing it to
be protonated to monoanionic and thus diminishing the strength of electrostatic interaction
between Bf-FAD and the protein. At pH 9, deprotonation of the FAD pyrophosphate could
raise its affinity for the protein to produce the observed stoichiometry of 2 FAD/ETF.
We also assessed the possibility that ADP or AMP could be bound in lieu of FAD in the
Bf-FAD binding site, in R165H-RpalETF at pH 8, as in canonical ETFs20, 62. The ratio of
absorbance at 260 nm to absorbance at 450 nm showed that the ratio of adenosine to flavin
corresponded to that of FAD, ruling out a significant additional population of bound AMP
or ADP. This contrasts with the situation in T94/97A ETF where AMP or ADP replaced
FAD in the Bf-site. The absence of AMP/ADP from the Bf site is consistent with
abrogation of an electrostatic interaction with the (di)nucleotide phosphate(s).

3.3.2

Identity of the FAD missing from R165H-RpalETF

We tested the above hypothesis that R165H-RpalETF lacks the Bf-FAD at pH 8 but retains
the ET-FAD. To do so, we collected the visible CD spectrum (Figure 3.2A) of pH 8
R165H-RpalETF and compared it with the CD signatures of the Bf- and ET-FADs
determined previously for WT RpalETF18, 29. R165H-RpalETF CD signal was less intense
than that of the WT, but its shape more general resemblance to the CD signals of ET-FAD,
as documented in both T94/97A ETF18 and WT RpalETF29. The negative signal around
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375 nm-425 nm is the signature feature of ET-FAD, which is present in R165H-RpalETF.
However, there is a large change in the amplitude of the lower energy flavin transition
between 425 and 500 nm, indicating that the ET flavin’s environment is significantly
altered in the R165H-RpalETF variant, even though that substitution is located in the other
domain of the ETF. A similar observation has been reported for human ETF, where
mutation of Tyr16.β to Ala significantly changed the lower energy flavin transition (band
I)71. The perturbed shape of R165H-RpalETF’s ET-flavin CD could also reflect a small
population of flavin-replete Bf sites. In the WT CD spectra at both pHs, the Bf-flavin
contributes strong negative CD at longer wavelengths (425 - 500 nm). Thus R165HRpalETF’s negative CD around 425-500 nm could be due to the presence of Bf-FAD in a
small fraction of the sample. This plausibility cannot be discerned from the absorbance
spectra of fully oxidized samples, because the OX absorption signals of the two flavins are
very similar. However, the near absence of any Bf-flavin predicts that we should not
observe reduction of flavin from OX to HQ in a single 2e step.
As an additional to test the presence of Bf-FAD in R165H-RpalETF, it was titrated with
NADH, because in bifurcating ETFs, NADH interacts with Bf-FAD site to reduce the
system,18, 4 whereas ETFs lacking Bf-flavin are not subjected to reduction by NADH26.
Thus, if Bf-FAD is present in R165H-RpalETF, ET-FAD would undergo reduction, via
two 1e steps. Interestingly, R165H-RpalETF was reduced in a 2e manner initially but could
not be fully reduced to HQ by NADH (Figure 3.3B), although full reduction was achieved
by sodium dithionite (Figure 3.3A). These data suggest population of some Bf sites by
FAD, but not all. Alternatively, we tested the reduction of NAD+ with half reduced R165HRpalETF. Initially the R165H-RpalETF was reduced by DT to produce maximum ASQ
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and titrated with NAD+, there were no sign of increase in the absorbance at 340 nm
indicating the absence of NADH formation. These experiments suggest Bf-FAD is not fully
occupied at Bf site for NADH/NAD+ to bind and carry out the electron transfer to ETFAD.
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A

B

WT RpalETF
R165H-RpalETF

C

Figure 3. 2: A) Visible CD spectrum of R165H-RpalETF (Black) and WT (Red), B)
Comparison of released FAD of R165H-RpalETF with authentic FAD, C) Spectral changes
of R165H-RpalETF, at the time of elution from the Ni-NTA column at pH 7.8 in Tris buffer
(Green), after buffer exchanging to BTP buffet at pH 8 (Pink), after reconstitution with
authentic FAD overnight in BTP buffer at pH 8, the spectrum of R165H-RpalETF in BTP
buffer at pH 9 (Blue).
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A

B

Figure 3. 3: Visible spectra observed in the course of stepwise reduction of R165-RpalETF.
A) with sodium dithionite (DT) and the absorbance increase at 374 nm indicates the ASQ
formation and decrease at 374 nm and 450 nm indicates ASQ reduces to HQ. B) with
NADH, both band 1 and 2 absorbance decreases, indicating the reduction in the 2e manner.
3.3.3

Absorbance spectral features

The R165H-RpalETF variant is unique in displaying absorbance in the 500-700 nm range,
which is not seen in WT RpalETF at pH 8. The long wavelength and breadth of the new
absorbance is suggestive of a charge-transfer interaction, for example with a nearby amino
acid side chain. This seems unlikely given the evidence above that this variant retains FAD
almost exclusively in the ET site whereas His165 is in the Bf site, unless a conformational
change can bring the two sites close together. Although the other variants did not display
new signals, the two canonical absorption bands of their oxidized flavins nevertheless
report on changes in the flavins’ environments. As shown in Figure 3.4, absorbance spectra
reflecting both the flavins in R273A-RpalETF, R273H-RpalETF, and R273K-RpalETF
mutants resembles those for WT RpalETF, suggesting that the overall environment and the
solvent exposure of the FAD isoalloxazine ring were generally unchanged. Bands 1 and 2
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absorb maximally at 452 and 380 nm, respectively, in the three ET-site variants, as in WT
RpalETF. By contrast, in R165K-RpalETF both bands have been red shifted, and absorb
maximally at 456 and 386 nm, respectively. Spectra of the ETF can conceal compensating
perturbations to each of the two flavins. Therefore, for better insight we deconvoluted the
spectra of the fully oxidized ETF into contributions from each of the two flavins, exploiting
the fact that in all variants the ET flavin underwent full reduction before the Bf-flavin began
to reduce, so a spectrum collected halfway through a reductive titration retained the
signature of OX Bf-flavin only.

Bf-FAD

ET-FAD
R165K - RpalETF

R273K - RpalETF
R273H - RpalETF
R273A - RpalETF

WT- RpalETF

Figure 3. 4: Deconvoluted Bf-FAD and ET-FAD: sodium dithionite reduction showed in
Figure 3.5 is used to deconvolute the ET and Bf-FAD. Following the deconvolution process
described in the Methods section, we extracted absorption maxima for each of the two
signals of each of the flavins (Table 3.3) and the ratio of the amplitudes of the two bands
(Table 3.4).
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Table 3. 3: Comparison of absorption maxima of individual flavins in each variant.
ET-FAD
Bf-FAD
Protein
Band 1 (±2
nm)

Band 2 (±2
nm)

Band 1(±2 nm)

Band 2 (±2
nm)

WT

448

394

454

374

R273A

448

392

454

374

R273H

448

386

454

374

R273K

452

392

454

374

R165H

450

384

N/A

N/A

R165K

448

396

460

378

Table 3. 4: Comparison of absorbance of band 1 and 2 of FADs in proteins
Protein
Band 1
Band 2
Band 2/band1
WT

452

380

0.93

R273A

452

380

0.95

R273H

452

380

0.95

R273K

452

380

0.96

R165K

456

386

1.01

Table 3. 5: Extinction coefficient of WT-RpalETF
OX-ASQ
ASQ-HQ
WT

7.3 mM-1
cm-1 at 374
nm

6. 6 mM-1
cm-1at 454
nm

OX-HQ
6.0 mM-1 cm1
at 454 nm

band 1’s absorption maximum responded only to substitutions within the Bf-flavin’s own
binding site and did not respond at all for the ET-flavin, band 2 of the ET-FAD shifted in
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response to substitutions in either of the flavin sites, whereas band 2 of the Bf flavin was
unresponsive to substitutions in the ET site but responded more strongly to substitution in
the Bf site (see Table 3.3). There is no significant difference between band 2 and band 1
ratio for R273 mutants and WT RpalETF, but this ratio is higher in R165K-RpalETF (see
Table 3.4) indicating isoalloxazine ring of R165K-RpalETF is more exposed to solvent
than WT and R273 mutants. The insensitivity of the Bf-FAD’s spectrum to changes in the
ET site is consistent with the ETF’s structure, wherein the Bf-flavin is deep inside the base
domain, sandwiched between the two subunits. By contrast, the fact that the deduced
spectra of the ET-flavin are responsive to substitutions in either site, including the
published T94/97A double substitution, can be rationalized as a consequence of the ETflavin being bound to a mobile head domain that brings the ET-flavin close to the base
domain in one conformation, but highly exposed in another. Thus, the environment of the
ET-flavin is expected to be affected by perturbations that affect the conformational
equilibria.
By contrast the Bf-FAD did not respond to mutations in the ET site, but the magnitudes of
its responses to substitutions in its own site were larger. In R165K-RpalETF band 1 and
band 2 of Bf-FAD were red shifted by 6 nm and 4 nm, respectively, despite retention of
the positive charge of Arg in the Lys substituent. This suggests that the interaction between
the Arg side chain and the flavin includes mechanisms additional to electrostatics. Besides
the shifts in absorption maxima, the vibronic structure characterizing the Bf flavin’s band
1 was lost in the R165K-RpalETF variant, but not variants perturbed in the ET site (see
Figure 3.4). Because the vibrational structure is a signature of hydrogen bonding6, its loss
in the R165K-RpalETF, specifically, suggests that in WT RpalETF the flavin H-bonds with
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Arg165. Unexpectedly, a longer wavelength absorbance from 500-750 nm was observed
in R165H at pH 8, even though the rest of the spectrum resembles the ET-FAD spectrum,
not the spectrum of the Bf-FAD, or as-observed spectra of any of the ETF variants with
both FADs bound, in agreement with the CD data. The long wavelength absorbance was
present before reconstitution with extra FAD overnight to achieve a system with both FAD
sites occupied (see Figure 3.2C, purple spectrum). Thus, and based on the CD spectrum, it
can be attributed to the ET flavin.
We tested the possibility that neutral semiquinone (NSQ, λmax typically 580 nm72) could be
the basis for the long-wavelength signal. To do so, we titrated with each of HCl and NaOH,
to lower and increase the pH in the system respectively and monitored the optical spectrum
to detect conversion to more NSQ or ASQ, respectively. If the long wavelength absorbance
were due to NSQ, decreasing the pH would further increase the absorbance between 500
and 700 nm, whereas increasing the pH would convert any NSQ to ASQ decreasing the
long-wavelength amplitude and replacing it with absorbance in the range of 370 nm.
Interestingly no change in the intensity of the 500 - 700 nm band was observed, arguing
against presence of any SQ species.

3.3.4

Potentiometric titration of ETF proteins.

We have previously determined the reduction midpoint potentials (E°) of all three reductive
phases observed in WT RpalETF at pH 9 and E°OX/ASQ of ET-FAD in T94/97A ETF at pH
818, 19, 29. This provides a reference point for evaluating the effects of each active site Arg.
To do so, we determined the effects on E° produced by their replacement. We determined
the E° of all the mutants including WT at pH 8. Although this choice precludes study of
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R165H- RpalETF with both FADs bound, it was chosen to suppress covalent modification
of the ET-flavin40 and thus ensure that changes observed are attributable to the residue
being varied, R273 and R165, no other factors. When all the mutants and WT were titrated
with DT or Ti(III)-citrate, they underwent reduction in three phases (Figure 3.5F), with the
exception of R165H- RpalETF which was reduced predominantly bi phasically (Figure
3.3A). There are many unanswered questions regarding the long wavelength absorbance
of R165H-RpalETF and the pH dependence of FAD binding at Bf-site. Therefore, the E°
determinations concentrated on the other RpalETF variants, which can be compared
directly with one-another and the WT.
A comparison of spectral properties of WT and variants under consideration indicates that
they were purified in the oxidized state. Consistent with previous works19, 29, anaerobic
reductive titration of WT with sodium dithionite or xanthine/xanthine oxidase (XO) system
reduced all the protein to the level ET-FAD ASQ at first, then ET-FAD ASQ was reduced
to HQ, and the third phase was associated with 2e reduction of OX Bf-FAD to HQ, based
on difference spectra obtained for each phase (Figures 3.5 and 3.6). However, the variants
displayed slight differences in the amount of ASQ accumulated in comparison with WT.
Extent of ASQ accumulation was compared via plots of the ratio of A374/A452 vs amount of
sodium dithionite added exploiting the high A374/A452 > 1 of ASQ, vs the lower A374/A452
< 1 of OX. Figure 3.5F indicates that maximal ASQ accumulation varies with active site
residue identities as R273H < R273K ~ R273A < R165H = WT RpalETF. Titration with
sodium dithionite is understood to be relatively insensitive to kinetic effects, whereas the
latter contribute more to reductions via the xanthine/XO system, so we repeated the
experiment using the latter. Prior work on canonical ETFs documents a potent kinetic
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impediment to reduction of ET-flavin from the ASQ state to HQ60. Comparison across
variants of A374/A452 vs reduction of the system shows ASQ formation in R273A-RpalETF
is less than R273K-RpalETF and the order of ASQ formation is R273H < R273A < R273K
= WT = R165K-RpalETF.
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A

B

C

D

E

F

Figure 3. 5: Visible spectra observed in during stepwise reduction of WT and variant ETFs
with sodium dithionite (NaDT), and plot of the A374/A452 vs NaDT addition illustrates the
three different slops in WT and the variants suggesting three phasic reductions. Increase in
the intensity at 374 nm compared to the initial spectrum is indicative of amount of ASQ
accumulated in each of the above protein.
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A

B

C

D

Figure 3. 6: Visible spectra of xanthine/XO reduction of 23 µM WT RpalETF in 20 mM
BTP, at pH 9 in the presence of 420 µM xanthine and 10 µM MV. A) Rainbow color pattern
from blue to green shows higher potential ET-FAD converts from OX to ASQ, green to
dark red indicates ASQ of ET-FAD forms HQ and finally the last step is shown in Maroon,
color, which is reduction of Bf-FAD in 2e manner. All these changes were plotted in the
difference spectrum B, C, and D respectively. Similar behavior is seen in all the mutants
except the variations in the amount of ASQ formation in phase 1.

To directly probe the role of a kinetic barrier in impeding formation of ASQ in R273ARpalETF and R273H-RpalETF we added a stoichiometric amount of NaDT calculated to
yield maximal ASQ in the presence of methyl viologen (MV) as a mediator and monitored
the system for 2-3 hours. Accumulation of ASQ was complete in 2 minutes, after which no
further accumulation of ASQ was observed. This argues against kinetic suppression of
ASQ formation, and instead indicates that removal of R273’s positive charge at the ETsite diminishes the amount of ASQ formed via thermodynamic effects instead. Therefore
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E° values of all three redox couples were determined using xanthine/XO reducing system,
in the presence of MV as a redox mediator and an appropriate indicator dye with an E°
close to that of the ETFs so that the two can equilibrate with one-another during reduction.
For example, our initial choice of Methylene blue (MB, E°’ = 11 mV, 2e/H+ at pH 7
calculated E° = -19 mV pH 8)73 based on previous work proved non-optimal for the current
variants, as the E°s determined in the presence of MB were ~ -50 mV for WT, R165K- and
R273K-RpalETF, and for R273A- and R273H-RpalETF E°OX/ASQ was around ~ 90 mV at
pH 8. Because these values were more than 30 mV from MB’s potential, -19 mV at pH 8
values reported in (see Table 3.10). In addition, we observed that the last steps of reduction
of R273A-RpalETF and R273H-RpalETF coincided with formation of significant amounts
of MV radical, even before the full reduction of the ETF was achieved, suggesting a very
low E° or slow equilibration with the indicator dye in later steps of reduction. Our final
choice of indicator dyes resolved this issue too (list of dyes is given in Table 3.10).
Table 3. 6: Comparison of E°’ of 1 and 2-FAD systems (values are adjusted to pH 7)29
System
Flavin E°’OX/ASQ; ASQ/HQ; OX/HQ (mV)
Ref.
content
N/A

-313; -101; -207

8

PaeETFAB

2

+33; -94; -285

19

AferETFAB

2

+134; -36; -249

30

WT RpalETF

2

-47; -83; -223

29

-61; -152; -243

This work

+81; -136; -279

26

Free flavin
2-FAD ETFs

MelsETF

2
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Table 3.6 (continued)
1-FAD ETFs
T94/97A RpalETF

1

-7; NA; NA

18

MmetETF WT

1

+153; <-250; NA

10, 60, 71

MmetETF αR237A

1

-43; -31; NA

10, 60

Human WT

1

+22; -42; NA

71

Pig liver

1

+4; -20; NA

29, 74

1

-6; -36; NA

29, 75

Sus domesticus
P.denitrificans

Table 3. 7: Slopes from linear plot for each of the reductive phases in all the variants
Protein
Phase 1
Phase 2
Phase 3
WT- RpalETF

0.506

0.513

1.036

R273A- RpalETF

0.502

0.501

1.035

R273H- RpalETF

0.503

0.509

1.035

R273K- RpalETF

0.519

0.526

0.995

R165K- RpalETF

0.502

0.515

1.015

71

Table 3. 8: Comparison of effect of Arg mutations on E° of ET-FAD of canonical ETFs
Calculated values from this work have been converted to pH 7.
System

Flavin

E°’OX/ASQ; ASQ/HQ; OX/HQ (mV)

Ref.

content
MmetETF WT

1

+153; <-250; NA

10, 60, 71

αR237A

1

-43; -31; NA

10, 60

αR237K

1

-62; <-250; NA

10

αR237C

1

-57; -145; NA

10

αR237E

1

-59; -199; NA

10

Human WT

1

+22; -42; NA

71

Human αR249K

1

-39: -124; NA

71

WT RpalETF

2

-61; -122; -243

R273A- RpalETF

2

-137; -118; -283

This work

R273H- RpalETF

2

-155; -126; -280

This work

R273K- RpalETF

2

-69; -125; -243

This work

R165K- RpalETF

2

-67.6; -122; -241

This work

This work

NA indicates not applicable
To monitor the redox potential of OX/ASQ couple of WT, R273K and R165K-RpalETF,
New methylene blue (NMB) with the calculated potential of -51 mV (E°’ = -21 mV, 2e/H+
at pH 7)76 was used. Initially the difference spectra of each phase were separated and in
phase 1, λmax of NMB is at 632 nm and 458 nm of R165K, and 454 nm for WT and R273KRpalETF were used to calculate the log [FAD]OX/[FAD]ASQ vs log [NMB]OX/[NMB]Red
and log/log plot was plotted as previously explained18 the E° were calculated -61 ± 3 mV
(n=2), -69 ± 4 mV (n=2) and -67.6 mV (n=2) for WT, R273K and R165K-RpalETF,
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respectively. Slope of 0.5 indicating the 1e transfer reaction (see Table 3.7). Based on our
data there is no significant difference between the E°OX/ASQ values of R273K-RpalETF and
R165K-RpalETF but a slight decrease of ~ 8-9 mV is observed compared to WT.
Contrasting to these observations, mutations which introduced Ala and His residue at ETsite dramatically decreased the amount of ASQ formation.
To determine the E° of ASQ/HQ couple in R273A-RpalETF and R273H-RpalETF,
Resorufin, RS (E°’ = -51 mV, 2e/2H+ at pH 7, calculated E° = -111 mV pH 8)77, 78 was
selected as a reference dye. log/log plot was created in the similar way but A572 nm of RS
and A454 of mutants were used, the slope of Nernst equation obtained for the redox reaction
of R273A-RpalETF and R273H-RpalETF is 0.5 representing a 1e transfer reaction of
OX/ASQ couple. Calculated E°s of ASQ/HQ couples are -137 mV (n=2) and -151 ± 1 mV
(n=2), respectively.
To determine the E° of ASQ/HQ couple, Nile blue, NB (E°’ = -116 mV, 2e/H+ at pH 7,
calculated E° = -146 mV pH 8)29, 73 was used as the reference dye. λmax of NB at 636 nm
was used to calculate [NB]Ox/[NB]Red and the slope of 0.5 indicates the 1e transfer reaction.
Calculated E°s of ASQ/HQ couple for WT, R273A-, R273H-, R273K- and R165KRpalETF is -182 ± 2 mV (n=2), -178 ± 2 mV, -196 ± 2 mV (n=2), -185 ± 5 mV (n=2) and
-182 ± 2 mV (n=2) respectively at pH 8. Our data shows no significant difference between
the calculated value for E°ASQ/HQ couples among the WT and mutants. However, the
separation between the E°s of OX/ASQ and ASQ/HQ couple tells us about how well the
ASQ in the system is stabilized. For WT, R273K- and R165K-RpalETF it is ~120 mV
whereas for R273H-RpalETF and R273A-RpalETF it is ~ 40 mV, these results explain that
R273A-RpalETF and R273H-RpalETF destabilizes ASQ in the ET-FAD.
73
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Figure 3. 7: log/log plot of WT (B) and R165K-RpalETF(A) Plot of log ([oxidized FAD]/
[reduced FAD]) for the flavins of R165K-RpalETF vs. analogous quantity for the dye
illustrating linear behavior consistent with the Nernst equation. The slope near 0.5 is
consistent with a 1-e event and slope 1.0 indicates the 2e event.

Conversion of oxidized FAD to an anionic semiquinone is not accompanied by proton
acquisition therefore the calculated E°OX/ASQ values are directly compared with other ETFs
having one FAD, also known as canonical ETF systems and bifurcating ETF systems as
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tabulated in Table 3.6 and 3.8 but where the E°ASQ/HQ was adjusted to pH 7 values. When
comparing with the other Bf systems such as Afer, Mels and Pae and canonical ETFs which
are homologous to RpalETF, E° of OX/ASQ couple for WT, R273K and R165K-RpalETF
is lower (much lower for R273A-RpalETF and R273H-RpalETF) and the E° of ASQ/HQ
couple obtained for WT and mutants are closer to the value calculated in MelsETF. The
difference between E° of OX/ASQ and ASQ/HQ couple calculated in this study is 91 mV
whereas in our previous study it is 36 mV 29, indicates lower amount of ASQ formation at
pH 9 than 8, considering the pKa of ASQ, 8.5 this couldn’t be true but we suspect the UVVisible spectral differences of RpalETF between pH 8 and 9 might play a role in redox
behavior.
Difference between the E° of OX/ASQ and ASQ/HQ couple of our data 91 mV is closer
to the calculated values in PaeETFAB (127 mV) and AferETFAB (136 mV). Also, this
difference is higher than the human ETF, pig ETF and Pde. Further, replacing the Arg
residue with a Lys residue at ET site still introduces a positive charge to stabilize ASQ in
ET-FAD, proving importance of a positive charge to stabilize ASQ. On the other hand,
mutation made at Bf site by introducing a Lys in place of R165, did not affect the redox
chemistry of ET-FAD as well as the amount of ASQ accumulation. Contrastingly, removal
of a positive charge at ET-site by introducing an Ala and a His residue destabilize the ASQ,
and we conclude that the His is not positively charged because adding an acid to lower its
pH and titrating to observe a neutral semiquinone or titrating at pH 7 and pH 9 with
dithionite did not give a significantly different redox behavior.
Similar observation was seen in homologous canonical ETF system, MmetETF10, 60, 79
where WT protein accumulates an enormous amount of ASQ with a E°OX/ASQ of +153 mV
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which is the highest E° calculated for OX/ASQ couple so far among the ETF family, and
conversion of ASQ to HQ has a kinetic barrier in this system and couldn’t fully reduce to
hydroquinone, mutating the R237 at ET-FAD or flavin binding site to an ala destabilizes
the formation of ASQ by ~200 mV. Further introducing a Lys residue in place of R237
also stabilizes the ASQ with a E°OX/ASQ of -67 mV, which is still much less than in the
presence of Arg residue, but the presence of a positive charge stabilizes considerably higher
than a neutral residue like Ala, where E°OX/ASQ of -43 mV. In the same study they have
shown the conversion of R237 into a Cys and Glu residue stabilizes the ASQ like a Lys
residue does but still significantly lower than a Arg and higher than an Ala residue10.
Frerman’s group has studied the significance of conserved Arg249 residue in human ETF
which is closely related to MmetETF71. Arg249 does not stabilize the flavin semiquinone
to anywhere near Mmet Arg237. In PdeETF, E° of Ox/ASQ couple is not widely separated
from ASQ/HQ couple75. Compared to all these canonical ETF relatives, RpalETF ET-FAD
stabilizes ASQ, even though which is less than other bifurcating systems. And unlike in
MmetETF replacing the Arg residue with a Lys residue in RpalETF had a similar effect
therefore presence of a positively charged residue is essential at ET-FAD site to stabilize
ASQ. This conclusion can be further explained by the destabilization of ASQ we see in the
presence of Ala and His.
To elucidate the E° of OX/HQ couple of Bf-FAD in all the mutants R273A-/R273HRpalETF and WT/R273K-/R165K-RpalETF, Safranin O (SO, E°’ = -289 mV, 2e/H+ at pH
7, calculated E° = -319 mV pH 8)19, 73 and Phenosafranin (PS, E°’ = -252 mV, 2e/H+ at pH
7, calculated E° = -282 mV pH 8)29, 73, respectively. PS and SO absorbs the visible light in
the region of flavins therefore, to calculate the spectral contribution of each individual
species the dye spectrum was completely subtracted from the collected spectral data by
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assigning the proportion of reduced amount of dye to the original dye alone spectra. The
log [FAD]OX/ [FAD]HQ for one flavin was calculated at A454 for WT and other mutants and
A458 for R165K-RpalETF and to determine the log [Dye]Ox/[Dye]Red, A520 for SO and PS
was used. The slope obtained from log/log plot is 1.0 (see Table 3.7) and calculated
potentials are -273 ± 5 mV (n=2), -313 ± 2 mV (n=2), -310 ± 2 mV (n=2), -273 ± 5 mV
(n=2) and -271 ± 5 mV (n=2) for WT, R273A-, R273H-, R273K- and R165K-RpalETF
respectively.
There is around 40 mV difference between the E°OX/HQ couple between R273A, R273HRpalETF and WT, R273K- and R165K-RpalETF. Interestingly, mutation at Bf site does
not affect the potentials of Bf-FAD but mutation at ET-site has altered it. This could be due
to the fact absence of an interdomain salt bridge between R273 and the residue in EtfS
subunit. As it is shown in MmetETF60, replacing the positive charge at R273 could have
broken the salt bridge and this may result in the change of the orientation of domain II
towards the base containing the domains I and III, due to this Bf-FAD has a lower potential
compared to the WT. This phenomenon is totally absent when R273 is present in WT,
R273K and R165K-RpalETF. This concept could be applied to explain the destabilization
of ASQ in R273H-RpalETF and R273A-RpalETF as well, because when introducing a
negative charge at ET-FAD by breaking the salt bridge, could have diminished the ASQ
stabilization. When comparing the E°OX/HQ value with the other bifurcating systems (based
on the E°’OX/HQ calculated at pH 7 and tabulated in Table 3.8), E°OX/HQ couple of WT,
R273A and R273K-RpalETF is closer to the value obtained in AferETF30 whereas in
R273A-RpalETF and R273H-RpalETF is closer to PaeETF19. Overall, effect of Arg
mutations on Bf-FAD redox behavior is very less when compared to the impact on ETFAD.
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3.4

Discussion

Many enzymologists and Structural biologists have demonstrated the structure and
functions of well-established canonical ETF systems10, 20, 21, 80. A major difference between
the canonical and bifurcating ETF is the presence of a second flavin between domains I
and III whose AMP portion replaces the AMP of canonical ETFs. Canonical ETFs consist
of 1 FAD and 1 AMP per heterodimer. In contrast, the first ETF demonstrated to contain
2 FAD was the ETF from Mels, which has since been shown to be a bifurcating ETF.
During isolation of the protein, 1 FAD was lost,51 but later work by Sato et al. reported that
reconstitution and provision of extra FAD during the lysing of the cells resulted in a higher
FAD content, yielding 2 FADs per dimer26. Similarly, incubation with exogenous FAD
resulted in ETF containing 2 FADs from Afer as described by Chowdhury et al.4.
To address the role of electron bifurcation in support of nitrogen fixation, Duan et al.
elucidated the thermodynamic requirement for electron bifurcation in the FixAB system
from Rpal. This work laid a foundation for understanding thermodynamic requirements for
electron bifurcation28, 29. As demonstrated in many previous works FixAB is homologous
to EtfBA (the A, B naming of the subunits is opposite in Fix’ from in ETF)15, 17, 21, 28.
Additional work by this team was able to identify spectral signatures of each FAD and their
role in RpalETF18, 29.

Duan et al., also observed an unusual long wavelength absorbance which was proposed to
represent a charge transfer (CT) band at 726 nm, and tentatively ascribe to direct flavinflavin interaction because both Bf-FAD and ET-FAD are required for its formation46. Note
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however that these works were carried out at pH 9, whereas at pH 8, 726 nm band formation
is slower. As noted in that work, we suspect a presence of a covalently modified FAD at
pH 9. Modification of the ET-FAD has been a long-standing feature among ETFs36, 37, 44.In
our previous work we created a canonical ETF like system from RpalETF containing only
ET-FAD by disrupting the H-bonds by which T94 and T97 of the large subunit bind the
Bf-FAD18. This too demonstrated spectral features due to covalently modified FAD present
in the domain II at pH 9 (unpublished data), but different from the spectral changes
observed in WT RpalETF. Protein purification of T94/97A ETF at pH 8 prevented
formation of the modified FAD, along with its attendant spectral signatures18. Therefore,
to exclude these modifications in WT RpalETF, the current work is conducted at pH 8. Coexpression of WT RpalETF in the presence of chaperone and equilibration of the protein
with the Ni-NTA resin for a shorter time interval18, 46 enhanced the yield by 10-fold as
compared to the previous work29. Similar to the reported work from AferETF4 and
MelsETF26, reconstituting with exogenous FAD produced holo-ETF with 2 FAD per WT
RpalETF heterodimer. Our protein yield, flavin quantification results and Tm values show
that R273A-, R273H-, R273K-, and R165K-RpalETF have comparable stability to WT
RpalETF and incorporate 2 FAD per dimer. However, R165H-RpalETF retains less than 1
FAD and is less stable than WT and the foregoing variants. Replacement of R273 or R165
with Gln did not produce a stable ETF but expressed soluble in vivo.
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Gln is near isosteric to Arg but possesses a polar side chain instead of Arg’s charged
guanidinium. There is a conserved Gln residue in human, Pde, and MmetETFs having a Hbonding interaction with pyrimidine ring of ET-FAD and in AferETF it is si phase to ETFAD4. But in RpalETF, replacing the R273 or R165 with a Gln residue yielded protein that
partitioned into the insoluble phase and therefore was presumed to be improperly folded.
Similar behavior was reported for human ETF, wherein substitution of Gln did not support
stable incorporation of flavin in domain II, although the protein was expressed and soluble
in the crude extract, although attempts to reconstitute with FAD or express with chaperones
did not yield a stable flavoprotein71. We also observed that R273Q-RpalETF is expressed
in soluble form in the presence of chaperone but failed to incorporate FAD during
reconstitution and was purified as a colorless protein.
On the other hand, introduction of a non-polar neutral Ala at the ET site produced a protein
with fully FAD content and WT-like stability. In this regard, RpalETF again resembles
MmetETF R237A which was well expressed as a stable protein with full FAD
incorporation10, 60, 79. When comparing R273A and R273Q, introduction of a polar group
to ET-site in RpalETF, appears to actively impede FAD binding. However, in the Bf site,
introduction of Ala in lieu of R165 produced an unstable protein despite its successful
expression into the soluble phase in vivo. Thus, a positive charge is required in the Bf-FAD
site, possibly to neutralize the charge of the incoming pyrophosphate component of FAD.
His has a shorter side chain than Arg but has a conjugated ring system that retains ability
to form a pi-pi interaction with the pyrimidine part of the FAD ring at ET site. The stability
of R165H-RpalETF at pH 9 is lower than that of R165K-RpalETF. This could be explained
using the basicity of His, even if the protein environment tunes its pKa. The basicity of His
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is lower than those of Lys and Arg, therefore, it may not be positive enough to stabilize BfFAD, in turn leading to destabilization of the protein. If this is true, then R165H should be
better able to stabilize the Bf-FAD at pH 8 than at pH 9. However, the reverse appears true
based on our data, as Bf-FAD bound at pH 9 but not at pH 8 (flavin quantification being
less than 1, the visible spectrum is similar to ET-FAD and the CD has intensity most
consistent with ET-FAD). Therefore, we suspect that there might be some mechanism
present at Bf site that prevents Bf-FAD binding in the presence of His, and further data are
needed to explain it. The deduced visible absorption spectrum of Bf-FAD in R165KRpalETF lacks the vibrational features that characterize WT-RpalETF’s Bf-flavin,
indicating destabilization of H-bonding interactions, even though the Bf-flavin is bound.
Overall, a positive charge at the Bf site is more important than a H-bonding interaction for
incorporation of Bf-FAD, because R165K-RpalETF retains Bf-FAD even without a
bidentate H-bonding interaction, and R165H-RpalETF fails to bind Bf-FAD at pH 8
although it is in-principle able to engage in bidentate H-bonding.
Considering all these observations, we argue our flavin quantification and titration results
show absence of one FAD, which is Bf-FAD therefore changes in the CD spectrum could
be due to the alteration in the ET-FAD binding site or presence of a very few percentages
of Bf-FAD. Far UV CD spectrum of R165K-RpalETF, WT-RpalETF and R165H-RpalETF
resembles and confirm the correctly folded protein and absence of second flavin is not due
to misfolding of the protein structure. If the protein environment changes the pKa of His
and if it is protonated at pH 9 we would expect that to happen at pH 8 as well, but it seems
like His may not be positively charged.
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Our deduced ET-FAD spectrum resembles the spectrum of T94/97A ETF which retains
only the ET-flavin18, the deduced spectrum of the corresponding FAD in Acidaminococcus
fermentans ETF (α FAD of Afer), and the corresponding FAD of Megasphaera elsdenii
ETF (FAD 2 of MelsETF)

26

and ETFs of some mutants R237E, R237A from

Methylophilus methylotrophus (Mmet) ETF10. Whereas deduced Bf-FAD spectrum
resembles the Bf-FAD in Afer 30,4 and FAD 1 in MelsETF26. In all these sp. the Bf-FAD
shows the vibrational features in band 1 and two bands are well separated by absorbing
around 370 nm, 450 nm. On the other hand, in ET-FAD, band 1 and band 2 separation is
less and amplitude of band 2 is higher than band 1 absorbing around 384-394 nm and 448452 nm respectively. Collectively, the band 2 in ET-FAD is subjected to red shift from
typical authentic FAD band 374 nm, as in T94/97A ETF (394 nm) and as in AferETF (~410
nm) and MelsETF. It is important to highlight the fact that Domain II in bifurcating ETFs
subjected to rotate during electron transfer mechanism4,

47

. Our data also draws our

attention in explaining the Domain II movement and protein dynamics because regardless
of the site of mutation, ET-FAD interaction towards the side chain amino acids might have
been altered due to the Domain II movement and dynamics.
Reduction of all the variants except R165H-RpalETF showed a triphasic reduction, when
titrating with sodium dithionite, NADH or the xanthine/xanthine oxidase (XO) system. As
in previous work on RpalETF and MelsETF26, reduction first generated an ASQ as
indicated by the optical signature feature of increased absorbance at 374 nm in conjunction
with decreased absorbance at 454 nm and an isosbestic around 390 nm. In the second phase,
absorbance intensity decreased at both 374 nm and 454 nm indicating formation HQ from
ASQ. These phases represent two sequential 1e reductions of a higher potential FAD (ET-
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FAD). Further change, in the third phase, revealed 2e reduction of the lower-potential FAD
(Bf-FAD) (Figure 3.6). The absence of significant SQ at the midpoint of this phase
indicates that the Bf-FAD has crossed potentials (Figure 3.6D). R165H-RpalETF shows
different behavior: a biphasic reduction comprising ASQ formation and decay (Figure 3.3).
This further demonstrates the presence of only one FAD, which is consistent with the
spectral and redox properties of ET-FAD of T94/97A RpalETF documented in previous
work18.
In this study, we explored the roles of both R273 and R165 in the redox tuning and stability
of the RpalETF protein. We calculated the E°’ for all phases in each variant and WT based
on E° values measured at pH 8, to allow direct comparison with E°’s of other ETFs (Table
3.8). The similar E°’ of the OX/ASQ couple of WT, R273K- and R165K-RpalETFs, of –
61, -69 and -67.6 mV respectively, indicate that replacement of Arg by similarly charged
Lys at either site do not alter the E°’ of ET-FAD. Likewise, the similar separations between
E°’OX/ASQ and E°’ASQ/HQ indicates that positive charge of Lys stabilizes an ASQ as much as
the WT Arg side chain does. This makes sense given that the spectral changes observed
indicate that in all cases, the SQ formed is the deprotonated negatively charged ASQ which
would benefit from favorable electrostatic interaction with a positively charged side chain.
At -61 mV, the E°’OX/ASQ of WT-RpalETF is considerably lower than the values reported
other Bf-ETFs: AferETF (+134 mV)30, MelsETF26 (+81 mV), and PaeETF (+33 mV)19.
This indicates that a factor additional to Arg273 is important in favoring ET-FAD reduction
in the other organisms. However, the Arg273 is clearly also critical since R273A- and
R273H-RpalETF E°’ values are -131, -151 mV, showing a significantly less driving force
for reduction of OX to ASQ compared to WT-, R273K- and R165K-RpalETF. Interestingly
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the similar observation has seen by Scrutton and coworkers in MmetETF

10, 60, 71, 79

.

MmetETF is the well-studied ETF system with highest E°’ for OX/ASQ calculated so far,
+153 mV. When they converted the R237 in domain II to an Ala residue it drastically
destabilized reduction of OX to ASQ by 200 mV and accelerated production of HQ. In our
system the formation of ASQ from OX has been destabilized by 76 mV in R273A-RpalETF
and 90 mV in R273H-RpalETF. Based on the sequence identity between the MmetETF and
bifurcating RpalETF, we suspected the role of R273 would be as similar as R237 in
MmetETF. Our data proves that our hypothesis is true, indeed R273 has a remarkable role
in stabilizing the ASQ in RpalETF. Thus, neutral Ala cannot stabilize the negatively
charged ASQ and His basicity is not sufficient to acquire the positive charge needed to
mimic Arg. Another work from Frerman and coworkers has demonstrated that mutating
the R249 in human into a Lys decreased the E°’ for the OX/ASQ couple but still stabilized
the ASQ, which is similar to the mutation shown in MmetETF R237K by Scrutton and
coworkers.
Thus, our data on R273 are in excellent agreement with prior work but are the first to extend
it to a group 2 ETF. Moreover, we are the first to publish analogous variations to the Bf
site. Measured E°’ASQ/HQ have not been possible for many ETFs due to a kinetic limitation
to formation of the HQ state. In WT-RpalETF and all the variants as shown (Table 3.8)
E°’ASQ/HQ could be determined and were found to vary only slightly from one-another and
closer to the literature values reported for MelsETF (-136 mV), although they are lower
than those of AferETF and PaeETF. Thus, the effect of R273 seems primarily to tune the
OX/ASQ couple, not the ASQ/HQ couple. This is consistent with formation of anionic HQ
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rather than neutral HQ as the absence of a change in charge would make the couple
independent of changes in active site charge, to first order.
Based on the separation of E°’OX/ASQ from E°’ASQ/HQ compared to other ETFs, RpalETF
stabilizes ASQ less than MmetETF, AferETF, MelsETF, PaeETF but more than pig ETF,
PdeETF and equal to human ETF. Based on previously calculated values for WT at pH 9,
difference between E°’ of OX/ASQ and ASQ/HQ couple has increased by 25 mV (Table
3.8) indicating ASQ is stabilized more. This could be due to the presence of CT band and
significant difference in the spectral changes of WT at pH 9 and 8. The conservative R-toK substitutions we made at the ET site had no significant effect on the potential of Bf-FAD,
and these values are same as that reported for AferETF. However, the two sites do not
appear independent, as R273A and R273H substitutions in the ET site produced 30 mV
decreases in the E°’OX/HQ values for Bf-FAD making them more similar to those of
PaeETF. It may be that these mutations are associated with a change in the conformational
equilibrium, providing a mechanism by which these distant substitutions could alter the
E°’OX/HQ of the Bf-FAD. However, it is most important that none of our variants stabilized
significant SQ at the Bf site. Suppression of SQ is deemed important in order for the FAD
to function as a Bf site. Thus, it was surprising to discover the presence of a positively
charged Arg residue in the Bf site.
The higher E°ASQ/HQ of the ET-FAD compared to the E°’OX/HQ of the Bf-FAD is also critical
for bifurcation, and this is preserved in all our variants. However, a mechanism preventing
the ET-FAD from engaging in 2e redox chemistry is also important. Our data indicate that
in R273A- and R273H-RpalETF, OX ET-FAD can be directly converted to HQ in some
fraction of the sites. Moreover, their lower E°OX/ASQ can cause the ET-FAD to be OX in
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some fraction of the sites in vivo. Thus, in the absence of Arg273, ET-FAD could accept
both electrons from the Bf-FAD to compete against the electron bifurcation reaction.
3.5

Conclusion

Our study is the first to report thermodynamic measurements on Bf-ETF bearing
substitutions in the Bf site. We have demonstrated that R165 plays an important role in
stabilizing bound Bf-FAD. This is consistent with the crystal structure of AferETF, in
which Arg165’s side chain forms an H-bond with the flavin N5. However, for that
interaction, a positive charge is not necessarily important. Our finding that Lys but not His
can retain bound Bf-FAD shows nevertheless that positive charge near Bf-FAD stabilizes
the FAD binding. The lower stability and affinity for FAD of R165H-RpalETF at pH 8,
than at pH 9 is a clue that deprotonation of a group with a pKa in that range could play a
role. Candidates to be investigated in future work include the flavin N3H and the
pyrophosphate component of the FAD. Therefore, we conclude here R273 plays a vital role
in stabilizing ET-FAD ASQ relative to OX in RpalETF, as in other ETFs. This conclusion
can be extended to other bifurcating ETFs as they are closely related to each other having
a conserved Arg residue throughout the ETF family. However, we note that in RpalETF,
in the presence of R273 the E°OX/ASQ is lower than in other ETFs pointing to additional
mechanisms being present in the other ETFs. On the other hand, Bf-FAD retains a
structural role similar to the AMP counterpart in canonical ETFs, in addition to functioning
as the site of bifurcation. Thus, we find that the R165H substitution in the Bf site affects
the entire rest of the protein at pH 8, because loss of Bf-FAD in the system leads to
structural destabilization in bifurcating ETFs. The converse is also true in a subtler way, as
the R273H and R273A substitutions in the ET site perturb the E°OX/HQ of the Bf site, by 30
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mV. Thus, the two sites should not be considered fully independent, and work directed at
understanding the conformational equilibrium may clarify its possible role in mediating
coupling between the two FAD sites.
3.6

Methods
3.6.1

Site-directed mutagenesis

Mutations were introduced into the gene for RpalETF: fixB carrying an N-terminal His tag
in the pMCSG21 plasmid (spectinomycin resistant)29. Primers encoding the desired amino
acid substitutions were designed using NEB base changer (Table 3.8) and employed
according to the vendor’s recommendations to introduce the mutations via polymerase
chain reactions using Q5 High Fidelity DNA polymerase (New England Biolabs, Ipswich
MA). The mutated construct encoding EtfL and native EtfS were transformed into
competent Nico21(DE3) Escherichia coli (New England Biolabs, Ipswich MA), along with
pGro7 (Takara Bio, Mountain View, CA, USA) for co-expression of molecular chaperones
GroES/EL. Note: Plasmids expressing R165H and R165K were obtained from Dr. Diessel
Duan.
Table 3. 9: Forward and Reverse primers
Variant

Forward Primer

Reverse primer

R165H

5’CGCCGCGACGCATC
CGACCTTCG-3’

5’-AGCGAATTGTCGGA

R165K

R165A

GTCGACCTCAAGC-3’

5’-CGCCGCGACGAAA

5’AGCGAATTGTCG

CCGACCTTCG-3’

GAGTCGAC-3’

5’-CGCCGCGACGG

5’-AGCGAATTGTCGGA

CGCCGACCTTCG-3’

GTCG-3’
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Table 3.9 (continued)
R273Q

R273H

R273K

R273A

5’-CGGCTGTTCGCAGC

5’-TATTCGGCGCCGA

CGCTGGTGC-3’

GCACGC-3’

5’-CGGCTGTTCGCATC

5’-TATTCGGCGCCGA

CGCTGGTGC-3’

GCACG-3’

5’-CGGCTGTTCGAA

5’-TATTCGGCGCCGA

ACCGCTGGTGC-3’

GCACG-3’

5’-CGGCTGTTCGGCG

5’-TATTCGGCGCCGA

CCGCTGGTGC-3’

GCACG-3’

3.6.2 Protein expression and Purification
Cells were grown in 1L of Terrific Broth supplemented with 20 mg/L riboflavin and 2 mM
MgSO4 along with carbenicillin (100 µg/mL), spectinomycin (100 µg/mL), and
chloramphenicol (50 µg/mL) at 37 °C, shaking at 250 rpm, to an A600 of ~1-2. After fully
cooling the culture to 18°C, groES/EL gene expression was induced with 1 mg/ml Larabinose. After 30 min of growth, ETF gene expression was induced with 0.1 mM
isopropyl 1- thio-β-D-galactopyranoside. Cultures were then grown for an additional 20 h
at 18 °C. Cells were harvested by centrifugation at 4500 rpm, 4 °C for 30 min, and the
pellet was stored at 80 °C after washing once in PBS (10 mM Na2HPO4, 1.8 mM KH2PO4,
137 mM NaCl, 2.7 mM KCl, pH 7.4). Frozen cell pellet (~ 30 g) was thawed and
resuspended in 60 ml of BugBuster (EMD Millipore, Burlington, MA, USA) containing 1
mM 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride, 1 mM FAD (Chem-Impex
International, Wood Dale, IL, USA), 2 µL of Benzonase® Nuclease HC, and 2 µL of
rLysozymeTM solution (EMD Millipore) and further incubated at 4 °C for 2 h with stirring.
After centrifugation at 15, 000 g for 30 min at 4 °C. The resulting protein solution was
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mixed with 1.5 mL of pre-equilibrated nickel-nitrilotriacetic acid resin (EMD Millipore)
and incubated at 4 °C with stirring for 30 min. Then the mixture was transferred to a column
at 4 °C. After collecting the flow-through, the column was washed with 20 column volumes
of 20 mM Tris, pH 7.8, 500 mM KCl containing 20 mM imidazole. Finally, the column
was developed with 2 column volumes of 20 mM Tris, pH 7.8, 500 mM KCl containing
100 mM imidazole, and the eluate was collected in different fractions. After SDS-PAGE
analysis, imidazole was removed from the pooled pure fractions by passage over a 10DG
column (Bio-Rad) equilibrated with 20 mM bis-Tris Propane, pH 8.0, 200 mM KCl, 10%
(w/v) glycerol. Any apoproteins were then reconstituted by overnight incubation of the
protein in 1 mM FAD at 4 °C in darkness. Excess flavin was then removed by gel filtration
on a 10DG column (above) prior to prompt use or flash-freezing in liquid nitrogen and
storage at -80 °C.
3.6.3

Flavin quantification:

The protein concentration (µg/mL) was determined using the Pierce 660 nm protein assay
with bovine serum albumin as the standard (Thermo Fisher scientific, Waltham, MA). ETF
concentration was calculated based on the molecular mass of 74, 545 Da29. In individual
1.5 mL microcentrifuge tubes 350 µL of ~30 µM ETF in working buffer was added and
wrapped in aluminum foil to exclude light and prevent photochemical transformation of
cofactors. Cofactors were released by denaturing the ETF by heating at 100 °C for 10 min
after which denatured protein was removed by centrifugation at 14, 000 g for 10 min after
cooling the samples. Supernatant was transferred to a quartz cuvette and the optical
spectrum was recorded on a HP 8453 spectrophotometer. Absorbance at 450 nm was used
to determine the released flavin concentration (ℇ450 = 11.3 mM-1 cm-1)26. From this and
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FAD’s (ℇ260 = 35.93 mM-1 cm-1) we calculated the absorbance due to FAD at 260 nm. The
excess A260 was used to determine the concentration of ADP (ℇ260 = 15.0 mM-1 cm-1)63 in
R165H-RpalETF.

3.6.4

CD measurements
3.6.4.1 Visible CD

CD spectra of 98 µM of R165-RpalETF and 68 µM of WT RpalETF were recorded using
a JASCO J-800 series spectropolarimeter from 600 to 300 nm at 4 °C in a 1.0 cm path
length quartz cuvette with the following parameters: scan speed = 100 nm min-1,
bandwidth= 2.00 nm, scanning speed = 100 nm min-1, and three accumulations. The molar
ellipticity was calculated using the equation, [θ] = θ/ (c × l), in which θ is the ellipticity in
millidegrees, c is the concentration in mM, and l is the cell path length in cm.
3.6.4.2 Far-UV CD for Tm measurement
Far-UV CD spectra of all the variants (17-30 µM) were recorded using a JASCO J-800
series spectropolarimeter from 250 to 190 nm starting at 20 °C in a 0. 2 cm path length
quartz cuvette with the following parameters: bandwidth= 1.00 nm, scanning speed = 50
nm min-1, and three accumulations. The molar ellipticity was calculated using the equation,
[θ] = θ/ (c × l), in which θ is the ellipticity in millidegrees, c is the concentration in mM,
and l is the cell path length in cm. CD measurements were taken in working buffer starting
from 20 °C to 60 °C every 2 °C interval.

90

3.6.5

Redox titrations

Reductive titrations were performed in inert atmosphere, monitored using a HP 8452A
spectrophotometer (Agilent technologies) equipped with an OLIS controller, inside a glove
box (Belle Technology, Waymouth, UK), using a 1 cm path length self-masking quartz
cuvette at room temperature. ETF was reduced by small aliquots amounting 1 µM sodium
dithionite ( ℇ315 = 8.04 mM-1 cm-1)64. This low concentration provides sufficient driving
force to fully reduce the FAD at the pH of 865.
3.6.6

Spectral Deconvolution

Individual spectra of each of the flavins in each of the variants and WT are deduced using
difference spectra. Difference spectra of each protein were calculated by subtracting each
successive spectrum from the initial spectrum (each phase is shown in Figure 3.8B)
collected during stepwise reduction of protein with sodium dithionite (step wise reduction
shown in Figure 3.5 A, B, C, D, and E). For example, blue spectrum minus orange spectrum
in Figure 3.8A gives the green spectrum in figure 3.8B. Using the characteristic shape of
the difference spectra (Figure 3.8B) phases were separated. In Figure 3.8A red spectrum is
the combination of oxidized Bf-FAD and reduced ET-FAD. Subtracting the reduced ETFAD spectrum from this spectrum will produce the oxidized Bf-FAD spectrum. Fully
reduced ET-FAD spectrum (HQ) of T94/97A RpalETF (ref. Figure 2.7 in Chapter 2) was
used as the HQ spectrum of ET-FAD, as this spectrum was observed only due to one flavin
and the ET site was not altered by the mutations. This HQ spectrum was subtracted from
the red spectrum in Figure 3.8A after adjusting to the one flavin concentration. This will
give the pure oxidized spectrum of Bf-FAD. Then oxidized Bf-FAD spectrum was
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subtracted from the initial spectrum containing both oxidized ET-FAD and Oxidized BfFAD spectrum to deduce the ET-FAD spectrum.

A

0.8
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Figure 3. 8: Steps showing the spectral deconvolution. Sodium dithionite titrations plotted
in Figure 3.5 were used to deduce the difference spectrum of each phase as in panel B
(shown here only for WT).
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3.6.7

Reduction midpoint potential determination

Table 3. 10: Reference dyes used to measure the E°
Dye

Abbreviation E˚’ (at pH
7, mV)

No

of

electron

E˚ at pH 8

References

(mV)

vs
proton
Methylene blue

MB

+11

2e/H+

-19

73

New-methylene

NMB

-21

2e/H+

-51

76

Resorufin

RS

-51

2e/2H+

-111

77, 78

Nile blue

NB

-116

2e/H+

-146

73

Phenosafranin

PS

-252

2e/H+

-282

73

Safranin O

SO

-289

2e/H+

-319

73

blue

Potentiometric titrations were also monitored optically using

a HP 8452A

spectrophotometer (Agilent technologies) equipped with an OLIS controller in an inert
atmosphere afforded by a glove box (Belle Technology, Waymouth, UK) using a 1 cm path
length self-masking quartz cuvette at room temperature. Xanthine oxidase in combination
with xanthine was used to provide a slow continuous delivery of reducing equivalents66.
The reaction mixture contained 420 µM xanthine, 10 µM methyl viologen, ~20- 30 µM of
ETF, and 3-5 µM of the applicable dye (Table 3.10) in working buffer. The reaction was

93

initiated by addition of 3-10 nM xanthine oxidase depending on the ETF and E° of the
phase under investigation, and spectra were recorded every 1 min.
The reduction midpoint potential E°OX/ASQ of the reduction of OX FAD to ASQ was
calculated by relating the extent of reduction of FAD with the extent of concurrent
reduction of the reference dye. Conversion of OX to ASQ was quantified based on
absorbance changes at 454 nm, while the reduction of the dye was quantified based on loss
of absorbance at λmax of the dye.
For WT RpalETF, the point in the titration corresponding to the maximum ASQ
concentration was identified and treated as the endpoint of the first 1-e reduction and
assigned to full conversion to ASQ based on the agreement between the shape of the
spectrum and that of authentic samples of 100% ASQ. Each spectrum up to that point in
the titration was converted to a difference spectrum by subtracting the endpoint spectrum,
to reveal the remaining OX population. The first point in the titration was not 100% OX,
as the RpalETF undergoes slow spontaneous reduction in the glove box. However, the
amount of ASQ in the spectrum could be estimated by subtracting a weighted spectrum of
purely ASQ RpalETF in such a way as to produce a flat zero baseline at wavelengths >500
nm where ASQ is positive, but OX generally does not absorb. The weighting required to
accomplish this revealed what fraction, f, of the total starting absorbance corresponded to
ASQ, and thus the magnitude of the residual population, 1- f, that underwent reduction in
the course of the measurement. We obtained 0.05 < f < 0 .10 in three titrations. The
difference spectra were thus interpreted to reflect the reaction of the (1- f) portion of the
sample and for the example of the midpoint in the change, f + (1-f)/2 = 0.5 + f/2 of the
sample is ASQ while 0.5-f/2 is OX. Absorbance at 454 nm was used to find the absorbance
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change due to reduction of one equivalent of FAD and thereby to calculate to calculate the
fraction of OX converted to ASQ. [FADOX]/[FADASQ] at each point in the titration were
calculated from the fractional populations. λmax of the dye was used to calculate the extent
to which oxidized dye, DYEOX, was converted to reduced dye, DYERED. The ratio of
oxidized to reduced dye along with that of the FAD were employed in the Nernst equation,

𝑙𝑜𝑔 (

[FAD𝑂𝑋 ]
[FAD𝐴𝑆𝑄 ]

)=

𝑜
𝑜 )
[DYE𝑂𝑋 ]
𝑛𝐹𝐴𝐷
𝐹(𝐸𝐷𝑌𝐸
− 𝐸𝐹𝐴𝐷
𝑙𝑜𝑔 (
) + 𝑛𝐹𝐴𝐷
𝑛𝐷𝑌𝐸
2.303𝑅𝑇
[DYE𝑅𝐸𝐷 ]

where nFAD, nDYE denote the number of electrons acquired by the flavin and the dye
respectively during the reaction under study, and F, R and T are Faraday's constant, the
[FAD

]

ideal gas constant, and the temperature, respectively. A plot of 𝑙𝑜𝑔 ([FAD 𝑂𝑋 ]) versus
𝐴𝑆𝑄

[DYE

]

𝑙𝑜𝑔 ([DYE 𝑂𝑋 ]) , was used to determine nFAD from the known value of nDYE = 2 (Table
𝑅𝐸𝐷

3.10) The intercept of the plot then permits calculation of E°FAD for the ET-FADOX/ASQ.
Similar steps were followed to calculate the E°ASQ/HQ of all the ETFs. But in phase 3
E°OX/HQ calculation in the presence of PS and SO, the dyes’ strong absorbances at 454 nm
interferes with the flavin spectra. Thus, the extent of flavin oxidation was assessed at the
isosbestic point of the dye’s reduction at 406 nm (for SO dye), where the extinction
coefficients of oxidized and reduced dye are equal.
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CHAPTER 4. NOVEL,
SITE-SELECTIVE
FLAVIN
MODIFICATION
BIFURCATING ELECTRON TRANSFER FLAVOPROTEINS.

4.1

IN

Abstract

RpalETF contains two chemically identical but functionally different FADs: ET-FAD is
bound in highly mobile domain II, which sits in a stable base created by domains I and III.
Bf-FAD is buried in between domain I and III. Here we describe an irreversible, pH
dependent, site selective, enzyme mediated, anaerobic covalent modification of FAD to a
pink FAD, which opens a new perspective with which to understand the 726 nm band
formed in bifurcating ETF. Incubation of purified WT RpalETF under anaerobic in
darkness at 4 °C results in accumulation of a pink modified FAD, which is not observed if
aerobic conditions are used. Based on optical spectral changes were used to monitor
changes as a function of time, showing that the process is complete within 48 hours. at pH
9. The spectrum of FAD released from the ETF demonstrates that the flavin rather than the
protein was changed. Modified flavin precipitates from high pH buffer leaving unmodified
FAD accounting for one of the two FADs in the ETF and indicating that the other FAD
undergoes quantitative conversion. By selectively displacing the ET-FAD using ADP, we
demonstrate that this is FAD that gets modified, consistent with published reports of
modification of the corresponding flavin of canonical ETFs. A combination of mass
spectrometry, variation of the identify and concentration of the buffer, and optical
signatures support the conclusion that the pink flavin results from displacement of the
flavin’s 8-methyl by an amine fragment of the buffer. Reductive nucleophilic attack on the
flavin by deprotonated buffer could thereby generate an amino flavin explaining the pink
color of released flavin, as well as the net reduction of the system implied by accumulation
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of the 726 nm band. Fragments of the pink flavin detected by electrospray ionization ES
(-) support this model and demonstrate that the proposed chemistry is not exclusive to bisTris-Propane buffer (BTP), but also occurs with Tris buffer. This attribution is further
supported by a red shift in the fluorescence emission peak of pink FAD relative to that of
authentic FAD. Our data demonstrate the presence of a modified FAD in ETF stored at
high pH, even at otherwise inert conditions, and serve as a strong warning that buffers
included in samples need to be considered as potential reagents as well.
Formation of the pink FAD in WT is correlated with spontaneous accumulation of the 726
nm charge transfer (CT) species which had previously been attributed to an intermediate
oxidation state of the ETF system, involving both flavins. Herein, we show that formation
of this species is also correlated with formation of pink flavin, following it in time. Both
species are suppressed at pH 8 but formed at pH 9, consistent with dependence on the
deprotonated state of the amine buffer. Spectral signatures observed in the course of
reductive titration suggest that bound pink FAD accumulates in the SQ state and that this
is the state which forms the CT band at pH 9 (upon interaction with the Bf-FAD). Positively
charged R273 situated near ET-FAD plays a role in accumulation of both the pink flavin
and the 726 nm band, possibly by stabilizing a proposed precursor for substitution of the
C8 methyl of FAD. The resulting modification in fact has the effect of enforcing the
sequential single electron reactions required of the ET-FAD, but not natural for free flavin.
Thus, we propose that the modified ETF retains bifurcating activity. Thus, our data not
only demonstrate site selective modification and solvent accessibility of the ET-FAD, but
also open a new path to understanding the requirements for the enigmatic 726 nm complex,
and electron bifurcation in RpalETF.
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4.2

Introduction

FMN and FAD are the two most common biochemical flavin-containing cofactors1. In
most flavoproteins both of these is non-covalently bound, but in some 10% of flavoproteins
the flavin cofactors are covalently attached to the peptide chain. Usually this is via the C8
or C6 position of isoalloxazine ring32, 81 (molecular labeling of isoalloxazine is given. in
Figure 1.2). Besides covalent attachment to proteins, flavins are also subject to covalent
modifications in many flavoproteins. Examples, include formate oxidase, lactate oxidase,
glycolate oxidase from pig liver and electron transfer flavoproteins (ETFs)36-42, 44. Two
different modifications to non-covalently bound FAD were discovered in an electron
transfer flavoprotein from Megasphaera elsdenii (formally known as Peptostreptococcus
elsdenii). Protein preparations were found to contain variable amounts of a green
chromophore determined to be 6-OH-FAD and/or an orange chromophore determined to
be 8-OH FAD36, 37. Similarly, in glycolate oxidase from pig liver contain unmodified FMN
as a main component in addition to 6-OH FMN36. In two of these cases the hydroxy flavins
render the enzyme nonfunctional, and analysis of crude cell extracts showed no sign of the
modified FAD suggesting that they were formed during protein purification. Researchers
suggested that this could be due to exposure to conditions which are absent in vivo37.
Lehman and Thorpe characterized two forms of ETFs isolated from pig kidney. Some
batches of ETF produced NSQ at pH 6.5 as opposed to the ASQ intermediate normally
observed during sequential reduction of ETF, and the authors demonstrated that formation
of NSQ is not simply an aging artifact, it is pH dependent and at higher pH, formation of
NSQ was diminished. Moreover, released FAD from the proteins had different spectral
features in the regions of both band 1 (near 450 nm) and band 2 (near 370 m,) of suggesting
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formation of a novel FAD derivative44. Optical spectra of this novel FAD and its reduced
form generated during stepwise reduction with dithionite (or photochemically) resembled
the spectra of the 8-formyl FMN reported by Massey and team in mutational studies of Llactate oxidase (LOX) from Aerococcus viridans41. In that case, conversion of an Arg268
residue to a Lys residue resulted in slow formation of modified FAD, which was not present
in the WT and was shown to possess a formyl group in place of a methyl group at the 8
position of the isoalloxazine ring.
Later, enzyme mediated formation of an 8-formyl FAD in WT formate oxidase (FOX)
from Aspergillus oryzae RIB40 was demonstrated by researchers, and according to the
investigators the spontaneously generated 8f-FAD is the catalytically active form38,
39, 43, 82

. Recently, Macheroux and coworkers conclusively documented formation of

8f-FAD in human ETF40. Their detailed study of requirements for modification and
spectral properties of the product made chemical sense of preliminary findings in
the pig ETF and MelsETF. In each of these cases, modified flavin is formed
spontaneously either during the purification of protein or when protein is stored
under conditions different from those likely in vivo. In addition to these spontaneously
formed C8 modified flavin, C8-N(CH3)2 amino flavin, known as roseoflavin, is formed in
nature by Streptomyces davawensis and Streptomyces cinnabarinus, which exploit its
antibacterial properties34, 83. Modification at the C6 position is also common and observed
among flavins covalently bound to amino acid side chains of proteins. Examples include
C6-S-cysteinyl flavin, C8-N1-histidyl or N3-histidyl, C8-O-tyrosyl and C8-S-cysteinyl
flavins are well-known32. It is notable that in all cases, a nucleophilic amino acid side chain
attaches to the flavin.
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Hemmerich et al., demonstrated that the C8 methyl is chemically active and deprotonates
under basic conditions to form flavin dimers via quinone-8-methide intermediates84. A
similar mechanism was proposed for formation of covalent links to basic protein residues
able to attack and/or deprotonate C8 or its methyl32.
Solvent accessibility of C8 and C6 position was compared by reconstituting the respective
apo protein with either 6-N3 and 8-N3 flavin analogs85, 86. Increase in the covalent labelling
during light irradiation indicates less solvent accessibility. In most of the proteins C6 has
less solvent accessibility than the C885. Further among naturally available covalent flavin
only Cys attaches to C6 but C8 binds to His, Tyr, and Cys. Most of the covalent
modification reported in C8 position (ex 8f-FAD and FMN).
Based on these naturally occurring flavin derivatives and flavoproteins’ environmental
adaptability to these changes, scientists synthesized these and other flavin derivatives, and
incorporated them into proteins in order to study enzymes’ catalytic mechanisms,

spectroscopic and thermodynamic properties31,

85-90

. One of the major benefits of

working with flavoproteins is that noncovalently bound flavin cofactor can be removed
using mild conditions and replaced with modified FAD or FMN derivatives with desired
spectral properties6, 37, 85-87, 89. Binding interactions between the apoprotein and the flavin
ribityl chain and phosphates can provide sufficient affinity although specific hydrogen
bonds between the apoprotein and the modified flavin positions may be altered6. This
facilitates incorporation of flavin derivatives in any stable apo flavoprotein such as lactate
oxidase, D-amino oxidase, glucose oxidase etc85-87,
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and tight binding of the flavin

derivatives similar to the native flavin enable illuminating biochemical characterization.
For example, Thorp and team incorporated 8-Cl-FAD into pig ETF45. Subsequent reaction
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with thiophenol then altered the spectral properties of bound FAD. A series of 8alkylmercapto-FAD analogues containing increasingly bulky substituents like 8-CoAFAD, bound tightly to apo-ETF and were fully reduced by octanoyl-CoA in the presence
of catalytic amount of the medium-chain acyl-CoA dehydrogenase45. Thus, Thorp and team
were able to delineate the size of the substrate binding cavity.
Modified flavins have thus been observed in several canonical ETFs, and also in an ETF
that is now understood to be a bifurcating ETF. Canonical ETFs are heterodimers
consisting of three domains. Domain II incorporates the FAD, domain III contains a buried
AMP and domain I is associates with domain III, holding the dimer together10, 20, 21. On the
other hand, bifurcating ETFs possess a second FAD in place of AMP and its flavin portion
is bound between domains I and III. Functionally related ETFs share 50% of sequence
identity among the members whereas functionally unrelated ETFs share only 30%17.
Amino acid residues in the immediate vicinity of the FAD binding site in domain II are
conserved throughout the ETF family20. Furthermore, crystal structures of human,
Paracoccus denitrificans, Methylophilus methylotrophus (Mmet) ETF, Clostridium
difficile, Acetobacterium woodii, and Acidaminococcus fermentans (Afer) ETF show that
domain II can adopt a wide range of orientations14 Moreover in one of the two
conformations, FAD bound in domain II is highly solvent accessible and could be
susceptible to flavin modifications as it is more expose to the external conditions compared
to the buried bifurcating FAD.
In this work we report i) a novel, site selective flavin modification in bifurcating WT
RpalETF in alkaline conditions, ii) formation of the modified flavin as a result of the
reaction with the amine buffers, we have used, iii) correlation between the modified FAD
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and spontaneous formation of the previously reported CT band at 726 nm and iv)
involvement of a highly conserved R273 residue in favoring the flavin modification.
Overall, this work opens a path for biosynthesis of amino derivatives of ET-FAD, for the
first time in bifurcating ETFs.
4.3

Results
4.3.1

Time dependent absorption changes of purified T94/97A ETF.

Covalent modifications in flavin have not been reported in any of the recently studied
bifurcating ETFs. But earlier work on Megasphera elsdenii (Mels) ETF (formally known
as Peptostreptococcus elsdenii ETF) documented formation of 8-OH and 6-OH flavin36, 37.
However the modifications could reflect differences in the protein preparation protocols
among different groups and over the years from 197436, 37, because later in 2003, Sato et
al. reported that MelsETF is purified with one FAD per dimer and upon addition of
exogenous FAD, the system can incorporate an additional FAD for a total of 2 FADs. This
ETF was later shown to be a bifurcating ETF26, 51. Meanwhile, many studies have reported
formylation of C8 position in FAD and FMN (8-formyl-FAD or FMN) in bifurcating as
well as canonical ETFs, in addition to other flavin containing enzymes39-41, 44, 82. We first
observed a covalent modification in RpalETF when the T94/97A ETF was purified at pH
9.
T94/97A ETF is a canonical ETF like system created from bifurcating RpalETF18, It
contains only one FAD in domain II (which is known as ET-FAD) and an AMP in domain
III18. In contrast, WT contains a second FAD in place of AMP. We observed that the
absorption spectrum of bound FAD in T94/97A ETF changes over the time when the
protein was purified at pH 9 in bis-Tris-Propane (BTP) buffer in air. Also, the optical
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spectrum was observed to vary depending on the time taken to purify the protein (Figure
4.1A). These two observations are related to one-another. Absorption maxima for bands 1
and 2 were observed at 450 nm and 382 nm in the freshly purified protein. However, over
a period of a few minutes at pH 9 in BTP buffer, this spectrum changed and a sharp peak
at 432 nm and a long wavelength absorption around 500-700 nm was observed (Figures
4.1A and 4.2A). We suspected that this spectral change could be due to chemical
modification of the bound flavin. To test this, protein was heat-denatured for 10 min at 100
°C and released flavin was isolated. Separated FAD after the purification and concentrating
the protein sample (within 15 min from purification) showed a 10 nm blue shift in the band
2 when compared to the authentic FAD (Figure 4.1B). When flavin was extracted from
T94/97A ETF absorbing maximally at 432 nm, the released FAD’s band 2 was observed
at 354 nm, which has been 20 nm blue shifted. Similarly, the released flavin’s band 1 has
been red shifted by 12 nm and appears at 462 nm, in contrast to authentic FAD (Figure
4.2A).
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A

B

Figure 4. 1: Visible spectra of T94/97A ETF illustrating the change of spectral properties
in different protein preparations. A) bound FAD spectrum changes from red to pink, red
shows at the time of purification, then changes to green, blue and pink, B) Shows the
released FAD and corresponding bound FAD spectrum compared to the authentic FAD
spectrum.

104

In preparing the T94/97A ETF, no exogenous FAD added during lysis, and the protein was
not reconstituted overnight, because our aim was to recreate a canonical ETF like system
with a single FAD and AMP incorporated in each cofactor binding sites. Therefore, the
observed modification is not because of any exogenous FAD. The band 1 and 2 wavelength
shifts in the optical spectra of released FAD resemble those of 8-formyl-FAD (8f-FAD)
reported by Augustin et al. and number of other authors, in both other ETFs40, 41, 44, and
other flavoproteins41, 42. However, we additionally see a slight absorption increase at 525
nm in the released FAD (Figures 4.2A, 4.3) which was not present in 8f-FAD spectra
shown by the other studies. Therefore, we suspect the presence of an additional modified
flavin, and propose that this can also explain our slightly lower intensity of band 2 than
band 1, which is unlike the literature spectra of 8f-FAD. Furthermore, the previous studies
on 8f-FAD reported a new peak that was always sharp, but occurred at somewhat different
wavelengths in different cases, specifically 425 nm in Yorita et al.41, 415 nm according to
Augustin et al.40 and 433 nm in Yoshifumi et al.82 Yorita et al. and Augustin et al. have
both demonstrated that their sharp signal is due to the semiquinone form of 8f-FAD, and
that longer wavelength absorption around 600 -700 nm also represents the semiquinone
state of normal FAD and modified FADs. Therefore, we suspect the 432 nm sharp peak in
our T94/97A ETF as well as the longer wavelength absorption around 500-700 nm is due
to the semiquinone of 8f-FAD (and some of the long wavelength intensity could also derive
from unmodified FAD).
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4.3.2

Spectral changes observed in T94/97A ETF is due to 8f-FAD

To test the chemical identity of the modified FAD, the FAD released from T94/97A ETF
displaying the spectral alterations was subjected to Mass Spectrometric (MS) analysis.
Negative ion mode in electrospray ionization (ES-) yielded a peak at 784 m/z (-)
corresponding to authentic FAD, accompanied by a strong peak at 822 m/z (-),
corresponding to 8f-FAD (Figure 4.2B). The combination of optical signatures matching
8f-FAD and a mass also matching this variant are considered conclusive because the flavin
optical spectra are highly sensitive to modifications, so a match with literature is almost
impossible unless the two flavins are chemically the same.

A

Figure 4. 2: A) Optical spectra of protein sample along with its released FAD compared
with authentic FAD spectrum.
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Figure 4. 2 B) MS ESI (-) analysis showing the m/z of 8f-FAD at 822 with a Na+ ion, C)
Chem Draw image showing the structure of 8f-FAD with its corresponding m/z 799.
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Moreover, the nature of the modification is consistent with the conditions under which it
arises in our hands. As reported by others, 8f-FAD is readily formed in the presence of
oxygen40, at high pH. Our ETF was purified in air-equilibrated buffers, exposing it to O2.
Although purified does not undergo conversion to 8f-FAD under the same conditions, there
is ample precedent for this process for FAD bound in ETF. Furthermore, the similar spectra
of modified FAD when bound to the protein testify that our ETF produces a flavin-binding
environment similar to that produced by other ETFs. The spectrum of bound 8f-FAD is
distinct from that of released 8f-FAD confirming that the enzyme subjects the flavin to a
peculiar environment, and the fact that modification occurs only when FAD is bound
demonstrates that the protein mediates the chemical modification. Based on our finding
that FAD is bound only at the ET site in domain II of RpalETF, we can conclude that this
is the site responsible for modification. High pH was shown to favor 8f-FAD formation by
Augustin et al., and our results concur. T94/97A ETF purified at pH 8 in the similar buffer
system did not display the spectral changes when exposed to air, even for a longer period,
and retained a spectrum similar to that of freshly purified ETF. Similarly, the FAD released
from samples maintained at pH 8 resembled authentic FAD18. Other than the pH, no
changes were made in the purification steps or buffer compositions, so retention of pH 8
sufficed to preserve the optical spectra of freshly purified T94/97A ETF, as well as the
visible CD spectra, and the flavin content (Figure 4.3, Figure 2.3, 2.4, 2.5). We thus confirm
that this protein-mediated modification of ET-FAD is also a pH dependent process.
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Figure 4. 3: Spectral changes of released FAD at pH 9 and 8, compared to the authentic
FAD spectrum.

4.3.3

Anaerobic vs aerobic covalent modification in WT RpalETF

While formation of 8f-FAD occurs only in the presence of O2, the environment produced
by the ET site appears to promote flavin modification even in O2’s absence. However,
under anaerobic conditions the nature of the modification is different. First clues appeared
in the course of earlier work on WT RpalETF by Duan et al. who reported formation of a
sharp absorption peak at 726 ± 2 nm during anaerobic reduction at pH 9 in BTP buffer,
regardless of the identity of the reductant29. This species is absent in the presence of oxygen
and when reduction was performed at pH 8 under the same buffer conditions. In later work
they proposed that the 726 nm band is due to a charge transfer (CT) between the reduced
ET-FAD and oxidized Bf-FAD. The band is not formed in the absence of either of the
flavins of the ETF, or in the presence of both flavins in the same oxidation state46. This is
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also true in the single-flavin-containing T94/97A ETF variant, which doesn’t produce 726
nm band regardless of the pH at which it has been reduced18. However, in this second work
from Duan et al., we suspected that additional criteria are required for formation of the CT
band. In particular, we speculated that presence of a modified FAD could also contribute.
Indeed, scrutiny of the spectrum of FAD released from ETF displaying the 726 nm band
suggests the presence of modified FAD. Therefore, this work evaluates the possibility of
anaerobic flavin modification in WT RpalETF, and tests for a relationship between
formation of the CT band and flavin modification.

A

B

C

D

Figure 4. 4: A and B show the visible spectral changes of WT RpalETF protein samples
collected in each time interval in the air and corresponding released FAD spectrum
respectively. C and D show the spectral changes of the WT RpalETF under anaerobic
conditions and corresponding released FAD, respectively.
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In contrast to the mutant T94/97A ETF, WT shows different type of modification in
anerobic and similar modification in aerobic conditions. To test whether observed spectral
changes were due to flavin modification, and to compare the modification with that
documented in T94/97A ETF, purified WT RpalETF at pH 9 in BTP buffer was stored at
4 °C in aerobic and anaerobic conditions in darkness. Samples were collected at the
beginning of the storage and then at 52 h, 96 h and 142 h. Optical spectra of collected
samples were collected. Each sample was then denatured to release flavin and optical
spectra from the released flavins were recorded after removal of protein by centrifugation.
Longer time intervals were sampled for WT RpalETF than in the previously described
studies of T94/97A ETF because the tell-tale spectral changes emerged much more slowly
in the WT RpalETF.
As shown in the Figure 4.4C, ETF maintained in anaerobic conditions started to form a
726 nm band as soon as the oxygen was completely removed from the system. The
corresponding released FAD (Figure 4.4D) showed absorption at 525 nm which was absent
from the spectrum of authentic FAD, suggesting that the altered spectrum of the ETF
represented alteration of the flavin itself, rather than indirect effects reflecting changes to
the protein site. Absorbance at 525 nm reached maximal intensity after 52 h and remained
constant through the longest time point at 142 h. The released FAD thus had three
absorbance features, at 374, 490 and 525 nm. The region of band 1 included two peaks
(525 nm and 490 nm) and both band 1 and 2 intensities dropped, but that of band 2
decreased more, compared to authentic FAD. The spectra of the source ETF material
continued to change over a longer time. Band 2 intensity decreased in parallel, and band 1
also decreased.
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Under aerobic conditions, we also observed modification of bound FAD manifested by
shifts in the absorption maxima of the ETF that were accompanied by alteration of the
spectra of flavin released from the protein at various times (Figure 4.4A and 4.4B). In
contrast to the changes in anaerobic samples, there was no sign of 726 nm band formation
throughout the same time interval. Nevertheless, in the released FAD, at the beginning
there was a 530 nm absorption reminiscent of that seen under anaerobic conditions.
However, intensity 530 nm increased up to 52 h and then decreased. Meanwhile, band 1
red shifted by 10 nm and band 2 blue shifted by 20 nm respectively to ultimate maxima at
460 nm and 354 nm, respectively.
In summary, our data demonstrate that WT RpalETF undergoes two types of modification
at pH 9, depending on whether or not O2 is present. Aerobic modification is consistent with
8f-FAD formation as observed in T94/97A ETF. However, the transformation process
appears to begin with a species absorbing at 525 nm. This could be due to presence of an
intermediate species which is unstable over the time during exposure to oxygen. All this
information collectively demonstrates that RpalETF’s ET-FAD is susceptible to
modification, as observed in other ETFs40. These modifications are not observed for free
flavin, so the protein environment activates the flavin for modification. The aerobic
reaction is consistent with published reports of conversion of the ET-FAD to 8f-FAD.
However, the reaction we observe under anaerobic conditions is, to the best of our
knowledge, unprecedented.
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4.3.4

Covalent modification is not observed in WT during isolation of the protein

To characterize 726 nm band formation in more depth, we focused on the changes that
occur under anaerobic conditions. The WT-ETF contains 2 FADs, the ET-flavin in domain
II and the Bf-flavin in the interface between domains I and III. Unlike the case in T94/97A
ETF, exogenous FAD was provided during cell lysis, and after purification any vacant
binding sites were reconstituted with 1 mM exogenous FAD overnight at 4 °C. This is
because as-isolated RpalETF from E. coli at Tris pH 7.8, contains only 1.4 FAD per dimer,
in the absence of exogenous FAD during lysis. Such material eventually aggregates after
passage through the gel filtration column and exchange into the working buffer, BTP pH
9. However, provision of exogenous FAD during lysis or even after the buffer exchange
yields ETF that is very stable and contains 2 FAD per dimer. Some later fractions collected
from the Ni column appear to have less FAD incorporated, so those fractions are further
reconstituted overnight at 4 °C with 1 mM FAD. This has been already explored before in
Mels41 and AferETF4, wherein reconstitution with exogenous FAD results in 2 FAD /ETF.
Therefore, adding authentic FAD is important to obtain a stable bifurcating RpalETF
worthy of biochemical experimentation.
Purification of WT RpalETF with exogenous FAD and without the exogenous FAD
(Figure 4.5B and C respectively) gives the same optical signal at 380 nm for band 2 and
452 nm for band 1 and the released FADs absorbs at 374 nm, 450 nm as similar to authentic
FAD. Further, during buffer exchanging from Tris pH 7.8 to BTP pH 9, after reconstituting
overnight with exogenous FAD and concentrating the protein using membrane centrifugal
filters have not caused any spectral changes or chemical modification in the FAD. This
observation contrasts with T94/97A ETF, which modifies during the isolation of the protein
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and the spectral features changes over the time. Further, T94/97A ETF was not
supplemented with exogenous FAD but still the modification was observed, whereas in
WT doesn’t undergo modification when supplemented with FAD or not. This shows, the
modification requires some external conditions (in our case one of the requirements is the
buffer) and this modification is not due to adding exogenous FAD.
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A

C

Figure 4. 5: A) and B) show the optical spectra of WT RpalETF, released and bound FAD,
collected at different stages of purification respectively.
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C

Figure 4.5: C) Visible spectra of WT collected during the early stages of purification
without adding exogenous FAD, right after eluting from the Ni-NTA column as it is
unstable at pH 9 BTP buffer.

4.3.5

Time dependent spectral changes in bound and released FAD

The FAD isolated from freshly purified ETF was not chemical modified (Figure 4.5 B and
C), but the prevalence of modification slowly increased with time. To monitor the
anaerobic modification, purified WT RpalETF at pH 9 in BTP buffer was degassed and
transferred into the anaerobic chamber and stored at 4 °C in darkness. Darkness was
maintained because flavins are known to engage in photochemical reactions, that we
wanted to exclude in order to focus on the modifications stimulated by the protein
environment at high pH. Samples were collected at 0, 3, 6, 12, 24, 26, 31, 37, 50, 60, 84
hours then at total times corresponding to 5 days. Optical spectra of ETF (reflecting bound
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FAD) and the corresponding released FAD were collected (Figures 4.7A, and B,
respectively). During this period the sample underwent a series of color change from
yellow to orange and finally to dark green which was the stable terminal color (Figure
4.7C). Even though there was no modification evident in the released FAD of freshly
purified protein (Figure 4.5A), over the time the extent of modification increased with the
duration of anaerobic storage based on absorbance at 525 nm (Figure 4.7B). The percentage
of modification was calculated relative to the maximal, asymptotic absorbance observed at
525 nm after 50 h in the released FAD. Thus, 100% modification was observed after 2 days
and there was no further increase in the intensity at 525 nm after that.
Spectral changes to the ETF-bound flavin at the same time points showed that formation
of 726 nm band lags behind flavin modification. Even though there was a 17% of
modification at the first time point based on A525, the 726 nm band did not start to form
until 6 h into the experiment and continued to grow even after the flavin modification was
complete at 50 h (Figures 4.4A, 4.7A). The reason for this delay could be due to presence
of traces of oxygen in the system. Because the 726 nm cannot be formed or stabilized in
the presence of oxygen as it requires a reduced FAD46 (Figure 4.6). The rate of formation
of 726 nm band was faster during flavin undergoes modification afterwards, the rate of
formation of 726 nm is slower (2 slopes observed) (Figure 4.8).
While the strength of the 726 nm band increased, the intensities of band 1 and band 2
decreased. The regular flavin bands dropped faster at the beginning, whereas later in the
experiment there was little further decrease (Figures 4.7A). This could be correlated with
the flavin modification, modified flavin absorbs at 374 nm, 490 nm and 525 nm, as shown
in Figure 4.7B. In the modified FAD the absorbance at 374 nm has been dropped
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significantly when compared to the beginning, and band 2 at 450 nm also has decreased
and shifted to 490 nm (Figure 4.7B). Due to this change in the flavin the intensity of the
bound flavin decreases. This observation further confirms spontaneous enzyme mediated
internal chemical modification of bound flavin in the ETF. As shown in Figure 4.6 during
the 726 nm formation, band 2 of bound flavin has a sharp peak at 354 nm and the band 1
has broaden after 6 h and absorbs around 500-600 nm along with the 726 nm band, this
also due to the absorbance of modified FAD around 525 nm.
As shown in Figure 4.6, when the intense band of 726 nm was exposed to oxygen, the
intensity decreased. The process was slow, as a small amount was still present 2 h after the
vessel was opened to air. While the 726 nm intensity dropped, the sharp absorption at 354
nm also decreased and band 1 intensity increased (blue to red) in the ETF. Usually, we do
not observe a sharp peak in band 2 when the ETF contains only authentic FAD, but its
presence in conjunction with the 726 nm band suggests participation of an SQ state of
modified FAD. Its decrease in the presence of oxygen is consistent with oxidation back to
OX state. These observations confirm the published correlation between the reduced state
of a flavin and the 726 nm band46.
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Figure 4. 6: Spectral changes observed when the exposure of 726 nm band accumulated
WT RpalETF to atmospheric oxygen.
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Figure 4. 7: A and B, spectral changes observed in WT RpalETF at pH 9 in BTP buffer
and the corresponding released FAD spectrum during the anaerobic flavin modification
monitored in short time intervals.
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Figure 4. 7: C) Color changes observed during the chemical modification in flavin, when
bound to protein (1, 2, 3) and after denaturing the green protein (orange) compared with
the unmodified flavin from a protein sample (yellow) (4), when the orange supernatant was
stored in refrigerator the separation of pink FAD (5) and the pink FAD settles at the bottom
(6), both unmodified, yellow FAD and modified, pink FAD dissolved in HPLC grade water
(7).

Figure 4. 8: A plot of absorbance at 525 nm (black square) and 726 nm (red circle) vs time
shows changes observed in the released FAD and 726 nm band respectively during the
anaerobic flavin modification process, 726 nm band continue to grow even after the 525
nm band intensity stopped changing, however 726 nm increases in a slower rate. Green
triangle shows intensity of 726 nm band increase when each collected sample was titrated
with Ti(III) citrate before the heat denaturation.
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4.3.6

Reductants further increases 726 nm intensity.

To confirm the contribution of correlation between the flavin modification and the
reduction of flavin, the collected sample in the above time interval was subjected to Ti(III)
citrate and sodium dithionite reduction. As plotted in the Figure 4.8, as the reducing
equivalents increases at the beginning of the titration in each collected samples the 726 nm
increases more than the amount already present from the spontaneous reduction from the
buffer, then continuity decrease. Here in the Figure 4.8, a comparison is made between the
two events happening (in the sample) before and after the addition of reductant in each
sample collected during the reported time interval. Together, with this and explained in the
later section shows the reducing equivalents enhance the CT band formation, indicating the
contribution of reduced and oxidized FAD in the system. Our system has two flavins, one
is ET-FAD and other one is Bf-FAD. Having a higher potential, ET-FAD is known to
undergo two steps reduction accumulating ASQ and then reducing the ASQ to HQ.
Whereas Bf-FAD undergoes one step, 2 e reduction producing a HQ from Oxidized flavin.
During the reduction of pre 726 nm band accumulated WT RpalETF, the intensity of 726
nm increases with the phase 1 when ET-FAD undergoes to reduction from OX to ASQ
then the 726 nm decreases with ASQ undergoes reduction to HQ and Bf-FAD reduces.
Reducing the protein using sodium dithionite and Ti(III) citrate, increases the intensity of
726 nm band and when Bf-FAD reduces the 726 nm band diminishes. This is further
explained below in section 4.3.15 and Figure 4.19.
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4.3.7

Selective modification of one FAD in WT RpalETF

Based on the spectra of released flavins, in particular retention of 50% band II intensity
even after all changes were complete, we suspected that only one of ETF’s two FADs was
modified. When the spectrum of one unmodified FAD (authentic FAD) is subtracted from
the spectrum of released flavins when modification was complete, the residual displays
absorption maxima at 490 nm and 525 nm. This spectrum, in Figure 4.9A, resembles that
of 8-amino flavin reported by Begley’s team and Massey’s team35, 55. This exercise also
demonstrates that only one FAD in the system undergoes modification. The presence of
two chemically distinct FAD variants in the ETFs stored anaerobically at pH 9 in darkness
was confirmed by their different solubilities. Although such ETF was dark green in color
(Figure 4.7C3), precipitation of the protein yielded a solution of flavin that was orange in
color (Figure 4.7C4). After aerobic storage at 4 °C for 2-3 days, a dark pink solid
precipitated from the buffer (Figure 4.7C6) and the solution was a clear yellow. The
spectrum of the soluble FAD was indistinguishable from that of authentic FAD (Figure
4.9B). The authentic FAD released from stored ETF corresponded to one equivalent of
FAD per ETF. Similarly, the flavin released from all the fractions collected during the time
course study (shown in Figure 4.7B) also yielded a pink precipitate and soluble FAD. This
further suggests starting from the time of modification to the end only one species has been
formed and no intermediate species accumulated in quantity. The isolated pink FAD
absorbs at 490 nm and 525 nm as we predicted earlier from pH 9 buffer, supporting our
prediction. Pink FAD is readily soluble in water and easy to separate from the solution
without using the HPLC.
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B

Figure 4. 9: A) Deconvoluted spectra of the modified FAD from the released FAD data
collected in the experiment done at pH 9, explained in section 4.3.5 and reported in Figure
4.7B. B) Shows the optical spectra after the pink modified FAD is separated from the
unmodified FAD (here the data is from an experiment in which modification studies were
carried out at pH 8 BTP buffer).
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4.3.8

BTP buffer forms an adduct with FAD

Based on the spectral signature and color, we suspected that the pink pigment is related to
naturally available roseoflavin35, 91. Roseoflavin possesses dimethyl amine in place of the
methyl at the 8-position of regular flavin, and in nature riboflavin is a precursor to
roseoflavin produced upon attack of an amine on 8f-Flavin92. The most abundant amine in
our system is the BTP buffer. BTP has pKas of 6.8 and 9 affecting its two tertiary amines,
so at pH 9 one N is fully deprotonated, and therefore a potent nucleophile93. To test for the
presence of an amine side chain of BTP origin in the pink flavin formed in ETF, released
FAD was subjected to MS analysis. ES in anion mode (-) yielded an ion at 402 m/z which
is not present in the standard FAD (Figure 4.10A) sample yet represented the highest
intensity fragment from the pink flavin. Figure 4.10C shows that this mass can be explained
by attachment of a fragment of BTP in place of the 8-methyl of FAD. Another less intense
fragment at 849 m/z was observed (Figure 4.10D), which we understand in terms of Na+
ion and fragmentation of a BTP: FAD adduct with m/z of 826 (Figure 4.10D, E). ES (-)
data of the pink FAD are compared with the ES (-) data of authentic or standard FAD,
which showed a parent ion at 784 m/z with less intensity compared to the fragment at 255,
346 and 528 m/z (Figure 4.10A, B).
To further test our hypothesis that the amine buffer is the source of an amine adduct to the
flavin, we repeated the experiment with a different amine buffer. WT RpalETF was
purified and then stored in Tris buffer at pH 9, which is a short chain amine buffer
comprising one amino half of the BTP molecule. Our hypothesis is that if an amine portion
of BTP modifies the flavin, then perhaps the analogous portion of Tris also should modify
the flavin, a spectrally similar flavin should result, but the m/z should be smaller than the
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pink flavin formed by BTP. Similar flavin modification at the equal rate was observed in
the Tris buffer. the ES (-) of the pink flavin isolated from this ETF showed a fragment at
384 m/z with a Na+ ion, and a corresponding second fragment at 528 m/z (Figure 4.10F,
G). This fragmentation pattern is absent in standard FAD. Both the masses are consistent
with fragments of this other amine buffer covalently attached to the FAD.
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Figure 4. 10: A) MS ESI (-) fragmentation pattern observed in authentic FAD.
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Figure 4. 10: B) Authentic FAD chemical structure and dashed arrows indicate the ESI
fragmentation pattern and m/z of fragments observed in authentic FAD as shown in
previous works94, 95.
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Figure 4. 10: C, D) MS ESI (-) fragmentation patterns of BTP: FAD adduct in the modified
FAD collected from the WT RpalETF protein sample in BTP buffer at pH 9.

128

E

Figure 4. 10: E) BTP: FAD adduct chemical structure and dashed arrows indicate the ESI
fragmentation pattern and m/z of fragments observed in pink FAD.
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Figure 4. 10: F) MS ESI (-) fragmentation patterns of Tris: FAD adduct in the modified
FAD collected from the WT RpalETF protein sample in Tris buffer at pH 9, G) Tris: FAD
adduct chemical structure and dashed arrows indicate the ESI fragmentation pattern and
m/z of fragments observed in pink FAD.
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4.3.9

BTP binds at C8 position of ET-FAD

As we observed an 8f-FAD in the T94/97A ETF, here we suspect the amine group is
attached to the C8 position of FAD. Studies on flavin modifications at C8, C6 showed the
dimethylbenzene ring of flavin to be solvent-accessible32, 41, 81, 85, 86, 89. Following Massey’s
work on solvent accessibility of the C8 position, Thorpe’s team demonstrated the solvent
accessibility of 8-Cl FAD in pig ETF, as well as binding of FAD with bulkier substituents.
Later, Kim’s team compared the crystal structures of human ETF and MmetETF stating
that based on the conserved residues present in the immediate vicinity of FAD in domain
II (which is ET-FAD), human ETF and MmetETF could accommodate bulkier covalent
substituents as C8 position is exposed to solvents45, 20.
Our use of BTP as the buffer, and its presence substantially in deprotonated form, creates
a possibility for the BTP to covalently attach to the flavin. As we observed chemical
modification of the FAD in T94/97A ETF, which contains only the ET-flavin, it seems
plausible that the modification we observe in WT RpalETF also applies to the ET-FAD.
This is also the flavin that has been modified in other ETFs, even though the canonical
ETFs were converted to 8f-Flavin, 8-OH and 6-OH32 82, distinct from the modified flavin
we now describe in WT RpalETF stored anaerobically. Prior work has also raised the
possibility that the ET-FAD’s susceptibility to modification by agents present in the solvent
is related to the extensive domain motion observed in the ETF family. This conspires with
the fact that the ET-FAD is more exposed whereas the Bf-FAD is buried in the domain I
and domain II interface.
Mass spectrometry indicates that fragments of the buffer compound covalently attach to
the flavin of FAD, but do not inform as to the position at which this happens. However, the
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placement of the adduct affects its spectroscopic consequences. Computational studies on
iLOV variants show that introducing covalently modified analogues of FMN, either 8amino-FMN or 8-methylamino-FMN, lead to red shifts of flavin fluorescence emission by
up to 100 nm96. Red shifted fluorescence is a characteristic feature of C8 substituted
flavins42. The fluorescence emission maximum of our pink flavin was 544 nm, red-shifted
by 14 nm compared with that of authentic FAD (Figure 4.11). Thus, our data are consistent
with addition of an amine group to the 8 positions of the flavin. Conjunction with our mass
spectrometry and the reactivity we infer for BTP at high pH, this suggests that the 8position is substituted by an alkyl amine of BTP origin, in our pink flavin.
To confirm the absence of C8 methyl protons, 1H-NMR spectrum of pink FAD was
collected. The flavin methyls are unsplit peaks visible near 2.29 and 2.33 ppm in FAD and
near 2.48 ppm in the pink flavin. Aromatic protons of the isoalloxazine and adenine are
visible between 7 and 8.5 ppm. Those of the adenine are stronger than those of the flavin
in ‘Authentic FAD’, likely due to adenine impurity. In the pink flavin, very strong signals
attributable to glycerol and buffer carried over from the sample are visible between 3 and
4 ppm (Figure 4.12).
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Figure 4. 11: Fluorescence emission spectrum of isolated pink FAD and authentic FAD:
Both pink FAD and authentic FAD were excited at 490 nm and 450 nm, respectively in
water.
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C7 C8

Figure 4. 12: 1H-NMR spectrum of pink FAD in blue (formed in BTP buffer at pH 9) and
authentic FAD in red. In pink FAD, presence of one peak for only one methyl protons and
the chemical shifts observed for the methyl groups in positions C7 and C8 indicate
chemical changes in the dimethylbenzene ring moiety of the isoalloxazine ring. All the
aromatic proton peaks are retained in pink FAD.
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4.3.10 ET-FAD is being modified to pink FAD
To determine experimentally which FAD undergoes chemical modification among the ETand Bf-FADs, WT-ETF was subjected to anaerobic chemical modification by storage for
4-5 days (ensuring the complete modification) and ET-FAD was selectively displaced by
incubating with ADP. As shown by Duan et al. in 2018, ADP selectively displaces the ETFAD from RpalETF, which retains the Bf-FAD even at high [ADP]. ADP was added and
every 30 min the spectra was collected (Figure 4.13A). While the ET-FAD was being
displaced, absorption at 525 nm increased indicating release of modified FAD, whereas
normal FAD does not absorb strongly at 525 nm. Meanwhile the 726 nm intensity
decreased, confirming our previous finding that the ET-FAD is required for the 726 nm
band46.
The correlated increased in absorbance at 450 nm and 490 nm could reflect oxidation of
modified FAD in conjunction with its release from the protein because half reduced pink
FAD predominantly absorbs at 450 and 550-800 nm (Figure 4.17B). Also, vibrational
feature in the band 2 increases, this is the signature feature of Bf-FAD in ETFs and is absent
in ET-FAD. It took 8-10 hours to displace the ET-FAD and after the maximum
displacement protein was passed through the gel filtration column to remove the released
flavin. The spectrum of the treated flavin was consistent with bound Bf-FAD
(deconvoluted Bf-FAD spectrum reported in Chapter 3), arguing for integrity of the Bfflavin without modification, and loss of ET-flavin. Pink FAD retained in the column as it
is immiscible in the BTP buffer. Presence of a minute amount of 726 nm indicates retention
of trace amounts of ET-FAD by the ETF.
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Figure 4. 13: Displacement of FAD by ADP after the WT protein was subjected to
accumulate 726 nm band. A) UV-visible spectra changes, from purple to red when 200
mM ADP is added to 50 µM protein, and the spectra was collected every 30 min. B) Visible
spectrum of bound FAD, after the ADP displacement, WT protein was separated from the
released FAD and ADP by passing through the gel filtration column.
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4.3.11 Increase of BTP concentration increases the rate of modification and 726 nm band
formation
We are making a proposal that has potentially far-reaching consequences for how
flavoproteins should be stabilized in solution, by proposing that common buffers may
covalently modify the flavin. A crucial prediction if BTP buffer attacks the flavin directly
is that the rate of flavin modification should increase with the concentration of BTP.
Furthermore, if formation of the 726 nm band also involves the buffer, for example as a
source of reducing equivalents, then the rate at which it grows should also correlate with
the concentration of the buffer.
To test these predictions, WT RpalETF was purified into different concentrations of BTP
buffer (7 mM, 20 mM, and 60 mM), with all the other conditions were held constant (pH
9 and 200 mM KCl with 10% (w/v) glycerol). Purified WT RpalETF in each of these BTP
concentrations was transferred to an anaerobic chamber and stored at 4 °C in the dark.
Aliquots were withdrawn from each sample starting from the time of transfer to the
anaerobic chamber, 6 hours later, and then every 24 hours up to 6 days. In this trial, WTETF was less stable in 60 mM BTP than in 7mM and 20 mM BTP buffer. Therefore,
samples were collected only until aggregation became significant, as indicated by
scattering. This occurred after140 hours for WT RpalETF in 60 mM BTP. Each collected
aliquot was diluted in the respective buffer to collect the visible spectrum of the ETF
(flavins bound in the protein) and then heat denatured to collect the corresponding released
FAD and its visible spectrum.
The signature feature of pink flavin is absorbance at 525 nm, which is negligible in
authentic FAD. Therefore, A525 of released flavin is plotted as a function of storage time in
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Figure 4.14B. Our spectra showed that the same flavin variant(s) formed at the three BTP
concentrations, thus the nature of the reactions appear the same, but their rates vary. Indeed,
our data show that as the concentration of BTP increased, the modification rate was faster
at shorter time points. At higher [BTP], modification was completed earlier, 36 hours, 48
hours and 72 hours in 60 mM, 20 mM, 7mM BTP buffer, respectively. Furthermore, the
final yield of modified flavin was slightly higher at the highest buffer concentration. This
could indicate existence of a competing reaction that does not yield pink flavin. However,
given the altered stability at 60 mM BTP, and the small magnitude of the effect, we
concentrate instead on the main reaction yielding pink flavin.
Analogous plots of 726 nm absorbance vs [BTP] also show the highest rate of modification
in 20 mM but slower modification in both 60 mM and 7 mM BTP. Whereas intensity of
726 nm band is higher in 20 mM BTP than 7 mM but rate of increase in the intensity is
similar in all the concentration. Final yield of 726 nm band formed leveled off with time
consistent with exhaustion of a limiting reagent which we propose is flavin. Surprisingly,
in 60 mM the maximal yield was lower than at 20 mM, opposite to what is expected
according to the simplest proposal that the buffer contributes only to a sequence of
reactions that yields 726 nm band. The distinction between this result and the BTPdependence of pink flavin formation casts in doubt the possibility that 726 nm species is a
sequel of pink flavin formation. However, the first step is to repeat this very interesting
experiment, as Duan et al.’s model for the 726 nm species attributes it to the Bconformation of the ETF, whereas we found that 60 mM BTP compromised the solubility
of the protein, and therefore could also be interfering with the stability of the B
conformation.
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Figure 4. 14: Absorbance change at 525 nm (A) and 726 nm (B) in the presence of different
concentration of BTP buffer.
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4.3.12 pH dependence modification of ET-FAD
To test our chemical model that it is the deprotonated state of BTP, specifically, that attacks
the ET-flavin, we compared the rate of flavin modification in the presence of 20 mM BTP,
but at two different pHs. pH 8 is well below the higher pKa whereas pH 9 coincides with
it. Both are higher than the low pKa of 6.8 at which BTP’s first amine would deprotonate.
Thus, this pair of pHs tests whether doubly deprotonated BTP reacts more vigorously than
singly deprotonated (pH 8).
WT RpalETF was purified separately into pH 8 or 9 20 mM BTP and incubated in the
anaerobic conditions. Formation of 726 nm band was monitored directly in the ETF protein
and aliquots were also withdrawn and denatured to release FAD, which was characterized
via its visible spectrum for presence of pink flavin via A525. Our results demonstrate that
WT RpalETF gets modified much faster at pH 9 than at pH 8. Within 1- 2 hours of transfer
into pH 9 an increase in A525 was evident for released FAD, whereas at pH 8 A525 was not
visible until after 12 hours, and the modification was much slower, requiring more than 5
days to reach its terminal plateau. On the other hand, at pH 9 complete modification was
observed within 48 hours. The optical signal of pink FAD collected from the pH 8 sample
was red shifted and absorbed at 536 nm and 566 nm. This is interesting even though the
spectra of both samples were collected in water. It may be that the dilution with water did
not eliminate pH differences stemming from the buffer present in the parent samples
(Figure 4.15), since the optical spectrum of pink flavin redissolved after precipitation
changes depending on the pH. The rate of formation of 726 nm band was also monitored
in both pH 8 and 9. It was very clear that at pH 9 the band starts to appear much earlier (~
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in 6 h) than at pH 8 (~ 24 h). Similarly, WT RpalETF in ADA buffer at pH 7 produces 726
nm band in much slower rate upon incubating the protein for a long period of time under
anaerobic condition.

Figure 4. 15: Visible spectra of pink FAD formed in BTP and Tris buffer: Released solid
pink FAD was dissolved in water.
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4.3.13 Enzyme mediated reduction of pink FAD: BTP is an electron donor
As it was demonstrated in the previous work by Duan et al. 2020, 726 nm band intensity
was increased by addition of chemical reductants, up to a point. In contrast, our current
observation is that the intensity of this band increases spontaneously (No external source
of reductant) over the time and continue to increase over the period of 1 month (Figure
4.16A). Our data in Figure 4.8 moreover showed that even if the 726 nm band was already
present because of slow spontaneous formation, it increased by some 20 % when more
reductant was added. This increase occurred without any change in the shape of the band,
suggesting that the reductant advanced the same chemical process. This is consistent with
attribution of the 726 nm band to a (partially) reduced state of the system.
It is interesting to see that flavin undergoes spontaneous reduction to produce the 726 nm
band, when there is no canonical reductant present in the system. However, because the
above data demonstrate the possibility of an optimal concentration of BTP for 726 nm band
formation, and Duan et al. attribute the 726 nm band to a species that is not completely
reduced, we wondered whether 20 mM BTP at pH 9 could act as a source of electrons to
the flavins of ETF. If so, is should be able to quench ETF flavin fluorescence. Indeed,
Figure 4.16B demonstrates that BTP quenches the flavin fluorescence more than other
nucleophilic buffers Tris and ADA. This suggests BTP could act as an electron donor to
reduce the flavin in the WT RpalETF.
Here we propose two biochemical activities responsible for this 726 nm band formation,
together with the modification, the modified ET-FAD is being reduced by the ETF as long
as BTP acts as an electron donor to the system in the anaerobic conditions (Figure 4.16A,
B). Reduction by the buffer could be slower than it does when it is excited by photons and
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Duan et al. 2021 has shown light driven electron transfer from BTP in RpalETF is a faster
process97. The slow intensity decreases in the band 1 and band 2 is also an evident for slow
reduction of bound pink FAD after modification and it is enzyme mediated process.
Spectral properties are similar when 726 nm self-accumulates (Figure 4.16A) and reduction
with the reducing agent (Figure 4.18A and B). However, the later one is much faster than
the self-reduction and still reduces the pink FAD in two different rates. This further
suggests BTP could act as a slower electron donor. Another evidence for enzyme mediated
reduction of pink FAD is, when ADP displaces the pink FAD (Figure 4.13A) from the
ETF, the intensity of band 1 increases and peak at 354 nm decreases, this is a sign of
oxidation as observed in the Figure 4.6 when the protein is exposed to air. As we shown in
the Figure 4.14B, rate of formation of 726 nm is much higher after the faster modification
in 20 mM BTP than in 7 mM, indicating more the electron donors faster the reduction of
Pink FAD. Thus, the reduction of pink FAD is an enzyme mediated reduction, in the
presence of BTP. BTP plays a dual role by acting as an electron donor and forming an
adduct with ET-FAD.
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Figure 4. 16: A) UV-Visible spectra of self-accumulating 726 nm band in WT RpalETF
in BTP buffer at pH 9 B) Fluorescence quenching of 6 µM WT RpalETF in different amine
buffers.
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4.3.14 Isolated pink FAD accumulates SQ
In order to understand the implications of FAD modification for ETF function, we assessed
the redox reactivity of the isolated modified FAD. Isolated pink FAD from the pH 9 BTP
buffer was dissolved in water and titrated with Ti(III) citrate. Stepwise anaerobic reduction
of pink FAD with (4 µM) Ti(III)citrate produced an intermediate species which gave way
to a fully reduced form upon further addition of the reducing equivalents until there were
no more changes to the spectrum (Figure 4.17A). Based on comparison with literature
spectra, it appears that the intermediate species formed is a semiquinone (SQ) state of the
flavin. In phase 1, absorbance at 490 and 520 nm of oxidized (OX) pink flavin decrease
and absorbance increases in the longer wavelength region from 550-820 nm or longer
(recorded as far as the spectrophotometer allows) concurrently (Figure 4.17B). This is
classic behavior for conversion of an OX flavin to neutral semiquinone. The isosbestic at
420 and 556 nm confirm that a single transformation is underway. Longer wavelength
absorbance from 500-700 is observed in NSQ of authentic FAD and FMN in various
proteins and usually at lower pHs, but not in ASQ which normally is the stable protonation
state at higher pH. Since the reduction of pink FAD was carried out at ~pH 7 in water, an
NSQ intermediate is plausible. 24 µM of reducing equivalent was consumed to produce
maximum longer wavelength absorbance. In phase 2, further addition of 24 µM electrons
fully reduced the FAD, as indicated by growth in short-wavelength absorbance at 330 nm
and 410 nm while the longer wavelength absorbance decreased (Figure 4.17C), with an
isosbestic at 428 nm. Formation of a stable SQ intermediate represents a change in the
reactivity of the flavin, since authentic FAD has crossed potentials and undergoes
predominantly two-electron reduction from OX directly to HQ. Thus, modification of the
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ET-flavin produces a flavin with the intrinsic property of uncrossed potentials and
sequential single-electron redox events. This is qualitatively the same reactivity that is
enforced by the ET site, however this reactivity is not natural to authentic FAD.
Based on the amount of Ti(III) citrate consumed, we infer that the pink flavin concentration
was 24 μM and used this to calculate its extinction coefficient at 520 nm to be Ɛ520 = 8.54
mM-1 cm-1.
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Figure 4. 17: A) Visible spectra of pink FAD during reduction with Ti(III) citrate, 1-12
indicates number of additions, each addition introduces 4 µM Ti(III) citrate to the working
solution. B) Difference spectrum of phase 1, Oxidized FAD changes to intermediate SQ
and C) Difference spectrum of Phase 2, intermediate SQ changes to fully reduced HQ.
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4.3.15 Presence of SQ is required in pink FAD to stabilize 726 nm band
Before the ET-FAD fully modifies the domain II is populated with two types of flavins,
one being pink FAD and other one is unmodified regular FAD. However, bifurcating site
is always occupied with 100% Bf-FAD in a fully oxidized state, considering the lower
midpoint potential.
Even though both the pink FAD and regular FAD binds at domain II, their redox properties
are very different (both the bound and unbound). Therefore, any redox titration carried out
before the ET-FAD fully converts to pink FAD, is complicated for analysis. Thus, the WT
with fully modified ET-FAD bound in domain II (pink FAD, produced by 3 days’
anaerobic storage at pH 9) along with the Bf-FAD in Bf site, was titrated with sodium
dithionite and correlation between the reduced state and 726 nm band formation was
demonstrated. After each addition of the reducing equivalent, the change in the FAD
absorbance and 726 nm intensity was carefully monitored.
The initial spectrum demonstrates the familiar vibrational structure in band 1 and a sharp
feature on band 2 which we associate with presence of pink flavin at 354 nm. The starting
spectrum also contains 70% of spontaneously formed 726 nm when compared to the
maximum amount obtained in any point of the titration (considered as 100%). After the
first NaDT addition the 354 nm peak increased and band 1 intensity decreased, meanwhile
726 nm increased, until the 726 nm intensity is stabilizing, the spectrum was collected then
the second reducing equivalent was added. Likewise, after each addition, the spectrum
capturing the full change in the FAD band 1, 2 and 726 nm was plotted in Figure 4.18A
and 4.18B. Based on the difference spectral analysis, reduction was taken place in three
phases (Figure 4.18C, D, E). Initially in phase 1, a small decrease in the band 2 at 374 nm
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was observed in the phase 1 meanwhile absorbance of band 1 at 490 nm continue to
decrease and 726 nm absorbance was maximized. later in phase 2, change in 374 nm was
negligible and absorbance difference in the conventional FAD bands I and II was much
smaller but the sharp 354 nm intensity decreased (resembles free pink FAD) along with the
726 nm band and increased number of vibrational peaks can be seen at the beginning
(Figure 4.18A, light green curve). Absorbance increases at 330, 410 nm and decreases at
460, 360 nm were seen. Among these, increase in the absorbance at 330 nm and 410 nm is
consistent with the phase 2 of free pink FAD reduction. Maximum amount (~ 87%) of 726
nm has been decreased in the phase 2. Difference spectra corresponding to phase 3
resembled the Bf- FAD with respect to their vibrational signatures, and both band 1 and 2
decrease at 460 nm and 374 respectively. Intensity decrease in both bands without
formation of any longer-wavelength signal indicates absence of any SQ state associated
with this reduction, in turn suggesting that the Bf-FAD undergoes a 2e reduction to HQ.
The 726 nm intensity continued to decrease but the decreases were smaller than in phase 2
(note different vertical axis scales).
Thus, changes in bands 1 and 2 in phase 1 and phase 2 appear to be due to reduction of
pink FAD based on parallels with what was observed for the free pink FAD. Sharp
increases in the intensity at 330 nm and 410 nm indicate formation of the HQ of pink FAD,
which has a better-defined HQ spectrum than does authentic FAD. Thus, even when both
FADs are reduced to their HQ states two clear bands were observed.
It takes longer to decrease the intensity of the 726 nm than it takes to reduce FAD region.
Thus, it may be that kinetic considerations are responsible for the contributions of that band
to phase 3. Considering the much stronger spectral change observed in the phase 2, what
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continues in phase 3 is relatively minor. Only 23% of 726 nm disappears with the reduction
of bifurcating FAD. However, this experiment makes the point that slow processes
participate. We also note that this titration largely separates two steps that could have been
concurrent in earlier titrations: modification of the ET-flavin and its reduction.
Changes in the absorbance at 354 nm in the free pink FAD is negligible in both phase 1
and 2, similarly in pink bound FAD. However, 354 nm peak intensity increases in a small
amount at the beginning in phase 1 and it continue to decrease later in phase1 and 2. This
peak is only present in the bound pink FAD, and a vibrational signature due to the protein
environment. However, decrease in the intensity at 490 nm in the bound FAD is consistent
with the λmax of pink FAD (Figure 4.18C, 4.17B). Our data are consistent with the presence
of pink FAD as a participant in the higher-E° events, like ET-FAD, as well as a succession
of two 1e steps accumulating an intermediate SQ. The increases observed at (selfaccumulated) 726 nm reflect further increases with the SQ state of pink FAD and decreases
with as the pink SQ converts to HQ.
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Figure 4. 18: Visible spectra showing the reduction of 726 nm band: A, B) WT RpalETF
with self-accumulated 726 nm, two insets of single spectra were shown to magnify the
FAD absorbing region and 726 nm absorbing region, C, D and E are difference spectrum
of each phase. C) Conversion of initial oxidized state to intermediate SQ, and 726 nm,
intensity increases D) SQ reduces to produce HQ, 726 nm band predominantly reduces, E)
OX Bf-FAD reduces in a two-electron manner to produce HQ.
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4.3.16 Role of positively charged Arg residue in the modification.
Previous works have proposed the participation of a quinone-methide intermediate in
modification of flavins at the 8 position. Upon an abstraction of a proton from the 8-methyl
group, resonance through the flavin is proposed to distribute negative charge to the
electronegative N1-C2=O2 region39, 40, 43. A similar mechanism is proposed for covalent
flavin-protein attachment via the C8 position of the isoalloxazine ring32, 81. Thus, during
modification of ET-FAD in T94/97A RpalETF to 8f-FAD, and pink FAD formation in WT
RpalETF, deprotonation of the C8-methyl group of FAD might occur to yield an anionic
quinone-methide intermediate (Figure 4.19). RpalETF contains conserved R273 and H310
residues in the ET-FAD binding site (Figure 4.20). R273 appears to form a 𝜋-𝜋 interaction
with ET-FAD, and the N1 group of R273 is situated 3.15 Å away from the C8 carbon.
Considering the pKa value of Arg, one expects R273 to have positive charge at pH 9. This
nearby cation could stabilize the negative charge of quinone methide intermediate.
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B:

Figure 4. 19: Reaction scheme showing the deprotonation of C8 methyl. ‘B:’ is a basic
amino acid residue.
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R273

T97

T94

Figure 4. 20: Ribbon diagrams of bifurcating ETF (Bf-ETF) based on the structure of
Acidaminococcus fermentans ETF (AfeETF, 4KPU.pdb)4. The FAD common to all known
ETFs is in yellow stick Cs with CPK colouring of other atoms, whereas the second FAD
found only in Bf-ETFs is in green. The inset highlighted in purple is R273 residue of
RpalEtfL and its interaction with ET-FAD, The residue highlighted in yellow shows the
T94 and T97 residues in EtfS, they form H-bonding interaction with the pyrophosphate of
Bf-FAD. These residues are conserved among Bf-ETFs and shared by AfeETF. Domain I
is formed by the large subunit (EtfL, red) while domain III is formed by the small subunit
(EtfS, light blue). Domain II is composed primarily of EtfL but EtfS also contributes its Cterminal helix. Domain II is understood to adopt different orientations relative to the base
formed by Domains I and III47. This and other molecular graphics were produced using
chimera50.

To test for a contribution of a negatively charged flavin intermediate stabilized by R273,
we created ETF variants in which the positively charged residue number 273 is replaced
by alanine, or the charge-tunable residue histidine. The control variant possessed a Lys at
position 273 to preserve the WT charge while removing the Arg. Mutations which created
neutral residues at pH 9: R273H-, R273A-RpalETF did not accumulate 726 nm band
during anaerobic titrations (Figure 4.21C). Interestingly, the variants R273H-RpalETF and
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R273A-RpalETF also did not support modification of flavin as the released FADs didn’t
show the characteristic maximum at 525 nm but instead had spectra matching authentic
FAD. However, our control: the R273K-RpalETF variant, accumulated 726 nm band
during the anaerobic titration (Figure 4.21B). FAD released from it after long-term
anaerobic storage included pink FAD, resembling that released from WT. These
experiments confirm a correlation between pink flavin and formation of 726 nm bands.
They provide the new information that the protein’s role in supporting these two species,
not formed in quantity by free flavin, likely includes stabilization of a negatively charged
form of flavin.
All the variants purified at pH 8 neither produce modified FAD nor 726 nm band. Perhaps
low pH suppresses the proposed methide intermediate. This too is consistent with the more
general hypothesis that a positively charged residue near the flavin C8 methyl could either
deprotonate that methyl and / or stabilize proposed negatively charged quinone methide
intermediate.
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R273H-RpalETF

Figure 4. 21: Visible spectra observed in the course of stepwise reduction of ETFs with
sodium dithionite at pH 9.

156

4.4

Discussion
4.4.1

Susceptibility of ET-FAD for flavin modification

Covalent modifications of flavins in bifurcating ETFs were known even before the ETF in
question, from M. elsdenii,36, 37 was shown to be a bifurcating ETF. It is worth noting the
differences in the protein preparations studied in early work, dating back to 1974, because
later in 2003 Sato et al. demonstrated that although purified with a single FAD per dimer,
the MelsETF acquired a second FAD upon reconstitution with exogenous FAD. The
material with 2 FADs is now known to be a bifurcating ETF26, 51. Lehman and Thorpe’s
work further confirms that pig ETF containing modified FAD could be recycled to a form
containing authentic FAD only, by incubating with exogenous FAD44. Over the years,
many studies have reported oxidation of the C8 methyl to yield formyl at the 8 positions in
FAD and FMN (8-formyl-FAD or -FMN). This species has been demonstrated in ETFs
and other flavoenzymes39-41, 44, 82.
We first observed a covalent modification in RpalETF when the T94/97A ETF was purified
at pH 9 under aerobic conditions. T94/97A ETF contains only the ET-FAD in domain II.
Exogenous FAD was not introduced in any of the protein purification steps, so spectral
changes observed during handling after purification is not due to the chemical variants
present exogenous FAD. We observed optical spectral changes that resembled those
associated with 8f-FAD formation in human ETF, as reported by Augustin et al. Also, FAD
released from our T94/97A ETF showed similar wavelength shifts to those observed in 8fFAD of human ETF, pig ETF, lactate oxidase and formate oxidase40, 41, 44, 82. Reduction of
8f-FAD or 8f-FMN was associated with a sharp peak observed at different wavelengths by
Yorita et al. (425 nm)41, Augustin et al. (415 nm)40 , Yoshifumi et al. (433 nm) and Robbins
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et al. (431 nm)38, 82. The sharp peak formed at 432 nm in T94/97A RpalETF resembles the
one observed by Robbins et al. and Yoshifumi et al. Yorita et al., suggesting that it
represents the semiquinone form of 8f-FAD and the longer wavelength absorption around
600 -700 nm represents the neutral semiquinone form. EPR studies carried out by Augustin
et al. confirmed it is due to the anionic semiquinone form of 8f-FAD. Therefore, we suspect
the 432 nm sharp peak, in the bound FAD and longer wavelength absorption around 500700 nm is due to the anionic semiquinone of 8f-FAD in the T94/97A ETF.
In ES (-) mode parent ion signal at 798 m/z and an Na+ ion attached to it appears at 822
m/z represents 14 mass unit change from 784 m/z of due to CH3 group is replaced by CHO
group. Similar m/z peaks were obtained by Bommarius and coworkers39. Others have
reported that 8f-FAD is readily formed in the presence of oxygen40. We also confirmed this
observation, as spectral changes occur while the ETF is being concentrated and exchanged
among buffers that are equilibrated with air and thus contain oxygen. Further, the
continuous changes in the optical spectra of bound and corresponding released FAD
indicates this is an enzyme mediated chemical modification at ET-FAD binding site in
domain II of RpalETF. Studies of 8f-FAD by Augustin et al., demonstrated that lower pH
suppresses the modification, this is similar in our system too, as maintenance of RpalETF
at pH 8 prevented conversion of ET-FAD to the 8f-FAD in RpalETF.
On the other hand, in WT RpalETF aerobic modification of the flavin is very slow and
fully modified FAD was accumulated in 5-6 days compared to the mutant which shows
drastic change in the spectrum from the time of purification. Spectral changes observed in
the bound FADs in WT during the modification resembles the spectral change observed by
Massey’s team in lactate oxidase41 but different from the formate oxidase and human
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ETF38, 40. This could be because WT contains two FADs unlike in those other systems. The
wavelengths shifts observed for WT and T94/97A ETF (due to protein-bound FAD) for
both bands 1 and 2 resembled lacate oxidase only, but the spectrum of our fully modified
released FAD displayed wavelength shifts resembling those of the 8f-flavin of formate,
lactate, pig ETF and human ETF40-42, 44. By analogy with the anaerobic modification
(discussed later) we suspect that only the ET-FAD in domain II undergoes modification
aerobically, because one of the orientations populated by domain II exposes the ET-FAD
to solution, whereas Bf-FAD is buried in the base domain interface. These modifications
arose when FAD was bound to protein, because the FAD we provided as part of
reconstitution did not reveal those species in mass spectra. To further confirm the
modification in one FAD and chemical identity, modified FAD can be separated using
HPLC and quantified and subjected to MS analysis.
One possible explanation for the different rates of aerobic modification seen in WT vs
T94/97A ETF population of different conformations. As reported in canonical ETFs from
pig and human, T94/97A ETF could be resting in the open conformation and therefore
more solvent-exposed40, 44. As reported in Toogood et al., and Augustin et al., a single
amino acid replacement (βE165A) disrupted an interaction between a residue in the other
subunit (αN259) and favored the open conformation, whereas WT human ETF is believed
to rest in the closed conformation16, 40. We propose that a similar conformational change
causes T94/97A ETF to spend a larger fraction of time in the open conformation than WTETF, because the rate of formation of 8f-FAD in WT-ETF is very slow compared to the
case in T94/97A-ETF. Because T94 is only 5 Å from residues of the EtfB arm involved in
domain II movement47, replacement of T94 with Ala could alter the equilibrium between
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the closed and open conformations. However, a more likely perturbation could be the
replacement of Bf-FAD by AMP in T94/97A ETF. The absence of the Bf flavin could have
consequences for the interface between domains I and III and thereby the two subunits of
the ETF. Whereas WT RpalETF could populate primarily the closed conformation (similar
to human WT ETF) T94/97A ETF could populate primarily the open one.
We note a weak additional absorption at 525 nm immediately upon purification of the WTETF, however it disappears later, possibly as a result of further reaction to form another
flavin derivative, (explained below), which could be unstable in the buffer during
prolonged exposure to oxygen.

4.4.2

Anaerobic modification produces a novel amino flavin derivative.

Different spectral changes accompanied aerobic modification of T94/97A ETF anaerobic
modification of WT RpalETF, confirming the formation of two different flavin derivatives.
In both cases, spectral deconvolution of the spectrum of flavins released after the process
was complete reveals that only one FAD undergoes modification. Indeed, the pink FAD
separates spontaneously from yellow unmodified FAD and the latter constitutes one
stoichiometric equivalent. We could attribute this FAD to the ET-FAD site based on its
displacement by ADP46. ET-FAD predominantly interacts with the protein via its ADP
moiety, similar to FAD in canonical ETFs and ADP has the highest affinity toward the
FAD binding site in domain II52,

53

whereas Bf-FAD additionally forms H-bonding

interaction via its flavin N1, C2, N3, C4 and N54. Based on the ADP displacement
experiment modified FAD was in ET-FAD binding site and was released from the system
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with the characteristic absorbance at 525 nm. Further, spectral properties of bound FAD
after gel filtration resembles the Bf-FAD with vibrational features (spectra shown in
Chapter 3). Therefore, ET-FAD is the one undergoes modification as demonstrated in
T94/97A ETF anaerobic modification.
We suspected the presence of an amino flavin as the modified FAD, because amino flavin
is pink in color like naturally occurring roseoflavin34, 91. This parallel was initially noted
by Prof. R. Stanley (Temple University). ES (-) m/z data indicates the attachment of amino
fragments from the amine buffer used, whether BTP or Tris. Spontaneous formation of
pink FAD is novel and hasn’t been demonstrated in any other bifurcating ETFs. Indeed,
we have seen no such report from any flavoenzyme. However, its formation in ETF may
reflect the high solvent accessibility of the flavin in the ET site.
The high exposure of the ET site was demonstrated by reconstituting the apoprotein with
flavin analogs bearing bulky substituents at the C8 and C6 positions, in canonical ETF45
and other flavoenzymes. 8-Cl-FAD was used as an active side probe to identify
flavoproteins with solvent accessible C8 methyl group31, 89. Thorpe’s team demonstrated
the solvent accessibility of the C8 methyl in ETF by reconstituting the pig ETF with 8-ClFAD. The addition of 8-Cl-FAD gives the similar two band native FAD spectrum, however
when thiophenol was added to the buffer, the typical two band spectrum was replaced with
a sharp single band at 472 nm. Furthermore, the analog is catalytically active confirming
that it remains bound in the protein. Spectral changes observed in the FAD indicated
binding of bulkier thiophenol near C8, replacing the Cl- leaving group and to yield a
product resembling 8-mercapto flavin45. In the same work they have demonstrated the
retention of catalytic activity by flavins bearing substituents, such as 8-CoA-FAD, and
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proved that bulkier groups can tightly bound to the active site without disrupting the
structure. This can be related to our system, as BTP and Tris are buffer components and
act as nucleophiles when deprotonated, and the entire ETF family shares key amino acids
in the immediate vicinity of the ET-FAD that can make the xylene ring susceptible to
nucleophilic attack at the C8 methyl group. This process is not as fast as when Cl is present,
because CH3 is a poor leaving group. However, the presence of basic groups surrounding
the CH3 could favor the substitution reaction. It would be interesting to know the fate of
the displaced methyl, in case it is activated for displacement, for example by hydroxylation.
Our data argue against that specific example, since we have shown that the rate-limiting
reaction involves a buffer molecule and there is no spectral evidence for accumulation of
an earlier intermediate.
To test whether the position of an amine substituent is at C8, it is common to monitor
fluorescence for a red shift in the emission maximum 32. A similar experiment was carried
out on 8f-FAD of formate oxidase82 and in a computational study of iLOV protein with 8amino flavin, which showed a 100 nm red shift in the fluorescence emission96. Our data
also agree with this qualitatively, as a 14 nm red shift relative to the emission maximum of
authentic FAD was observed, when the released pink FAD was excited at 490 nm.
The nature of the absorption spectrum also provides clues as to the point of attachment of
the amine substituent of our pink flavin. Among the naturally available and synthetic flavin
analogs, the optical spectrum of our pink FAD most resembles those of hydroxy-,
mercapto- and amino-flavins. Comparison of the optical absorbance of flavins derivatized
by the same substituent but at different positions, C6 vs C8, reveals trends that can infer
whether the pink FAD is modified at C8 or C6. Comparing 6-OH-FAD36 and 8-OH-FAD37,
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6-amino55, 85 and 8-amino-FMN55, 91, 6-mercapto88 and 8-mercapto FAD89 and 6-N385, and
8-N3-FAD86, all the C6-substituted flavins absorb around 400-450 nm whereas, the C8substituted isomers absorb maximally at wavelengths of 472 nm or longer. Our pink FAD's
absorption maximum at 490 nm and longer (depending on pH) supports the fluorescence
in suggesting modification at C8. Furthermore, in pink FAD sample only one methyl peak
and all the aromatic protons are retained. Since C6 and C8 positions are the chemically
active regions, and C6 proton peak is present in pink FAD the BTP is not being substituted
at C6 position. But it has replaced the C8 methyl group.

4.4.3

pH and substrate dependent modification of ET-FAD

Modification of FAD doesn’t occur when the FAD is free in solution thus, we conclude
that modification is promoted by amino acid residues in the isoalloxazine binding site. A
frequently proposed mechanism for modification of bound flavins involves a negatively
charged quinone methide intermediate1, 31, 87. Its stabilization by positively charged active
site amino acids would therefore enhance the rate and yield of flavin modification39, 40, 43.
This has been verified by cases in which removal of positively charged residues results in
loss of modification, even when the residue in question does to form part of the flavin
adduct. In formate oxidase from Aspergillus oryzae, conversion of R87 to an Ala residue
suppressed modification of FAD to 8f-FAD39, 43. Similarly in human ETF, conversion of
R249 to a Cys residue diminished the rate of 8f-FAD formation40. On the other hand, in
lactate oxidase mutation at R268 to a Lys residue resulted in formation of 8f-FMN, which
is not formed in WT41. However, the corresponding R87K conversion in formate oxidase
did not favor the 8f-FAD formation39. Thus, placement or other details can be important,
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in addition to charge. We have also showed the similar results, since replacement of
positively charged R273 is in WT RpalETF by Ala or His abrogates formation of pink
FAD. Mutations in the ET-site strongly affected the modification whereas the analogous
mutation in the Bf-side did not, supporting the displacement experiments and spectral
analyses in assigning the modification reaction to the ET site, Therefore, presence of a
positive charge near the C8 methyl of ET-flavin is a requirement for pink FAD formation.
Since R273 is near the xylene ring it might aid in lowering the pKa of the 8-CH3 group and
stabilize the electron cloud of methide intermediate.
Formation of Pink FAD strongly depended on the pH of the solution, and the rate of
modification is faster when the substrate BTP concentration is higher. Together, these
findings suggest that the substrate is the deprotonated BTP in particular. Pink FAD
formation is accelerated by alkaline pH and is undetectably slow at pH 7. At pH 8 it is slow
but detectable. A similar observation was reported for the human ETF. Thus, in addition to
the contribution of amino acids in the isoalloxazine binding pocket, we showed that the
substrate is BTP and its concentration and protonation state are important in a ratecontributing step.

4.4.4

A reduced state of Pink FAD is required for 726 nm CT band formation.

As previously reported by Duan et al., a reduced state of ET-FAD is required for the
formation of 726 nm CT band, but the earlier work concluded that the state in question was
a HQ. In this study we found that the ET flavin must have been converted to the pink FAD
in order for CT band formation. We could find no literature precedent for our proposal and
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have therefore had to gather a larger than usual body of biochemical and spectroscopic
characterization in order to formulate a new model. Increase in the 726 nm intensity upon
addition of reducing equivalents confirms a requirement for a reduced state of pink FAD.
Based on the difference spectra, RpalETF containing pink ET-FAD and Bf-FAD undergoes
three phases of reductions, wherein the lower potential Bf-FAD does not accumulate any
intermediate SQ state and reduces directly to HQ at the end of the titration. This is evident
from the spectral features observed in third phase and resembles the behavior observed at
pH 8 and in R273A-RpalETF confirming that the Bf-flavin is not directly affected by the
modification. However, the ET-FAD is a higher-E° FAD and accumulates SQ, evident in
the first two phases of reduction. This demonstrates that bound pink FAD undergoes two
sequential single-electron reductions and displays a stable SQ intermediate. Furthermore,
we showed that this behavior is intrinsic for the pink flavin, in contrast to the case for
authentic FAD. Thus, the modification reinforces the catalytic activity of ETFs and would
be compatible with it in vivo. As for formate oxidase, it is not clear that this modification
would inactivate the ETF and it could even support activity. The 726 nm band accumulates
to maximal amplitude in the first phase of pink FAD reduction but decreases in the second
phase of reduction. This demonstrates that the CT band represents a SQ state of pink FAD
in conjunction with the oxidized state of Bf-FAD. In addition to this, difference spectral
feature of self-accumulation of 726 nm indicates the intensity continuity increase with the
reduction of phase 1 by the electron source from the BTP buffer. Accumulation of 726 nm
stabilizes the protein however once the maximum 726 nm accumulated protein tends to
precipitate and 726 nm intensity decreases. Since addition of reductant in phase I increases
the amplitude of 726 nm band, we conclude that a pre-existing reductant must have been
responsible for spontaneous 726 nm band. With BTP already implicated and demonstrated
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to attack the flavin, we propose a reductive attack of BTP. If the SQ state of the pink ETflavin is associated with the 726 nm band, then one of the two reducing equivalents will
need to pass elsewhere. A missing piece of the puzzle is the departing methyl group.
Without more information on the nature of this second product we cannot rule out a radical
mechanism fostered by flavins’ abilities to stabilize radicals. Thus, low-level of 726 nm
species including flavin SQ could represent an intermediate that does not accumulate so
long as the reaction is turning over, but eventually builds up once some other substrate is
exhausted, or a terminal product is formed (such as the pink flavin). Precipitation of the
726 nm species could be due to SQ state of pink FAD being reduced to HQ. and less tightly
bound (as reported by Chowdhury4 and Sato team26,

51

) than the OX or SQ state,

dissociating and thereby destabilizing the protein.

4.5

Conclusion

We conclude here, ET-FAD in WT RpalETF is more susceptible to modification and
solvent exposed thereby, BTP buffer play a dual role as a reducing agent and a nucleophile
to attack the C8 position of ET-FAD. Semi reduced form of modified amino FAD is
responsible for the CT band formation. Further, protein environment plays a role in ETFAD modification and CT band formation.
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4.6

Methods
4.6.1 T94/97A ETF Purification

Note: Same steps included in Chapter 2 were followed to purify T94/97A ETF, except
the working buffer was at pH 9.0.
The T97A/94A ETF variant of RpalETF containing an N-terminal His tag on fixB(L) and
C-terminal His tag on fixA(S) was overexpressed in Terrific Broth medium supplemented
with 20 mg/mL riboflavin, 20 mg/L adenosine 5-monophosphate (AMP), 2 mM MgSO4,
100 µg/mL of carbenicillin and 100 µg/mL of spectinomycin. Cultures were grown at 37
°C, with shaking at 250 rpm until they reached an optical density (OD) at A600 of ~1 and
then cooled to 18–20 °C. Gene expression was induced with 0.1 mM IPTG and the cultures
were grown for 20 hours at 18–20 °C. Cells were harvested by centrifugation at 11900 g
at 4 °C for 10 min. Harvested cells (10 g/L culture) were washed with PBS (phosphate
buffered saline at pH 7.4 containing 137 mM NaCl, 2.7mM KCl, 8mM Na2HPO4, and
2mM KH2PO4) and then lysed by resuspending in 80 mL of BugBuster (primary amine
free, Millipore) supplemented with 1 mM AMP, 2 µL/80 mL benzonase nuclease (HC, 250
U/µL,), 2 µL/80 mL lysozyme (30 kU/µL), 1 mM TCEP (tris(2-carboxyethyl) phosphine)
and 1 mM AEBSF (4-(2-aminoethyl)benzenesulfonyl fluoride) hydrochloride protease
inhibitor, and incubated at 4 °C with stirring for 2 hours. The insoluble fraction was
removed by centrifugation at 15, 000g for 45 min at 4 °C.
Clarified cell lysate was mixed with 1.5 mL of co-nitrilotriacetate (NTA) resin (Thermo
Fisher, Cat. No. 89966) that had been pre-equilibrated with 3 mL of equilibration buffer
containing 20 mM Tris pH 7.4, 500 mM KCl, 10% w/v glycerol and 1 mM TCEP. After a
binding interval of 30 min with gentle stirring at 4 °C, protein-bound resin was loaded into
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a column (2.5 x 30 cm) and washed with 20 x bed volumes of wash buffer containing 20
mM Tris pH 7.4, 500 mM KCl, 10% (w/v) glycerol, 1 mM TCEP and 20 mM imidazole.
Protein was eluted with 2 x bed volumes of elution buffer containing 20 mM Tris pH 7.4,
500 mM KCl, 10% (w/v) glycerol, 1 mM TCEP and 100 mM imidazole. Eluate was
subjected to buffer exchange by gel filtration on 10-DG desalting column (Bio Rad) in
order to remove the imidazole and transfer the protein to the working buffer containing 20
mM bis-Tris Propane (pH 9.0), 200 mM KCl and 10% (w/v) glycerol.
4.6.2

WT RpalETF purification

Note: Same steps included in Chapter 3 were followed to purify WT RpalETF, except the
working buffer was at pH 9.0.
Cells were grown in 1L of Terrific Broth supplemented with 20 mg/L riboflavin and 2 mM
MgSO4 along with carbenicillin (100 µg/mL), spectinomycin (100 µg/mL), and
chloramphenicol (50 µg/mL) at 37 °C, shaking at 250 rpm, to an A600 of ~1-2. After fully
cooling the culture to 18 °C, groES/EL gene expression was induced with 1 mg/mL Larabinose. After 30 min of growth, ETF gene expression was induced with 0.1 mM
isopropyl 1- thio-β-D-galactopyranoside. Cultures were then grown for an additional 20 h
at 18 °C. Cells were harvested by centrifugation at 4500 rpm, 4 °C for 30 min, and the
pellet was stored at 80 °C after washing once in PBS (10 mM Na2HPO4, 1.8 mM KH2PO4,
137 mM NaCl, 2.7 mM KCl, pH 7.4). Frozen cell pellet (~30 g) was thawed and
resuspended in 60 mL of BugBuster (EMD Millipore, Burlington, MA, USA) containing
1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride, 1 mM FAD (Chem-Impex
International, Wood Dale, IL, USA), 2 µL of Benzonase® Nuclease HC, and 2 µL of
rLysozymeTM Solution (EMD Millipore) and further incubated at 4 °C for 2 h with stirring.
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After centrifugation at 15, 000 g for 30 min at 4 °C. The resulting protein solution was
mixed with 1.5 mL of pre-equilibrated nickel-nitrilotriacetic acid resin (EMD Millipore)
and incubated at 4 °C with stirring for 30 min. Then the mixture was transferred to a column
at 4 °C. After collecting the flow-through, the column was washed with 20 column volumes
of 20 mM Tris, pH 7.8, 500 mM KCl containing 20 mM imidazole. Finally, the column
was developed with 2 column volumes of 20 mM Tris, pH 7.8, 500 mM KCl containing
100 mM imidazole, and the eluate was collected in different fractions. After SDS-PAGE
analysis, imidazole was removed from the pooled pure fractions by passage over a 10DG
column (Bio-Rad) equilibrated with 20 mM bis-Tris Propane, pH 9.0, 200 mM KCl, 10%
(w/v) glycerol. Any apoproteins were then reconstituted by overnight incubation of the
protein in 1 mM FAD at 4 °C in darkness. Excess flavin was then removed by gel filtration
on a 10DG column (above) prior to prompt use or flash-freezing in liquid nitrogen and
storage at -80 °C.
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4.6.3

Flavin Quantification:

The protein concentration (µg/mL) was determined using the Pierce 660 nm protein assay
with bovine serum albumin as the standard (Cat. No. 23208, Thermo Fisher scientific,
Waltham, MA). From this the ETF concentration was calculated based on the molecular
mass of 74, 545 Da29. In individual 1.5 mL microcentrifuge tubes 350 µL of ~30 µM ETF
in working buffer was added and wrapped in aluminum foil to exclude light and prevent
photochemical transformation of cofactors. Cofactors were released by denaturing the ETF
by heating at 100 °C for 10 min, after which denatured protein was removed by
centrifugation at 14, 000 g for 10 min after cooling the samples. Supernatant was
transferred to a quartz cuvette and the optical spectrum was recorded on a HP 8453
spectrophotometer. Absorbance at 450 nm was used to determine the released flavin
concentration (ℇ450 = 11.3 mM-1 cm-1)26.

4.6.4

Steps followed to monitor flavin modification in T94/97A ETF

Purified T94/97A ETF sample was diluted (~10 µL, this volume varies depending on the
stock concentration) in 20 mM BTP buffer at pH 9 to collect a visible spectrum with
absorbance above 0.2. Then the protein was heat denatured to release the FAD and the
absorbance of released FAD was recorded using HP 8453 spectrophotometer. Purified
protein was (~100 µM) wrapped in an Eppendorf tube with aluminum foil and incubated
at 4 °C for overnight, resulting sample was scanned to collect the optical signal, then
denatured and centrifuged to separate the soluble FAD for mass spectrometric analysis.
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4.6.5

Steps followed to monitor flavin modification in WT RpalETF
4.6.5.1 Aerobic conditions

Freshly purified WT protein in the working buffer (~300-400 µM protein) was wrapped in
an Eppendorf tube was wrapped with an aluminum foil and stored at 4 °C. 0 h indicates at
the beginning of incubation. After 52 h, 96 h, and 142 h of incubation an aliquot of protein
was removed from the incubating solution and diluted in the working buffer to record the
visible spectrum. Then this sample was heat denatured to release flavin and centrifuged to
remove the protein. The resulting released FAD was characterized by collection of an
optical spectrum.
4.6.5.2 Anaerobic conditions
A second incubation was conducted using more protein from the same purification batch.
This second incubation was conducted under unaerobic conditions to assess the
significance of O2. Approximately 400 µM of protein sample was degassed in the
antechamber of glove box (Belle Technology, Waymouth, UK) for 15 min and transferred
to the anaerobic chamber. There the protein sample was stored in a cooler at 4 °C in
darkness. At the time of transfer into the anaerobic chamber, an aliquot was removed and
diluted in the degased BTP working buffer at pH 9. The optical spectrum was collected
using a HP 8452A spectrophotometer (Agilent technologies) equipped with an OLIS
controller, housed in the anaerobic chamber. This is denoted as 0 h, likewise at 52 h, 72 h,
96 h, and 142 h, samples were collected. For all aliquots, spectra of both bound and released
FAD were collected, as detailed above.
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Similar steps were followed to monitor flavin modification under anaerobic conditions for
longer periods and samples were also collected at shorter time intervals, starting from 0 h,
3h, 6 h, 12 h, 24 h, up to 5 days. Collected aliquot volumes and final volumes after dilution
were recorded to permit correction for dilution in the spectra and flavin quantifications. All
the spectra of ETF protein were collected and compared along with the respective released
FAD spectra. In some cases, aliquots were also characterized by reductive titration.

4.6.6

Redox titration of sample collected in above time intervals.

Reductive titrations were performed in an inert atmosphere, monitored using a HP 8452A
spectrophotometer (Agilent technologies) equipped with an OLIS controller, inside a glove
box (Belle Technology, Waymouth, UK), using a 1 cm path length self-masking quartz
cuvette (Cat. No.18-Q-10-GL14-C, Starna Cells) at room temperature. At each time
interval reported in the results section, the diluted protein sample (~25 µM) was reduced
in small steps using Ti(III) citrate ( ℇ340 = 0.74 mM-1 cm-1)98.

4.6.7

ADP driven displacement of FAD.

Freshly purified WT protein (700 µM) in BTP buffer at pH 9 was stored in the anaerobic
chamber at 4 °C for 4-5 days to accumulate the 736 nm signal. About 25 µL of this material
with pre accumulated 726 nm signal was diluted with the degased working buffer to 350
µL final protein concentration is 50 µM) and the optical spectrum was collected under inert
conditions. Then 200 mM ADP was added, and optical spectra were collected every 30
min for 8-10 hours.
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4.6.8

Pink FAD sample preparation for mass spectrometric analysis.

As previously stated, concentrated WT protein sample was stored in anaerobic conditions
for 4-5 days. Then the dark green protein sample was removed from the anaerobic chamber
to heat denature the protein which was removed by centrifugation to yield dark orange
supernatant containing both flavins. The supernatant was stored in the refrigerator at 4 °C
for 2-3 days during which time pink flakes precipitated leaving a yellow liquor. Then the
precipitated pink flavin solid was isolated by decanting the yellow supernatant. The pink
solid was redissolved in HPLC grade water and mass spectrometry analysis was performed.
The mass spectrometer facility at Georgia State University. We would like to thank Dr.
Gadda and Graduate student Archana Iyer for their assistance in handling our samples.

4.6.9

Fluorometric analysis of pink FAD

The emission spectrum of a solution of the pink flavin was recorded at 20 °C using a
Thermo Fisher Lumina fluorimeter with the following parameters: excitation at λex = 490
nm, emission measured over λem = 500–700 nm, scan speed = 100 nm min-1, excitation slit
5 nm, emission slit 5 nm, gain: ‘high’, data interval: 0.5 nm, instrument zeroing conditions,
emission shutter: closed. After collection of an initial spectrum, 2 µL of 6 mU
phosphodiesterase solution was added (Abnova, cat no. P5263) to convert FAD into FMN
and AMP, thereby releasing the flavin from adenine-mediated fluorescence quenching54.
Emission spectra were recorded each minute after mixing, until no further changes are
observed using the same settings as given above54. We would like to thank Dr. Kim, from
Department of Chemistry, University of Kentucky for the access to fluorometer.
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4.6.10 1H-NMR spectroscopy
Released flavin was allowed to sit in the refrigerator for several days, until a pink
precipitate was evident. The supernatant was decanted gently, then the pink precipitate was
resuspended in D2O. Thus, the sample contained both pink flavin and residues of BTP
buffer plus KCl and glycerol. An authentic FAD sample was generated by dissolving FAD
(from Chem-Impex International, Wood Dale, IL, USA). For the pink flavin, the signal of
residual HOD was suppressed using weak presaturation as implemented in Bruker’s
noesypr1d sequence. Chemical shift was referenced vs. residual HOD at 4.7 ppm. I would
like to thank Dr. Anne-Frances Miller for running the 1H-NMR and producing the Figure
4.12.
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CHAPTER 5. FUTURE PROSPECTS
The RpalETF system is a versatile protein in which to study the fundamental requirement
for electron bifurcation. Preliminary work done in crystallographic studies helped us to
identify a buffer (ADA, pKa =6.6) in which RpalETF is stable near physiological
conditions (pH = 7). This buffer system could be utilized to study the electron bifurcation
mechanism near the physiological pH, as reported in AferETF, MelsETF, and PaeETF.
Currently the BTP buffer only allows us to work above pH 8, which is too far from the
natural environment. Also, use of a more physiological pH may help partner proteins such
as flavodoxin to bind to the RpalETF and perform the diaphorase and bifurcation assays.
Based on the chemical modification work in Chapter 4, use of pH 7 helps to eliminate the
formation of flavin derivatives and thereby permits study of the catalytic activity of the
natural form of the FADs (without any chemical modification). However, ADA could be
used as a precursor to form a flavin derivative if the protein is stored in the buffer for more
than a month. This is likely a function of the offset between the chosen pH and the buffer
pKa which together determine the extent to which the buffer amine is deprotonated.
Similarly, other buffers such as bicine, glycine, and tricine are determined to stabilize the
protein with a higher Tm value and at high pH 8-9.6. Therefore, these nucleophilic buffers
could be used as a precursor to synthesize different amino flavin derivatives. Not only the
amino buffers but also sulfhydryl and hydroxyl group containing buffers could be a
precursor, as the other ETFs is document producion of other flavin derivatives. As Gorelick
and Thorpe reported in pig ETF45 and from our work, it is evident RpalETF can incorporate
flavin analogues selectively at Domain II and engage in remarkable interactions with the
Bf-FAD. This property could be utilized to study the effect of flavin analogues, in electron
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bifurcation or to study how the protein environment tunes the interactions between the two
different flavins.
Based on the crystal structures of AferETF and human ETF, it appears that a conserved His
residue in Domain II near the flavin N1-C(2)O region stabilizes the negative charge in the
ET-flavin. Thus, in addition to the R273 we believe that H310 could be stabilizing the
quinone methide intermediate proposed to participate in the chemical modification of
flavin. To test this hypothesis, variants were created, so that the contribution of this H310
residue in the ET site can be determined. Once the CT band is accumulated, the RpalETF
protein becomes more stable than its native form. Together with the findings from current
work and previous work it appears that there has been a conformation change such that the
two FADs come in contact with one another to form the CT band. Therefore, this stable
and resting conformation could be utilized to crystalize the RpalETF.
Our findings in this work could be further extended to study the contribution of the
described Arg variants in confirmational changes. Here, we proved that the charge of the
conserved R273 enables accumulation of ASQ during reductive titration. To test whether
there are conformational changes associated with the amino acid substitution, altered E°
values and suppression of flavin modification, fluorescence emission studies on mutants
could be carried out, because Domain II can undergo extensive conformational changes.
Thus, variants created might help in determining the conformation of the RpalETF and in
characterizing confirmational changes associated with turnover.
Our data could not explain the pH dependent Bf-FAD binding and the long wavelength
absorption seen in the R165H variant at pH 8. We suspect that nearby amino acids
contribute, to specifically neutralize the His but not Lys and Arg at pH 8 and 9. Further, it
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appears that the bound FAD in R165H-RpalETF at pH 8 is the ET-FAD. Since our studies
show that ET-FAD is susceptible to chemical modification and the spectroscopic signatures
of bound and released modified FAD are not evident therefore, we can test for possible
modification using HPLC and MS analysis. However, the effect of the lower pH may
suffice to explain the non-modification of this variant at pH 8. The variant is robustly
modified at pH 9 when the Bf-FAD is also present.
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